BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roffi M, Patrono C, Collet J, Mueller C, Valgimigli M, Andreotti F, Bax JJ, Borger MA, Brotons C, Chew DP, Gencer B, Hasenfuss G, Kjeldsen K, Lancellotti P, Landmesser U, Mehilli J, Mukherjee D, Storey RF, Windecker S. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). Eur Heart J 2016;37:267-315. [DOI: 10.1093/eurheartj/ehv320] [Cited by in Crossref: 3534] [Cited by in F6Publishing: 2702] [Article Influence: 504.9] [Reference Citation Analysis]
Number Citing Articles
1 Yu XF, Li Y, Wang QC, Wang XZ, Liang M, Zhao X, Xu K, Han YL. Staged versus "one-time" multivessel intervention in elderly patients with non-ST-elevation acute coronary syndrome. J Geriatr Cardiol 2016;13:760-7. [PMID: 27899940 DOI: 10.11909/j.issn.1671-5411.2016.09.004] [Reference Citation Analysis]
2 Goorden SM, van Engelen RA, Wong LS, van der Ploeg T, Verdel GJ, Buijs MM. A novel troponin I rule-out value below the upper reference limit for acute myocardial infarction. Heart 2016;102:1721-7. [PMID: 27067356 DOI: 10.1136/heartjnl-2015-308667] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
3 Schoepf IC, Buechel RR, Kovari H, Hammoud DA, Tarr PE. Subclinical Atherosclerosis Imaging in People Living with HIV. J Clin Med 2019;8:E1125. [PMID: 31362391 DOI: 10.3390/jcm8081125] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
4 Nakano S, Otake H, Kawamori H, Toba T, Sugizaki Y, Nagasawa A, Takeshige R, Matsuoka Y, Tanimura K, Takahashi Y, Fukuyama Y, Shite J, Kozuki A, Iwasaki M, Kuroda K, Takaya T, Hirata KI. Association Between Visit-to-Visit Variability in Low-Density Lipoprotein Cholesterol and Plaque Rupture That Leads to Acute Coronary Syndrome. Circ Rep 2021;3:540-9. [PMID: 34568633 DOI: 10.1253/circrep.CR-21-0080] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Sousa-uva* M, Head SJ, Milojevic M, Collet J, Landoni G, Castella M, Dunning J, Gudbjartsson T, Linker NJ, Sandoval E, Thielmann M, Jeppsson A, Landmesser* U. 2017 EACTS Guidelines on perioperative medication in adult cardiac surgery. European Journal of Cardio-Thoracic Surgery 2018;53:5-33. [DOI: 10.1093/ejcts/ezx314] [Cited by in Crossref: 141] [Cited by in F6Publishing: 110] [Article Influence: 28.2] [Reference Citation Analysis]
6 Goodman SG, Nicolau JC, Requena G, Maguire A, Blankenberg S, Chen JY, Granger CB, Grieve R, Pocock SJ, Simon T, Yasuda S, Vega AM, Brieger D. Longer-term oral antiplatelet use in stable post-myocardial infarction patients: Insights from the long Term rIsk, clinical manaGement and healthcare Resource utilization of stable coronary artery dISease (TIGRIS) observational study. International Journal of Cardiology 2017;236:54-60. [DOI: 10.1016/j.ijcard.2017.02.062] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
7 Steg PG, Simon T. Duration of antiplatelet therapy after DES implantation: can we trust non-inferiority open-label trials? Eur Heart J 2017;38:1044-7. [PMID: 28329323 DOI: 10.1093/eurheartj/ehx110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
8 Koziński M, Ostrowska M, Adamski P, Sikora J, Sikora A, Karczmarska-Wódzka A, Marszałł MP, Boinska J, Laskowska E, Obońska E, Fabiszak T, Kubica J. Which platelet function test best reflects the in vivo plasma concentrations of ticagrelor and its active metabolite? The HARMONIC study. Thromb Haemost 2016;116:1140-9. [PMID: 27628615 DOI: 10.1160/TH16-07-0535] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
9 Mohamed MO, Rashid M, Farooq S, Siddiqui N, Parwani P, Shiers D, Thamman R, Gulati M, Shoaib A, Chew-Graham C, Mamas MA. Acute Myocardial Infarction in Severe Mental Illness: Prevalence, Clinical Outcomes, and Process of Care in U.S. Hospitalizations. Can J Cardiol 2019;35:821-30. [PMID: 31292080 DOI: 10.1016/j.cjca.2019.04.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
10 Kuno T, Ueyama H, Takagi H, Ando T, Numasawa Y, Briasoulis A, Fox J, Bangalore S. Meta-analysis of Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention. The American Journal of Cardiology 2020;125:521-7. [DOI: 10.1016/j.amjcard.2019.11.022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
11 Panovský R, Borová J, Pleva M, Feitová V, Novotný P, Kincl V, Holeček T, Meluzín J, Sochor O, Štěpánová R. The unique value of cardiovascular magnetic resonance in patients with suspected acute coronary syndrome and culprit-free coronary angiograms. BMC Cardiovasc Disord 2017;17:170. [PMID: 28659139 DOI: 10.1186/s12872-017-0610-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
12 Sanghvi KA, Montgomery M, Varghese V. Effect of hemostatic device on radial artery occlusion: A randomized comparison of compression devices in the radial hemostasis study. Cardiovascular Revascularization Medicine 2018;19:934-8. [DOI: 10.1016/j.carrev.2018.08.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
13 Wei W, Peng J, Shen T. Rosuvastatin Alleviates Ischemia/Reperfusion Injury in Cardiomyocytes by Downregulating Hsa-miR-24-3p to Target Upregulated Uncoupling Protein 2. Cell Reprogram 2019;21:99-107. [PMID: 30835496 DOI: 10.1089/cell.2018.0039] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sörensen NA, Neumann JT, Ojeda F, Giannitsis E, Spanuth E, Blankenberg S, Westermann D, Zeller T. Diagnostic Evaluation of a High-Sensitivity Troponin I Point-of-Care Assay. Clinical Chemistry 2019;65:1592-601. [DOI: 10.1373/clinchem.2019.307405] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
15 Merella P, Lorenzoni G, Saderi L, Sotgiu G, Casu G. Vascular Assisted Tracking for Challenging Transradial Percutaneous Intervention. Cardiovasc Revasc Med 2021;29:38-42. [PMID: 32896494 DOI: 10.1016/j.carrev.2020.08.007] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Su YM, Zhang R, Xu RF, Wang HL, Geng HH, Pan M, Qu YY, Zuo WJ, Ji ZJ, Ma GS. Triglyceride to high-density lipoprotein cholesterol ratio as a risk factor of repeat revascularization among patients with acute coronary syndrome after first-time percutaneous coronary intervention. J Thorac Dis 2019;11:5087-95. [PMID: 32030225 DOI: 10.21037/jtd.2019.12.26] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Alushi B, Douedari A, Froehlig G, Knie W, Wurster TH, Leistner DM, Stahli BE, Mochmann HC, Pieske B, Landmesser U, Krackhardt F, Skurk C. Impella versus IABP in acute myocardial infarction complicated by cardiogenic shock. Open Heart 2019;6:e000987. [PMID: 31218000 DOI: 10.1136/openhrt-2018-000987] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 9.7] [Reference Citation Analysis]
18 Capodanno D, Mehran R, Gibson CM, Angiolillo DJ. CSL112, a reconstituted, infusible, plasma-derived apolipoprotein A-I: safety and tolerability profiles and implications for management in patients with myocardial infarction. Expert Opinion on Investigational Drugs 2018;27:997-1005. [DOI: 10.1080/13543784.2018.1543399] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
19 Agewall S. Cardiovascular pharmacotherapy and real-world data. Eur Heart J Cardiovasc Pharmacother 2018;4:65-6. [PMID: 29554294 DOI: 10.1093/ehjcvp/pvy008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
20 Harada Y, Kastrati A. Polymer-free drug-eluting stents — a safe and effective option for ACS. Nat Rev Cardiol 2016;13:447-8. [DOI: 10.1038/nrcardio.2016.110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Goss F, Brachmann J, Hamm CW, Haerer W, Reifart N, Levenson B. High adherence to therapy and low cardiac mortality and morbidity in patients after acute coronary syndrome systematically managed by office-based cardiologists in Germany: 1-year outcomes of the ProAcor Study. Vasc Health Risk Manag 2017;13:127-37. [PMID: 28435280 DOI: 10.2147/VHRM.S119490] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.6] [Reference Citation Analysis]
22 Puddu PE, Iannetta L, Placanica A, Cuturello D, Schiariti M, Manfrini O. The role of Glycoprotein IIb/IIIa inhibitors in acute coronary syndromes and the interference with anemia. Int J Cardiol 2016;222:1091-6. [PMID: 27522492 DOI: 10.1016/j.ijcard.2016.07.207] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
23 Lemor A, Basir MB, Patel K, Kolski B, Kaki A, Kapur NK, Riley R, Finley J, Goldsweig A, Aronow HD, Belford PM, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, Lalonde T, Gorgis S, O'neill W, Lemor A, Basir MB, O'neill WW, Patel K, Kolski B, Schreiber T, Kaki A, Tehrani B, Truesdell AG, Lasorda D, Bharadwaj A, Hanson I, Almany S, Timmis S, Dixon S, Lalonde T, Attallah A, Todd J, Marso S, Wilkins C, Patel N, Senter S, Mcrae T, Rahman A, Gelormini J, Kapur N, Singh IM, Riley R, O'neill B, Overly T, Sharma R, Dupont A, Green M, Lim M, Khuddus M, Caputo C, Larkin T, Askari R, Marso S, Nsair A, Akhtar Y, Hanson I, Lin L, Mcallister D, Finley J, Goldsweig A, Park J, Gorwara S, Nazir R, Martin S, Foster M, Smith C, Rangaswamy C, Zuberi O, Federici R, Baker J, Cawich I, Korpas D, Srivastava N, Aronow HD, Schaeffer M, Wohns D, Belford PM, Mehra A, Blank N, Alraies MC, Ashbrook M, Abdel-hafez O, Khandelwal A, Alaswad K, Gorgis S, Johnson T, Hacala M. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock. JACC: Cardiovascular Interventions 2020;13:1171-8. [DOI: 10.1016/j.jcin.2020.03.012] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
24 Liu Y, Zhang C, Jiang L, Tian J, Zhao XY, Xu JJ, Liu R, Xu B, Hui RT, Gao RL, Yuan JQ, Xu LJ, Song L. Direct Bilirubin Levels Predict Long-Term Outcomes in Patients With Acute Coronary Syndrome Under Different Glucose Metabolism Status: A 6.5-Year Cohort Study of Three-Vessel Disease. Front Cardiovasc Med 2021;8:715539. [PMID: 34458340 DOI: 10.3389/fcvm.2021.715539] [Reference Citation Analysis]
25 Anderson HV, Jacob R. Assessing Performance and Quality After Non-ST Segment Elevation Acute Coronary Syndromes. Curr Cardiol Rep 2018;20:133. [PMID: 30311003 DOI: 10.1007/s11886-018-1081-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
26 Han XN, Qiao SB, Ge JB, Han YL, Chen JY, Yuan ZY, Yu B, Jiang J, Huo Y. Long-term follow-up of antithrombotic management patterns in patients with acute coronary syndrome in China. J Geriatr Cardiol 2020;17:246-55. [PMID: 32547607 DOI: 10.11909/j.issn.1671-5411.2020.05.008] [Reference Citation Analysis]
27 Pirlet C, Pierard L, Legrand V, Gach O. Ratio of high-sensitivity troponin to creatine kinase-MB in takotsubo syndrome. Int J Cardiol 2017;243:300-5. [PMID: 28595746 DOI: 10.1016/j.ijcard.2017.05.107] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
28 Montinari MR, Minelli S, De Caterina R. The first 3500 years of aspirin history from its roots – A concise summary. Vascular Pharmacology 2019;113:1-8. [DOI: 10.1016/j.vph.2018.10.008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 23] [Article Influence: 13.0] [Reference Citation Analysis]
29 Rasmussen MB, Stengaard C, Sørensen JT, Riddervold IS, Hansen TM, Giebner M, Rasmussen CH, Bøtker HE, Terkelsen CJ. Predictive value of routine point-of-care cardiac troponin T measurement for prehospital diagnosis and risk-stratification in patients with suspected acute myocardial infarction. Eur Heart J Acute Cardiovasc Care 2019;8:299-308. [PMID: 29199427 DOI: 10.1177/2048872617745893] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
30 Baris L, Hakeem A, Moe T, Cornette J, Taha N, Farook F, Gaisin I, Bonanomi C, Parsonage W, Johnson M, Hall R, Roos-Hesselink JW; ROPAC Investigators Group. Acute Coronary Syndrome and Ischemic Heart Disease in Pregnancy: Data From the EURObservational Research Programme-European Society of Cardiology Registry of Pregnancy and Cardiac Disease. J Am Heart Assoc 2020;9:e015490. [PMID: 32750301 DOI: 10.1161/JAHA.119.015490] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
31 Koziński M, Rejszel-Baranowska J, Młodawska E, Siller-Matula JM, Tomaszuk-Kazberuk A. Updated overview of evidence on optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutanous coronary intervention. Postepy Kardiol Interwencyjnej 2020;16:127-37. [PMID: 32636896 DOI: 10.5114/aic.2020.96055] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
32 González-Juanatey JR, Almendro-Delia M, Cosín-Sales J, Bellmunt-Montoya S, Gómez-Doblas JJ, Riambau V, García-Moll X, García-Alegría J, Hernández JL, Lozano FS, Suarez Fernández C. Residual risk reduction opportunities in patients with chronic coronary syndrome. Role of dual pathway inhibition. Expert Rev Clin Pharmacol 2020;13:695-706. [PMID: 32434452 DOI: 10.1080/17512433.2020.1772056] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
33 Avram A, Chioncel V, Iancu A, Guberna S, Cuciureanu I, Andrei C, Sinescu C. Wellens Sign: Monography and Single Center Experience. Maedica (Bucur) 2021;16:216-22. [PMID: 34621343 DOI: 10.26574/maedica.2021.16.2.216] [Reference Citation Analysis]
34 Moledina SM, Rashid M, Nolan J, Nakao K, Sun LY, Velagapudi P, Wilton SB, Volgman AS, Gale CP, Mamas MA. Addressing disparities of care in non-ST-segment elevation myocardial infarction patients without standard modifiable risk factors: insights from a nationwide cohort study. Eur J Prev Cardiol 2021:zwab200. [PMID: 34897399 DOI: 10.1093/eurjpc/zwab200] [Reference Citation Analysis]
35 Lee CK, Lai CL, Lee MH, Su FY, Yeh TS, Cheng LY, Hsieh MY, Wu YW, Liu YB, Wu CC. Reinforcement of patient education improved physicians' adherence to guideline-recommended medical therapy after acute coronary syndrome. PLoS One 2019;14:e0217444. [PMID: 31170175 DOI: 10.1371/journal.pone.0217444] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
36 Vicent L, Ariza-Solé A, Alegre O, Sanchís J, López-Palop R, Formiga F, González-Salvado V, Bueno H, Vidán MT, Díez-Villanueva P, Abu-Assi E, Martínez-Sellés M. Octogenarian women with acute coronary syndrome present frailty and readmissions more frequently than men. Eur Heart J Acute Cardiovasc Care 2019;8:252-63. [PMID: 30168725 DOI: 10.1177/2048872618798226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
37 Donato LJ, Wockenfus AM, Katzman BM, Baumann NA, Jaffe AS, Karon BS. Analytical and Clinical Considerations in Implementing the Roche Elecsys Troponin T Gen 5 STAT Assay. Am J Clin Pathol 2021:aqab082. [PMID: 34223873 DOI: 10.1093/ajcp/aqab082] [Reference Citation Analysis]
38 Clerico A, Zaninotto M, Aimo A, Dittadi R, Cosseddu D, Perrone M, Padoan A, Masotti S, Belloni L, Migliardi M, Fortunato A, Trenti T, Malloggi L, Cappelletti P, Galli GA, Bernardini S, Sciacovelli L, Plebani M. Use of high-sensitivity cardiac troponins in the emergency department for the early rule-in and rule-out of acute myocardial infarction without persistent ST-segment elevation (NSTEMI) in Italy. Clin Chem Lab Med 2021. [PMID: 34927403 DOI: 10.1515/cclm-2021-1085] [Reference Citation Analysis]
39 Hou J, Zhong Z, Deng Q, Lin L, Zeng X. The role of MTHFR C677T and ALDH2 Glu504Lys polymorphism in acute coronary syndrome in a Hakka population in southern China. BMC Cardiovasc Disord 2020;20:127. [PMID: 32160861 DOI: 10.1186/s12872-020-01410-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
40 Schuster A, Backhaus SJ, Stiermaier T, Navarra JL, Uhlig J, Rommel KP, Koschalka A, Kowallick JT, Bigalke B, Kutty S, Gutberlet M, Hasenfuß G, Thiele H, Eitel I. Impact of Right Atrial Physiology on Heart Failure and Adverse Events after Myocardial Infarction. J Clin Med 2020;9:E210. [PMID: 31940959 DOI: 10.3390/jcm9010210] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
41 Jiang P, Gao Z, Zhao W, Song Y, Tang X, Xu J, Wang H, Jiang L, Chen J, Qiao S, Yang Y, Gao R, Xu B, Yuan J. Prognostic Significance of In-hospital Acquired Thrombocytopenia in Stable Coronary Artery Disease Undergoing Percutaneous Coronary Intervention. Am J Med Sci 2019;358:19-25. [PMID: 31228966 DOI: 10.1016/j.amjms.2019.04.008] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
42 Kozinski M, Krintus M, Kubica J, Sypniewska G. High-sensitivity cardiac troponin assays: From improved analytical performance to enhanced risk stratification. Critical Reviews in Clinical Laboratory Sciences 2017;54:143-72. [DOI: 10.1080/10408363.2017.1285268] [Cited by in Crossref: 33] [Cited by in F6Publishing: 23] [Article Influence: 6.6] [Reference Citation Analysis]
43 Spence N, Abbott JD. Coronary Revascularization in Cardiogenic Shock. Curr Treat Options Cardio Med 2016;18. [DOI: 10.1007/s11936-015-0423-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
44 Zhou Y, Liu L, Fan F, Hong-Yun Y. Relation between elevated first SBP from baseline (delta SBP) and postoperative outcome. J Hypertens 2021;39:1982-90. [PMID: 34493696 DOI: 10.1097/HJH.0000000000002872] [Reference Citation Analysis]
45 von Knobelsdorff-Brenkenhoff F, Schulz-Menger J. Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology. J Cardiovasc Magn Reson 2016;18:6. [PMID: 26800662 DOI: 10.1186/s12968-016-0225-6] [Cited by in Crossref: 88] [Cited by in F6Publishing: 59] [Article Influence: 14.7] [Reference Citation Analysis]
46 Gerrits AJ, Jakubowski JA, Sugidachi A, Michelson AD, Frelinger AL 3rd. Incomplete reversibility of platelet inhibition following prolonged exposure to ticagrelor. J Thromb Haemost 2017;15:858-67. [PMID: 28092426 DOI: 10.1111/jth.13627] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
47 Jaffe R, Karkabi B, Goldenberg I, Shlomo N, Vorobeichik D, Zafrir B, Shiran A, Adawi S, Iakobishvili Z, Beigel R, Rubinshtein R, Flugelman MY. Avoidance of Coronary Angiography in High-Risk Patients With Acute Coronary Syndromes: The ACSIS Registry Findings. Cardiovascular Revascularization Medicine 2020;21:1230-6. [DOI: 10.1016/j.carrev.2019.12.021] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Collet J, Roffi M, Byrne RA, Costa F, Valgimigli M, Valgimigli M, Bueno H, Byrne RA, Collet J, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Badimon L, Vranckx P, Agewall S, De Luca L, Desmet W, James S, Lettino M, Mcfadden EP, Storey R, Ten Berg JM, Aboyans V, Jofresa AB, Biščević A, Calabrò P, Constantinides S, Damrina E, Diakite M, Dzudovic B, Ruiz VG, Yáñez IK, Lacalzada-almeida J, Leite L, Maskon O, Myat LL, Ricottini E, Saporito F, Wong PSC, Yamaji K, Zeitouni M; Task Force for the Management of Dual Antiplatelet Therapy in Coronary Artery Disease of the European Society of Cardiology (ESC), ESC Scientific Document Group. Case-based implementation of the 2017 ESC Focused Update on Dual Antiplatelet Therapy in Coronary Artery Disease. European Heart Journal 2018;39:e1-e33. [DOI: 10.1093/eurheartj/ehx503] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
49 Valgimigli M, Bueno H, Byrne RA, Collet J, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, Badimon L, Vranckx P, Agewall S, Andreotti F, Antman E, Barbato E, Bassand J, Bugiardini R, Cikirikcioglu M, Cuisset T, De Bonis M, Delgado V, Fitzsimons D, Gaemperli O, Galiè N, Gilard M, Hamm CW, Ibanez B, Iung B, James S, Knuuti J, Landmesser U, Leclercq C, Lettino M, Lip G, Piepoli MF, Pierard L, Schwerzmann M, Sechtem U, Simpson IA, Uva MS, Stabile E, Storey RF, Tendera M, Van de Werf F, Verheugt F, Aboyans V; ESC Scientific Document Group. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. European Journal of Cardio-Thoracic Surgery 2018;53:34-78. [DOI: 10.1093/ejcts/ezx334] [Cited by in Crossref: 116] [Cited by in F6Publishing: 93] [Article Influence: 23.2] [Reference Citation Analysis]
50 González-D'Gregorio J, Miñana G, Núñez J, Núñez E, Ruiz V, García-Blas S, Bonanad C, Mollar A, Valero E, Amiguet M, Sastre C, Sanchis J. Iron deficiency and long-term mortality in elderly patients with acute coronary syndrome. Biomark Med 2018;12:987-99. [PMID: 30043644 DOI: 10.2217/bmm-2018-0021] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
51 Eriksson D, Khoshnood A, Larsson D, Lundager-Forberg J, Mokhtari A, Ekelund U. Diagnostic Accuracy of History and Physical Examination for Predicting Major Adverse Cardiac Events Within 30 Days in Patients With Acute Chest Pain. J Emerg Med 2019:S0736-4679(19)30828-5. [PMID: 31780182 DOI: 10.1016/j.jemermed.2019.09.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
52 Liu YH, Fan HL, Zeng LH, Duan CY, Chen G, Chen PY, Zhao D, Liu J, Hao YC, He WF, Tao S, Wei XB, Jiang L, Guo W, Guo YS, Chen W, Li J, Hu YZ, Li WS, Chen YY, Luo JF, Zhou YL, Yu DQ, Han YL, Tan N, Chen JY, He PC. Association of Parenteral Anticoagulation Therapy With Outcomes in Non-ST-Segment Elevation Acute Coronary Syndrome Patients Without Invasive Therapy: Findings from the Improving Care for Cardiovascular Disease in China (CCC) project. Clin Pharmacol Ther 2021. [PMID: 34287856 DOI: 10.1002/cpt.2370] [Reference Citation Analysis]
53 Morici N, Savonitto S, Ferri LA, Grosseto D, Bossi I, Sganzerla P, Tortorella G, Cacucci M, Ferrario M, Crimi G, Murena E, Tondi S, Toso A, Gandolfo N, Ravera A, Corrada E, Mariani M, Di ascenzo L, Petronio AS, Cavallini C, Vitrella G, Antonicelli R, Piscione F, Rogacka R, Antolini L, Alicandro G, La Vecchia C, Piatti L, De Servi S. Outcomes of Elderly Patients with ST-Elevation or Non-ST-Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. The American Journal of Medicine 2019;132:209-16. [DOI: 10.1016/j.amjmed.2018.10.027] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
54 Dégano IR, Subirana I, Fusco D, Tavazzi L, Kirchberger I, Farmakis D, Ferrières J, Azevedo A, Torre M, Garel P, Brosa M, Davoli M, Meisinger C, Bongard V, Araújo C, Lekakis J, Francès A, Castell C, Elosua R, Marrugat J. Percutaneous coronary intervention reduces mortality in myocardial infarction patients with comorbidities: Implications for elderly patients with diabetes or kidney disease. International Journal of Cardiology 2017;249:83-9. [DOI: 10.1016/j.ijcard.2017.07.054] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
55 Rocca B, Husted S. Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes. Drugs Aging 2016;33:233-48. [PMID: 26941087 DOI: 10.1007/s40266-016-0359-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
56 Szummer K, Wallentin L, Lindhagen L, Alfredsson J, Erlinge D, Held C, James S, Kellerth T, Lindahl B, Ravn-Fischer A, Rydberg E, Yndigegn T, Jernberg T. Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995-2014. Eur Heart J 2017;38:3056-65. [PMID: 29020314 DOI: 10.1093/eurheartj/ehx515] [Cited by in Crossref: 154] [Cited by in F6Publishing: 121] [Article Influence: 38.5] [Reference Citation Analysis]
57 Olivari Z, Chinaglia A, Gonzini L, Falsini G, Pilleri A, Valente S, Gregori G, Rollo R, My L, Scrimieri P, Lanzillo T, Corrado L, Chiti M, Picardi E; BLITZ 4 Investigators. Invasive strategy in non-ST-segment elevation acute coronary syndrome: What should be the benchmark target in the real world patients? Insights from BLITZ-4 Quality Campaign. Int J Cardiol 2016;220:761-7. [PMID: 27393863 DOI: 10.1016/j.ijcard.2016.06.089] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
58 Leistner DM, Kränkel N, Meteva D, Abdelwahed YS, Seppelt C, Stähli BE, Rai H, Skurk C, Lauten A, Mochmann HC, Fröhlich G, Rauch-Kröhnert U, Flores E, Riedel M, Sieronski L, Kia S, Strässler E, Haghikia A, Dirks F, Steiner JK, Mueller DN, Volk HD, Klotsche J, Joner M, Libby P, Landmesser U. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur Heart J 2020;41:3549-60. [PMID: 33080003 DOI: 10.1093/eurheartj/ehaa703] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 17.0] [Reference Citation Analysis]
59 Storey RF, Angiolillo DJ, Bonaca MP, Thomas MR, Judge HM, Rollini F, Franchi F, Ahsan AJ, Bhatt DL, Kuder JF, Steg PG, Cohen M, Muthusamy R, Braunwald E, Sabatine MS. Platelet Inhibition With Ticagrelor 60 mg Versus 90 mg Twice Daily in the PEGASUS-TIMI 54 Trial. Journal of the American College of Cardiology 2016;67:1145-54. [DOI: 10.1016/j.jacc.2015.12.062] [Cited by in Crossref: 74] [Cited by in F6Publishing: 69] [Article Influence: 12.3] [Reference Citation Analysis]
60 Díez-Villanueva P, Méndez CJ, Alfonso F. Non-ST elevation acute coronary syndrome in the elderly. J Geriatr Cardiol 2020;17:9-15. [PMID: 32133032 DOI: 10.11909/j.issn.1671-5411.2020.01.009] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
61 Çetinkal G, Koçaş C, Balaban Koçaş B, Arslan Ş, Abacı O, Karaca OŞ, Dalgıç Y, Ser ÖS, Keskin K, Yıldız A, Doğan SM. Comparative performance of AnTicoagulation and Risk factors In Atrial fibrillation and Global Registry of Acute Coronary Events risk scores in predicting long-term adverse events in patients with acute myocardial infarction. Anatol J Cardiol 2018;20:77-84. [PMID: 30088481 DOI: 10.14744/AnatolJCardiol.2018.54815] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
62 Barbarawi M, Kheiri B, Zayed Y, Barbarawi O, Chahine A, Haykal T, Kanugula AK, Bachuwa G, Alkotob ML, Bhatt DL. Meta‐analysis of optimal timing of coronary intervention in non‐ST‐elevation acute coronary syndrome. Catheter Cardiovasc Interv 2019;95:185-93. [DOI: 10.1002/ccd.28280] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
63 García Rodríguez LA, Cea Soriano L, de Abajo FJ, Valent F, Hallas J, Gil M, Cattaruzzi C, Rodriguez-Martin S, Vora P, Soriano-Gabarró M, Gaist D. Trends in the use of oral anticoagulants, antiplatelets and statins in four European countries: a population-based study. Eur J Clin Pharmacol 2021. [PMID: 34791521 DOI: 10.1007/s00228-021-03250-6] [Reference Citation Analysis]
64 Zhang J, Yu Y, Pan L, Yu T, Luo G. C Deletion at the re74650330 Locus of the SLC39A8 Gene (rs74650330) Increases the Risk of Coronary Artery Disease in Individuals with Low-Density Lipoprotein Cholesterol Levels. Genet Test Mol Biomarkers 2021;25:660-7. [PMID: 34672770 DOI: 10.1089/gtmb.2021.0083] [Reference Citation Analysis]
65 Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China. Cardiovasc Diabetol 2020;19:108. [PMID: 32641127 DOI: 10.1186/s12933-020-01086-5] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
66 Regan B, Boyle F, O'Kennedy R, Collins D. Evaluation of Molecularly Imprinted Polymers for Point-of-Care Testing for Cardiovascular Disease. Sensors (Basel) 2019;19:E3485. [PMID: 31395843 DOI: 10.3390/s19163485] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
67 Allahyari A, Jernberg T, Lautsch D, Lundman P, Hagström E, Schubert J, Boggs R, Salomonsson S, Ueda P. Low-density lipoprotein-cholesterol target attainment according to the 2011 and 2016 ESC/EAS dyslipidaemia guidelines in patients with a recent myocardial infarction: nationwide cohort study, 2013-17. Eur Heart J Qual Care Clin Outcomes 2021;7:59-67. [PMID: 32142112 DOI: 10.1093/ehjqcco/qcaa016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
68 de Silva R, Steg PG. Identifying patients with acute total coronary occlusion in NSTEACS: finding the high-risk needle in the haystack. European Heart Journal 2017;38:3090-3. [DOI: 10.1093/eurheartj/ehx520] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
69 Rathod KS, Koganti S, Iqbal MB, Jain AK, Kalra SS, Astroulakis Z, Lim P, Rakhit R, Dalby MC, Lockie T, Malik IS, Knight CJ, Whitbread M, Mathur A, Redwood S, Maccarthy PA, Sirker A, O’mahony C, Wragg A, Jones DA. Contemporary trends in cardiogenic shock: Incidence, intra-aortic balloon pump utilisation and outcomes from the London Heart Attack Group. European Heart Journal: Acute Cardiovascular Care 2018;7:16-27. [DOI: 10.1177/2048872617741735] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 10.4] [Reference Citation Analysis]
70 Adamo M, Curello S, Chiari E, Fiorina C, Chizzola G, Magatelli M, Locantore E, Cuminetti G, Lombardi C, Manzato A, Metra M, Ettori F. Percutaneous edge-to-edge mitral valve repair for the treatment of acute mitral regurgitation complicating myocardial infarction: A single centre experience. International Journal of Cardiology 2017;234:53-7. [DOI: 10.1016/j.ijcard.2017.02.072] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
71 Augustine DX, Keteepe-Arachi T, Malhotra A. Coronavirus Disease 2019: Cardiac Complications and Considerations for Returning to Sports Participation. Eur Cardiol 2021;16:e03. [PMID: 33708264 DOI: 10.15420/ecr.2020.36] [Reference Citation Analysis]
72 Sörensen NA, Neumann JT, Ojeda F, Schäfer S, Magnussen C, Keller T, Lackner KJ, Zeller T, Karakas M, Münzel T, Blankenberg S, Westermann D, Schnabel RB. Relations of Sex to Diagnosis and Outcomes in Acute Coronary Syndrome. J Am Heart Assoc 2018;7:e007297. [PMID: 29525782 DOI: 10.1161/JAHA.117.007297] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 4.3] [Reference Citation Analysis]
73 Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/American College of Cardiology (ACC)/American Heart Association (AHA)/World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction (2018). J Am Coll Cardiol. 2018;72:2231-2264. [PMID: 30153967 DOI: 10.1016/j.jacc.2018.08.1038] [Cited by in Crossref: 797] [Cited by in F6Publishing: 662] [Article Influence: 199.3] [Reference Citation Analysis]
74 Garcia-Osuna A, Gaze D, Grau-Agramunt M, Morris T, Telha C, Bartolome A, Bishop JJ, Monsalve L, Livingston R, Estis J, Nolan N, Sandlund J, Ordonez-Llanos J. Ultrasensitive quantification of cardiac troponin I by a Single Molecule Counting method: analytical validation and biological features. Clin Chim Acta 2018;486:224-31. [PMID: 30110608 DOI: 10.1016/j.cca.2018.08.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.8] [Reference Citation Analysis]
75 Möckel M. [Biomarkers in the diagnosis of cardiovascular emergencies : Acute coronary syndrome and differential diagnoses]. Internist (Berl) 2019;60:564-70. [PMID: 31062038 DOI: 10.1007/s00108-019-0620-9] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
76 Gimbel ME, Ten Berg JM. Management of elderly patients with a non-ST-segment-elevation acute coronary syndrome. Neth Heart J 2017;25:409-15. [PMID: 28516369 DOI: 10.1007/s12471-017-1002-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
77 Tabata N, Weber M, Sugiura A, Ishii M, Öztürk C, Tsujita K, Sinning JM, Werner N, Nickenig G. Impact of combined baseline and postprocedural troponin values on clinical outcome following the MitraClip procedure. Catheter Cardiovasc Interv 2020;96:E735-43. [PMID: 32212302 DOI: 10.1002/ccd.28869] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
78 Brennan PF, McNeil AJ, Jing M, Awuah A, Moore JS, Mailey J, Finlay DD, Blighe K, McLaughlin JAD, Nesbit MA, Trucco E, Moore TCB, Spence MS. Assessment of the conjunctival microcirculation for patients presenting with acute myocardial infarction compared to healthy controls. Sci Rep 2021;11:7660. [PMID: 33828174 DOI: 10.1038/s41598-021-87315-7] [Reference Citation Analysis]
79 Alexopoulos D, Xanthopoulou I, Moulias A, Lekakis J. Long-Term P2Y12-Receptor Antagonists in Post-Myocardial Infarction Patients. Journal of the American College of Cardiology 2016;68:1223-32. [DOI: 10.1016/j.jacc.2016.05.088] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
80 Aarsetøy R, Aarsetøy H, Hagve TA, Strand H, Staines H, Nilsen DWT. Initial Phase NT-proBNP, but Not Copeptin and High-Sensitivity Cardiac Troponin-T Yielded Diagnostic and Prognostic Information in Addition to Clinical Assessment of Out-of-Hospital Cardiac Arrest Patients With Documented Ventricular Fibrillation. Front Cardiovasc Med 2018;5:44. [PMID: 29930943 DOI: 10.3389/fcvm.2018.00044] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
81 Lucreziotti S, Persampieri S, Belletti S, Carugo S. Coronary artery disease or hypertrophic cardiomyopathy? Show me the ventricle! Minerva Cardioangiol 2019;67:489-91. [PMID: 31633316 DOI: 10.23736/S0026-4725.19.05056-4] [Reference Citation Analysis]
82 Sim DS, Jeong MH, Kim HS, Gwon HC, Seung KB, Rha SW, Chae SC, Kim CJ, Cha KS, Park JS, Yoon JH, Chae JK, Joo SJ, Choi DJ, Hur SH, Seong IW, Cho MC, Kim DI, Oh SK, Ahn TH, Hwang JY. Utility of GRACE and ACUITY-HORIZONS risk scores to guide dual antiplatelet therapy in Korean patients with acute myocardial infarction undergoing drug-eluting stenting. Journal of Cardiology 2018;72:411-9. [DOI: 10.1016/j.jjcc.2018.04.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
83 Dahl Aarvik M, Sandven I, Dondo TB, Gale CP, Ruddox V, Munkhaugen J, Atar D, Otterstad JE. Effect of oral β-blocker treatment on mortality in contemporary post-myocardial infarction patients: a systematic review and meta-analysis. Eur Heart J Cardiovasc Pharmacother 2019;5:12-20. [PMID: 30192930 DOI: 10.1093/ehjcvp/pvy034] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
84 Watti H, Dahal K, Zabher HG, Katikaneni P, Modi K, Abdulbaki A. Comparison of prasugrel and ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized and non-randomized studies. International Journal of Cardiology 2017;249:66-72. [DOI: 10.1016/j.ijcard.2017.07.103] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
85 Dai B, Wang F, Nie X, Du H, Zhao Y, Yin Z, Li H, Fan J, Wen Z, Wang DW, Chen C. The Cell Type-Specific Functions of miR-21 in Cardiovascular Diseases. Front Genet 2020;11:563166. [PMID: 33329700 DOI: 10.3389/fgene.2020.563166] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
86 Schäfer A, Werner N, Westenfeld R, Møller JE, Schulze PC, Karatolios K, Pappalardo F, Maly J, Staudacher D, Lebreton G, Delmas C, Hunziker P, Fritzenwanger M, Napp LC, Ferrari M, Tarantini G. Clinical scenarios for use of transvalvular microaxial pumps in acute heart failure and cardiogenic shock - A European experienced users working group opinion. Int J Cardiol 2019;291:96-104. [PMID: 31155332 DOI: 10.1016/j.ijcard.2019.05.044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
87 Liu X, Xu X, Chu Y, Ren Y, Wang L. Zofenopril versus ramipril in the early phase of acute myocardial infarction with systolic dysfunction: A retrospective study. J Renin Angiotensin Aldosterone Syst 2020;21:1470320320946530. [PMID: 32883157 DOI: 10.1177/1470320320946530] [Reference Citation Analysis]
88 Bouget J, Balusson F, Viglino D, Roy PM, Lacut K, Pavageau L, Oger E. Major bleeding risk and mortality associated with antiplatelet drugs in real-world clinical practice. A prospective cohort study. PLoS One 2020;15:e0237022. [PMID: 32764775 DOI: 10.1371/journal.pone.0237022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
89 Li X, Wang Z, Wang Q, Xu Q, Lv Q. Clopidogrel-associated genetic variants on inhibition of platelet activity and clinical outcome for acute coronary syndrome patients. Basic Clin Pharmacol Toxicol 2019;124:84-93. [PMID: 30098132 DOI: 10.1111/bcpt.13110] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
90 Cespón-Fernández M, Raposeiras-Roubín S, Abu-Assi E, Pousa IM, Queija BC, Paz RJC, Erquicia PD, Rodríguez LMD, Rodríguez EL, Busto MC, Barbeira SF, Romo AÍ. Angiotensin-Converting Enzyme Inhibitors Versus Angiotensin II Receptor Blockers in Acute Coronary Syndrome and Preserved Ventricular Ejection Fraction. Angiology 2020;71:886-93. [PMID: 32757765 DOI: 10.1177/0003319720946971] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
91 Komiyama K, Nakamura M, Tanabe K, Niikura H, Fujimoto H, Oikawa K, Daida H, Yamamoto T, Nagao K, Takayama M; Tokyo CCU Network Scientific Committee. In-hospital mortality analysis of Japanese patients with acute coronary syndrome using the Tokyo CCU Network database: Applicability of the GRACE risk score. J Cardiol 2018;71:251-8. [PMID: 29102289 DOI: 10.1016/j.jjcc.2017.09.006] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
92 Wadowski PP, Pultar J, Weikert C, Eichelberger B, Panzer B, Huber K, Lang IM, Koppensteiner R, Panzer S, Gremmel T. Protease-activated receptor-mediated platelet aggregation in acute coronary syndrome patients on potent P2Y12 inhibitors. Res Pract Thromb Haemost 2019;3:383-90. [PMID: 31294325 DOI: 10.1002/rth2.12213] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
93 Kalyoncuoglu M, Durmus G. Relationship between C-reactive protein-to-albumin ratio and the extent of coronary artery disease in patients with non-ST-elevated myocardial infarction. Coronary Artery Disease 2020;31:130-6. [DOI: 10.1097/mca.0000000000000768] [Cited by in Crossref: 14] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
94 Task Force for the management of COVID-19 of the European Society of Cardiology . ESC guidance for the diagnosis and management of cardiovascular disease during the COVID-19 pandemic: part 2-care pathways, treatment, and follow-up. Cardiovasc Res 2021:cvab343. [PMID: 34864876 DOI: 10.1093/cvr/cvab343] [Reference Citation Analysis]
95 Savonitto S, Ferri LA, Piatti L, Grosseto D, Piovaccari G, Morici N, Bossi I, Sganzerla P, Tortorella G, Cacucci M, Ferrario M, Murena E, Sibilio G, Tondi S, Toso A, Bongioanni S, Ravera A, Corrada E, Mariani M, Di Ascenzo L, Petronio AS, Cavallini C, Vitrella G, Rogacka R, Antonicelli R, Cesana BM, De Luca L, Ottani F, De Luca G, Piscione F, Moffa N, De Servi S, Bolognese L, Bovenzi F, Steffenino G, Santilli I, Bassanelli G, Sacco A, Canziani F, Ferri M, Lo Jacono E, Canosi U, Fornaro G, Leoncini M, Rosa Conte M, Farina R, Stefanin C, Di Pede F, Chella P, Chiara Nardoni M, Tamburrini P, Trimarco B, Galasso G, Elia R, Bolognese L, Grotti S, Bovenzi F, Borrelli L, Tamburino C, Capranzano P, Francaviglia B, Campana C, Bonatti R, Martinoni A, Abate F, Coscarelli S, Rubartelli P, Villani GQ, Rossini R. Comparison of Reduced-Dose Prasugrel and Standard-Dose Clopidogrel in Elderly Patients With Acute Coronary Syndromes Undergoing Early Percutaneous Revascularization. Circulation 2018;137:2435-45. [DOI: 10.1161/circulationaha.117.032180] [Cited by in Crossref: 62] [Cited by in F6Publishing: 11] [Article Influence: 15.5] [Reference Citation Analysis]
96 Bisceglia I, Canale ML, Lestuzzi C, Parrini I, Russo G, Colivicchi F, Gabrielli D, Gulizia MM, Iliescu CA; on the behalf of ANMCO Cardio-Oncology Task Force. Acute coronary syndromes in cancer patients. J Cardiovasc Med (Hagerstown) 2020;21:944-52. [PMID: 32520859 DOI: 10.2459/JCM.0000000000000993] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
97 Lorusso R, Whitman G, Milojevic M, Raffa G, McMullan DM, Boeken U, Haft J, Bermudez CA, Shah AS, D'Alessandro DA. 2020 EACTS/ELSO/STS/AATS Expert Consensus on Post-cardiotomy Extracorporeal Life Support in Adult Patients. ASAIO J 2021;67:e1-e43. [PMID: 33021558 DOI: 10.1097/MAT.0000000000001301] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Burlacu A, Genovesi S, Goldsmith D, Rossignol P, Ortiz A, Kalra PA, Małyszko J, Banach M, Kanbay M, Covic A. Bleeding in advanced CKD patients on antithrombotic medication - A critical appraisal. Pharmacol Res 2018;129:535-43. [PMID: 29208494 DOI: 10.1016/j.phrs.2017.12.004] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
99 Åkerblom A, Wojdyla DM, Wallentin L, James SK, de Souza Brito F, Steg PG, Cannon CP, Katus HA, Himmelmann A, Storey RF, Becker RC, Lopes RD; PLATO Investigators. Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial. Am Heart J 2019;213:57-65. [PMID: 31108273 DOI: 10.1016/j.ahj.2019.04.006] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
100 Noble S. Radial Access in Patients Invasively Treated for Acute Coronary Syndromes: A Lifesaving Approach. JACC Cardiovasc Interv 2016;9:671-3. [PMID: 27056304 DOI: 10.1016/j.jcin.2016.02.008] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
101 Keller K, Hobohm L, Münzel T, Ostad MA. Sex-specific differences regarding seasonal variations of incidence and mortality in patients with myocardial infarction in Germany. Int J Cardiol 2019;287:132-8. [PMID: 31005418 DOI: 10.1016/j.ijcard.2019.04.035] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
102 Haj-Yehia E, Mertens RW, Kahles F, Rückbeil MV, Rau M, Moellmann J, Biener M, Almalla M, Schroeder J, Giannitsis E, Katus HA, Marx N, Lehrke M. Peptide YY (PYY) Is Associated with Cardiovascular Risk in Patients with Acute Myocardial Infarction. J Clin Med 2020;9:E3952. [PMID: 33291235 DOI: 10.3390/jcm9123952] [Reference Citation Analysis]
103 Toya T, Kagami K, Adachi T. Friend or foe: food-dependent exercise-induced anaphylaxis associated with acute coronary syndrome aggravated by adrenaline and aspirin: a case report. Eur Heart J Case Rep 2019;3:ytz143. [PMID: 31660504 DOI: 10.1093/ehjcr/ytz143] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
104 Shi Y, Zhu C, Jiang R, Zhang M, Cai H, Hu Z, Sun H, Liu Y, Ye Y, Ma Y, Cao X, von Känel R, Li J. Job burnout is associated with slow improvement of quality of life in the employees after a first episode of acute coronary syndrome: A hospital-based longitudinal study in China. J Psychosom Res 2021;152:110690. [PMID: 34896702 DOI: 10.1016/j.jpsychores.2021.110690] [Reference Citation Analysis]
105 Dekker M, Waissi F, van Bennekom J, Silvis MJM, Timmerman N, Schoneveld AH, Grobbee DE, de Winter RJ, Mosterd A, Timmers L, de Kleijn DPV. Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain. PLoS One 2020;15:e0237036. [PMID: 32756583 DOI: 10.1371/journal.pone.0237036] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
106 Lan NSR, Nguyen LT, Vasikaran SD, Wilson C, Jonsson J, Rankin JM, Bell DA. Short- and long-term biological variation of cardiac troponin I in healthy individuals, and patients with end-stage renal failure requiring haemodialysis or cardiomyopathy. Clin Chem Lab Med 2020;58:1941-9. [PMID: 32598297 DOI: 10.1515/cclm-2020-0046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
107 Mezger STP, Mingels AMA, Bekers O, Cillero-Pastor B, Heeren RMA. Trends in mass spectrometry imaging for cardiovascular diseases. Anal Bioanal Chem 2019;411:3709-20. [PMID: 30980090 DOI: 10.1007/s00216-019-01780-8] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 5.7] [Reference Citation Analysis]
108 Das D, Asher A, Ghosh AK. Cancer and Coronary Artery Disease: Common Associations, Diagnosis and Management Challenges. Curr Treat Options in Oncol 2019;20. [DOI: 10.1007/s11864-019-0644-3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
109 Choudhury T, West NE, El-Omar M. ST elevation myocardial infarction. Clin Med (Lond) 2016;16:277-82. [PMID: 27251920 DOI: 10.7861/clinmedicine.16-3-277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
110 Macaya F, Salinas P, Gonzalo N, Fernández-Ortiz A, Macaya C, Escaned J. Spontaneous coronary artery dissection: contemporary aspects of diagnosis and patient management. Open Heart 2018;5:e000884. [PMID: 30487978 DOI: 10.1136/openhrt-2018-000884] [Cited by in Crossref: 24] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
111 Gasior M, Gierlotka M, Pyka Ł, Zdrojewski T, Wojtyniak B, Chlebus K, Rozentryt P, Niedziela J, Jankowski P, Nessler J, Opolski G, Hoffman P, Jankowska E, Polonski L, Ponikowski P. Temporal trends in secondary prevention in myocardial infarction patients discharged with left ventricular systolic dysfunction in Poland. Eur J Prev Cardiolog 2018;25:960-9. [DOI: 10.1177/2047487318770830] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
112 Giannitsis E, Katus HA. Troponins: established and novel indications in the management of cardiovascular disease. Heart 2018;104:1714-22. [PMID: 29724751 DOI: 10.1136/heartjnl-2017-311387] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
113 Yang YL, Xiang ZJ, Yang JH, Wang WJ, Xu ZC, Xiang RL. Association of β-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: a systematic review and meta-analysis. Eur Heart J 2020;41:4415-22. [PMID: 33211823 DOI: 10.1093/eurheartj/ehaa793] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 15.0] [Reference Citation Analysis]
114 Vigen R, Kutscher P, Fernandez F, Yu A, Bertulfo B, Hashim IA, Molberg K, Diercks DB, Metzger JC, Soto J, Alzubaidy D, Thibodeaux L, Joglar JA, de Lemos JA, Das SR. Evaluation of a Novel Rule-Out Myocardial Infarction Protocol Incorporating High-Sensitivity Troponin T in a US Hospital. Circulation 2018;138:2061-3. [DOI: 10.1161/circulationaha.118.033861] [Cited by in Crossref: 22] [Cited by in F6Publishing: 5] [Article Influence: 5.5] [Reference Citation Analysis]
115 Janssen PWA, Claassens DMF, Willemsen LM, Bergmeijer TO, Klein P, Ten Berg JM. Perioperative management of antiplatelet treatment in patients undergoing isolated coronary artery bypass grafting in Dutch cardiothoracic centres. Neth Heart J 2017;25:482-9. [PMID: 28612281 DOI: 10.1007/s12471-017-1006-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
116 He P, Luo X, Li J, Li Y, Wang X, Huang L, Jin J, Han Y. Clinical Outcome between Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndrome and Diabetes. Cardiovasc Ther 2021;2021:5546260. [PMID: 34737792 DOI: 10.1155/2021/5546260] [Reference Citation Analysis]
117 Kupka D, Sibbing D. De-Escalation of P2Y12 Receptor Inhibitor Therapy after Acute Coronary Syndromes in Patients Undergoing Percutaneous Coronary Intervention. Korean Circ J 2018;48:863-72. [PMID: 30238704 DOI: 10.4070/kcj.2018.0255] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
118 Ilardi F, Gargiulo G, Paolillo R, Ferrone M, Cimino S, Giugliano G, Schiattarella GG, Verde N, Stabile E, Perrino C, Cirillo P, Coscioni E, Morisco C, Esposito G. Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome. J Cardiovasc Med (Hagerstown) 2020;21:660-6. [PMID: 32520854 DOI: 10.2459/JCM.0000000000000981] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
119 Phan DQ, Rostomian AH, Schweis F, Chung J, Lin B, Zadegan R, Lee M. Revascularization Versus Medical Therapy in Patients Aged 80 Years and Older with Acute Myocardial Infarction. J Am Geriatr Soc 2020;68:2525-33. [DOI: 10.1111/jgs.16747] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
120 Schulte C, Zeller T. Biomarkers in primary prevention : Meaningful diagnosis based on biomarker scores? Herz 2020;45:10-6. [PMID: 31807790 DOI: 10.1007/s00059-019-04874-2] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
121 Traby L, Kollars M, Kaider A, Siller-Matula JM, Steinbrecher O, Wolzt M, Kyrle PA, Eichinger S. Differential Effects of Clopidogrel With or Without Aspirin on Platelet Reactivity and Coagulation Activation: A Randomized Trial in Healthy Volunteers. Clin Pharmacol Ther 2021;109:1546-54. [PMID: 33141921 DOI: 10.1002/cpt.2106] [Reference Citation Analysis]
122 Va Den Berg P, Burrows G, Lewis P, Carley S, Body R. Validation of the (Troponin-only) Manchester ACS decision aid with a contemporary cardiac troponin I assay. Am J Emerg Med 2018;36:602-7. [PMID: 29079376 DOI: 10.1016/j.ajem.2017.09.032] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
123 Ma W, Gao S, Huang S, Yuan J, Yu M. Hyperuricemia as a prognostic marker for long-term outcomes in patients with myocardial infarction with nonobstructive coronary arteries. Nutr Metab (Lond) 2021;18:107. [PMID: 34930343 DOI: 10.1186/s12986-021-00636-2] [Reference Citation Analysis]
124 Zheng B, Huo Y, Lee SW, Sawhney JPS, Kim HS, Krittayaphong R, Pocock SJ, Nhan VT, Alonso Garcia A, Chin CT, Jiang J, Jan S, Vega AM, Hayashi N, Ong TK. Long-term antithrombotic management patterns in Asian patients with acute coronary syndrome: 2-year observations from the EPICOR Asia study. Clin Cardiol 2020;43:999-1008. [PMID: 32618009 DOI: 10.1002/clc.23400] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
125 Bordejevic DA, Pârvănescu T, Petrescu L, Mornoș C, Olariu I, Crișan S, Văcărescu C, Lazăr M, Morariu VI, Citu IM, Tomescu MC, Cozma D. Left Ventricular Remodeling Risk Predicted by Two-Dimensional Speckle Tracking Echocardiography in Acute Myocardial Infarction Patients with Midrange or Preserved Ejection Fraction in Western Romania. Ther Clin Risk Manag 2021;17:249-58. [PMID: 33790565 DOI: 10.2147/TCRM.S295251] [Reference Citation Analysis]
126 Rashid M, Lawson C, Potts J, Kontopantelis E, Kwok CS, Bertrand OF, Shoaib A, Ludman P, Kinnaird T, de Belder M, Nolan J, Mamas MA. Incidence, Determinants, and Outcomes of Left and Right Radial Access Use in Patients Undergoing Percutaneous Coronary Intervention in the United Kingdom: A National Perspective Using the BCIS Dataset. JACC Cardiovasc Interv 2018;11:1021-33. [PMID: 29778726 DOI: 10.1016/j.jcin.2018.01.252] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
127 Shoaib A, Mohamed M, Rashid M, Khan SU, Parwani P, Contractor T, Shaikh H, Ahmed W, Fahy E, Prior J, Fischman D, Bagur R, Mamas MA. Clinical Characteristics, Management Strategies and Outcomes of Acute Myocardial Infarction Patients With Prior Coronary Artery Bypass Grafting. Mayo Clin Proc 2021;96:120-31. [PMID: 33413807 DOI: 10.1016/j.mayocp.2020.05.047] [Reference Citation Analysis]
128 Gilhofer TS, Saw J. Spontaneous coronary artery dissection: a review of complications and management strategies. Expert Review of Cardiovascular Therapy 2019;17:275-91. [DOI: 10.1080/14779072.2019.1598261] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
129 Sörensen NA, Nikorowitsch J, Neumann JT, Rübsamen N, Goßling A, Hartikainen TS, Blankenberg S, Westermann D, Zeller T, Karakas M. Predictive value of soluble urokinase-type plasminogen activator receptor for mortality in patients with suspected myocardial infarction. Clin Res Cardiol 2019;108:1386-93. [PMID: 30989318 DOI: 10.1007/s00392-019-01475-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
130 Shah R, Askari R, Haji SA, Rashid A. Mortality and operator experience with vascular access for percutaneous coronary intervention in patients with acute coronary syndromes: A pairwise and network meta-analysis of randomized controlled trials. Int J Cardiol 2017;248:114-9. [PMID: 28942869 DOI: 10.1016/j.ijcard.2017.05.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
131 Vogel B, Baber U. Antiplatelet treatments: recent evidence from randomized controlled trials. Current Opinion in Cardiology 2017;32:356-62. [DOI: 10.1097/hco.0000000000000416] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
132 Sim DS, Jeong MH, Ahn Y, Kim YJ, Chae SC, Hong TJ, Seong IW, Chae JK, Kim CJ, Cho MC, Rha SW, Bae JH, Seung KB, Park SJ; other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators. Clinical impact of immediate invasive strategy in patients with non-ST-segment elevation myocardial infarction. Int J Cardiol 2016;221:937-43. [PMID: 27441472 DOI: 10.1016/j.ijcard.2016.07.128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
133 Vasile VC, Jaffe AS. High-Sensitivity Cardiac Troponin for the Diagnosis of Patients with Acute Coronary Syndromes. Curr Cardiol Rep 2017;19. [DOI: 10.1007/s11886-017-0904-4] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
134 Morais J, De Caterina R. Stroke Prevention in Atrial Fibrillation: A Clinical Perspective on Trials of the Novel Oral Anticoagulants. Cardiovasc Drugs Ther 2016;30:201-14. [PMID: 26780749 DOI: 10.1007/s10557-015-6632-3] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 3.2] [Reference Citation Analysis]
135 Blin P, Philippe F, Bouée S, Laurendeau C, Torreton E, Gourmelin J, Leproust S, Levy-bachelot L, Steg PG. Outcomes following acute hospitalised myocardial infarction in France: An insurance claims database analysis. International Journal of Cardiology 2016;219:387-93. [DOI: 10.1016/j.ijcard.2016.06.102] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]
136 Reyentovich A, Barghash MH, Hochman JS. Management of refractory cardiogenic shock. Nat Rev Cardiol 2016;13:481-92. [DOI: 10.1038/nrcardio.2016.96] [Cited by in Crossref: 64] [Cited by in F6Publishing: 53] [Article Influence: 10.7] [Reference Citation Analysis]
137 Lettino M. Long-term treatment with NAO in acute coronary syndromes: rationale and clinical data. J Cardiovasc Med (Hagerstown) 2017;18 Suppl 1:e129-33. [PMID: 28240991 DOI: 10.2459/JCM.0000000000000456] [Reference Citation Analysis]
138 Chang CC, Chichareon P, Modolo R, Takahashi K, Kogame N, Tomaniak M, Gao C, Royaards K, Cequier A, Oldroyd K, Steg PG, Hamm C, Jüni P, Valgimigli M, Windecker S, Onuma Y, Stables RH, Jan van Geuns R, Serruys PW. Association between post-percutaneous coronary intervention bivalirudin infusion and net adverse clinical events: a post hoc analysis of the GLOBAL LEADERS study. European Heart Journal - Cardiovascular Pharmacotherapy 2020;6:22-30. [DOI: 10.1093/ehjcvp/pvz051] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
139 Bugiardini R, Badimon L. The International Survey of Acute Coronary Syndromes in Transitional Countries (ISACS-TC): 2010–2015. International Journal of Cardiology 2016;217:S1-6. [DOI: 10.1016/j.ijcard.2016.06.219] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
140 Schiavone M, Gobbi C, Biondi-Zoccai G, D'Ascenzo F, Palazzuoli A, Gasperetti A, Mitacchione G, Viecca M, Galli M, Fedele F, Mancone M, Forleo GB. Acute Coronary Syndromes and Covid-19: Exploring the Uncertainties. J Clin Med 2020;9:E1683. [PMID: 32498230 DOI: 10.3390/jcm9061683] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 12.5] [Reference Citation Analysis]
141 Mueller C, Twerenbold R, Reichlin T. Early Diagnosis of Myocardial Infarction with Sensitive Cardiac Troponin Assays. Clinical Chemistry 2019;65:490-1. [DOI: 10.1373/clinchem.2018.298638] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
142 Villablanca PA, Olmedo W, Weinreich M, Gupta T, Mohananey D, Albuquerque FN, Kassas I, Briceño D, Sanina C, Brevik TA, Ong E, Ramakrishna H, Attubato M, Menegus M, Wiley J, Kalra A. Staged Percutaneous Intervention for Concurrent Chronic Total Occlusions in Patients With ST-Segment-Elevation Myocardial Infarction: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018;7:e008415. [PMID: 29654206 DOI: 10.1161/JAHA.117.008415] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
143 Riccio C Coordinator, Gulizia MM Facc Fesc Coordinator, Colivicchi F Facc Fesc Coordinator, Di Lenarda A Facc Fesc Coordinator, Musumeci G, Faggiano PM, Abrignani MG, Rossini R, Fattirolli F, Valente S, Mureddu GF, Temporelli PL, Olivari Z, Amico AF, Casolo G Facc Fesc, Fresco C, Menozzi A, Nardi F Facc Fesc. ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathy. Eur Heart J Suppl 2017;19:D163-89. [PMID: 28533729 DOI: 10.1093/eurheartj/sux021] [Reference Citation Analysis]
144 Cerrato E, Giacobbe F, Quadri G, Macaya F, Bianco M, Mori R, Biolè CA, Boi A, Bettari L, Rolfo C, Ferrari F, Annibali G, Scappaticci M, Pavani M, Barbero U, Buccheri D, Cavallino C, Lombardi P, Bernelli C, D'Ascenzo F, Infantino V, Gambino A, Cinconze S, Rognoni A, Montagna L, Porto I, Musumeci G, Escaned J, Varbella F; DISCO Collaborators . Antiplatelet therapy in patients with conservatively managed spontaneous coronary artery dissection from the multicentre DISCO registry. Eur Heart J 2021:ehab372. [PMID: 34338759 DOI: 10.1093/eurheartj/ehab372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
145 Schuhbäck A, Kolwelter J, Achenbach S. [Diamond-Forrester and cardiac CT : Is there a need to redefine the pretest probability of coronary artery disease?]. Herz 2016;41:371-5. [PMID: 27272195 DOI: 10.1007/s00059-016-4437-1] [Reference Citation Analysis]
146 Simonsson M, Winell H, Olsson H, Szummer K, Alfredsson J, Hall M, Dondo TB, Gale CP, Jernberg T. Development and Validation of a Novel Risk Score for In-Hospital Major Bleeding in Acute Myocardial Infarction:-The SWEDEHEART Score. J Am Heart Assoc 2019;8:e012157. [PMID: 30803289 DOI: 10.1161/JAHA.119.012157] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
147 Montecucco F, Carbone F, Schindler TH. Pathophysiology of ST-segment elevation myocardial infarction: novel mechanisms and treatments. Eur Heart J 2016;37:1268-83. [DOI: 10.1093/eurheartj/ehv592] [Cited by in Crossref: 54] [Cited by in F6Publishing: 48] [Article Influence: 7.7] [Reference Citation Analysis]
148 de Waha S, Desch S, Fuernau G, Pöss J, Ledwoch J, Jobs A, Eitel I, Thiele H. Interventional therapies in acute myocardial infarction complicated by cardiogenic shock. Herz 2017;42:11-7. [PMID: 27909767 DOI: 10.1007/s00059-016-4511-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
149 Tan JWC, Lam CSP, Kasim SS, Aw TC, Abanilla JM, Chang WT, Dang VP, Iboleon-Dy M, Mumpuni SS, Phommintikul A, Ta MC, Topipat P, Yiu KH, Cullen L. Asia-Pacific consensus statement on the optimal use of high-sensitivity troponin assays in acute coronary syndromes diagnosis: focus on hs-TnI. Heart Asia 2017;9:81-7. [PMID: 28466882 DOI: 10.1136/heartasia-2016-010818] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
150 McRae AD, Innes G, Graham M, Lang E, Andruchow JE, Ji Y, Vatanpour S, Abedin T, Yang H, Southern DA, Wang D, Seiden-Long I, DeKoning L, Kavsak P. Undetectable Concentrations of a Food and Drug Administration-approved High-sensitivity Cardiac Troponin T Assay to Rule Out Acute Myocardial Infarction at Emergency Department Arrival. Acad Emerg Med 2017;24:1267-77. [PMID: 28544100 DOI: 10.1111/acem.13229] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 4.2] [Reference Citation Analysis]
151 Modaragamage Dona AC, Abuelgasim E, Abuelgasim B, Kermali M, Zahra SA, Hewage S, Harky A. Dissection of coronary artery: A clinical overview. J Cardiol 2021;77:353-60. [PMID: 32994072 DOI: 10.1016/j.jjcc.2020.08.011] [Reference Citation Analysis]
152 Bliden KP, Tantry US, Chaudhary R, Byun S, Gurbel PA. Extended-release acetylsalicylic acid for secondary prevention of stroke and cardiovascular events. Expert Review of Cardiovascular Therapy 2016;14:779-91. [DOI: 10.1080/14779072.2016.1188005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
153 Navarese EP, Khan SU, Kołodziejczak M, Kubica J, Buccheri S, Cannon CP, Gurbel PA, De Servi S, Budaj A, Bartorelli A, Trabattoni D, Ohman EM, Wallentin L, Roe MT, James S. Comparative Efficacy and Safety of Oral P2Y12 Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials. Circulation 2020;142:150-60. [PMID: 32468837 DOI: 10.1161/CIRCULATIONAHA.120.046786] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
154 Huber K, Goldstein P. Covid-19: implications for prehospital, emergency and hospital care in patients with acute coronary syndromes. Eur Heart J Acute Cardiovasc Care 2020;9:222-8. [PMID: 32375487 DOI: 10.1177/2048872620923639] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
155 Regan B, O'Kennedy R, Collins D. Advances in point-of-care testing for cardiovascular diseases. Adv Clin Chem 2021;104:1-70. [PMID: 34462053 DOI: 10.1016/bs.acc.2020.09.001] [Reference Citation Analysis]
156 Cole EM, Docherty AB. Troponin in critical care patients and outcomes. Br J Hosp Med (Lond) 2020;81:1-8. [PMID: 32468943 DOI: 10.12968/hmed.2020.0164] [Reference Citation Analysis]
157 Borna C, Kollberg K, Larsson D, Mokhtari A, Ekelund U. The objective CORE score allows early rule out in acute chest pain patients. Scandinavian Cardiovascular Journal 2018;52:308-14. [DOI: 10.1080/14017431.2018.1546891] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
158 Mauermann E, Puelacher C, Lurati Buse G. Myocardial injury after noncardiac surgery: an underappreciated problem and current challenges. Current Opinion in Anaesthesiology 2016;29:403-12. [DOI: 10.1097/aco.0000000000000336] [Cited by in Crossref: 24] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
159 Ofori-Asenso R, Zomer E, Chin KL, Markey P, Si S, Ademi Z, Curtis AJ, Zoungas S, Liew D. Prevalence and impact of non-cardiovascular comorbidities among older adults hospitalized for non-ST segment elevation acute coronary syndrome. Cardiovasc Diagn Ther 2019;9:250-61. [PMID: 31275815 DOI: 10.21037/cdt.2019.04.06] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
160 Diab S, Arazi M, Sternik L, Raanani E, Kachel E, Grosman-Rimon L, Shalabi A, Amir O, Carasso S. Coronary artery bypass graft surgery in patients on ticagrelor therapy is not associated with adverse perioperative outcomes. J Cardiothorac Surg 2021;16:139. [PMID: 34022927 DOI: 10.1186/s13019-021-01521-y] [Reference Citation Analysis]
161 Claeys MJ, Ahrens I, Sinnaeve P, Diletti R, Rossini R, Goldstein P, Czerwińska K, Bueno H, Lettino M, Münzel T, Zeymer U. Editor’s Choice-The organization of chest pain units: Position statement of the Acute Cardiovascular Care Association. European Heart Journal: Acute Cardiovascular Care 2017;6:203-11. [DOI: 10.1177/2048872617695236] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
162 Kochly F, Haddad C, Harbaoui B, Falandry C, Lantelme P, Courand P. Therapeutic management and outcome of nonagenarians versus octogenarians admitted to an intensive care unit for acute coronary syndromes. Archives of Cardiovascular Diseases 2020;113:780-90. [DOI: 10.1016/j.acvd.2020.05.020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
163 Elbaz-Greener G, Rozen G, Kusniec F, Marai I, Ghanim D, Carasso S, Gavrilov Y, Sud M, Strauss B, Ko DT, Wijeysundera HC, Planer D, Amir O. Trends in Utilization and Safety of In-Hospital Coronary Artery Bypass Grafting During a Non-ST-Segment Elevation Myocardial Infarction. Am J Cardiol 2020;134:32-40. [PMID: 32919619 DOI: 10.1016/j.amjcard.2020.08.019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
164 Schunkert H, Boening A, von Scheidt M, Lanig C, Gusmini F, de Waha A, Kuna C, Fach A, Grothusen C, Oberhoffer M, Knosalla C, Walther T, Danner BC, Misfeld M, Zeymer U, Wimmer-greinecker G, Siepe M, Grubitzsch H, Joost A, Schaefer A, Conradi L, Cremer J, Hamm C, Lange R, Radke PW, Schulz R, Laufer G, Grieshaber P, Pader P, Attmann T, Schmoeckel M, Meyer A, Ziegelhöffer T, Hambrecht R, Kastrati A, Sandner SE. Randomized trial of ticagrelor vs. aspirin in patients after coronary artery bypass grafting: the TiCAB trial. European Heart Journal 2019;40:2432-40. [DOI: 10.1093/eurheartj/ehz185] [Cited by in Crossref: 26] [Cited by in F6Publishing: 20] [Article Influence: 8.7] [Reference Citation Analysis]
165 Almendro-Delia M, Seoane García T, Villar Calle P, García González N, Lorenzo López B, Cortés FJ, García Del Río M, Ruiz García MDP, Hidalgo Urbano RJ, García-Rubira JC. Prevalence and clinical significance of totally occluded infarct-related arteries in patients with non-ST-segment elevation acute coronary syndromes. Int J Cardiol 2021;324:1-7. [PMID: 32931857 DOI: 10.1016/j.ijcard.2020.09.040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
166 Wongcharoen W, Pinyosamosorn K, Gunaparn S, Boonnayhun S, Thonghong T, Suwannasom P, Phrommintikul A. Vascular access site complication in transfemoral coronary angiography between uninterrupted warfarin and heparin bridging. J Interven Cardiol 2017;30:387-92. [DOI: 10.1111/joic.12403] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
167 Zengin A, Karaca M, Aruğaslan E, Yıldırım E, Karataş MB, Çanga Y, Emre A, Tayyareci G. Performance of neutrophil to lymphocyte ratio for the prediction of long-term morbidity and mortality in coronary slow flow phenomenon patients presented with non-ST segment elevation acute coronary syndrome. J Cardiovasc Thorac Res 2021;13:125-30. [PMID: 34326966 DOI: 10.34172/jcvtr.2021.12] [Reference Citation Analysis]
168 Merinopoulos I, Gunawardena T, Wickramarachchi U, Ryding A, Eccleshall S, Vassiliou VS. Percutaneous Coronary Intervention in the Elderly: Are Drug-coated Balloons the Future? Curr Cardiol Rev 2018;14:45-52. [PMID: 29278215 DOI: 10.2174/1573403X14666171226144120] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Grandjean T, Degrauwe S, Tessitore E, Iglesias JF. The 'de Winter' electrocardiogram pattern as a ST-elevation myocardial infarction equivalent: a case report. Eur Heart J Case Rep 2019;3:1-5. [PMID: 31911997 DOI: 10.1093/ehjcr/ytz210] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
170 Kitayama H, Kondo T, Sugiyama J, Kurimoto K, Nishino Y, Kawada M, Hirayama M, Tsuji Y. High-sensitive troponin T assay can predict anthracycline- and trastuzumab-induced cardiotoxicity in breast cancer patients. Breast Cancer 2017;24:774-82. [DOI: 10.1007/s12282-017-0778-8] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 6.4] [Reference Citation Analysis]
171 Ski CF, Jones M, Astley C, Neubeck L, Thompson DR, Gallagher R, Du H, Clark RA. Development, piloting and validation of the Recommending Cardiac Rehabilitation (ReCaRe) instrument. Heart & Lung 2019;48:405-13. [DOI: 10.1016/j.hrtlng.2019.04.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
172 Zusman O, Bebb O, Hall M, Dondo TB, Timmis A, Schiele F, Fox KA, Kornowski R, Gale CP, Iakobishvili Z. International comparison of acute myocardial infarction care and outcomes using quality indicators. Heart 2019;105:820-5. [DOI: 10.1136/heartjnl-2018-314197] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
173 Hinton J, Gabara L, Curzen N. Is the true clinical value of high-sensitivity troponins as a biomarker of risk? The concept that detection of high-sensitivity troponin 'never means nothing'. Expert Rev Cardiovasc Ther 2020;18:843-57. [PMID: 32966128 DOI: 10.1080/14779072.2020.1828063] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
174 Karbach S, Hobohm L, Wild J, Münzel T, Gori T, Wegner J, Steinbrink K, Wenzel P, Keller K. Impact of Psoriasis on Mortality Rate and Outcome in Myocardial Infarction. J Am Heart Assoc 2020;9:e016956. [PMID: 32914667 DOI: 10.1161/JAHA.120.016956] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
175 Martha JW, Sihite TA, Listina D. The Difference in Accuracy Between Global Registry of Acute Coronary Events Score and Thrombolysis in Myocardial Infarction Score in Predicting In-Hospital Mortality of Acute ST-Elevation Myocardial Infarction Patients. Cardiol Res 2021;12:177-85. [PMID: 34046112 DOI: 10.14740/cr1247] [Reference Citation Analysis]
176 Ye Z, Lu H, Su Q, Long M, Li L. RETRACTED: Short-term and long-term effects of a loading dose of atorvastatin before percutaneous coronary intervention on major adverse cardiovascular events in patients with acute coronary syndrome: a meta-analysis of 13 randomized controlled trials. Eur Heart J 2019;40:e1-e10. [PMID: 30608526 DOI: 10.1093/eurheartj/ehy833] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
177 Marian MJ, Abu Daya H, Chatterjee A, Al Solaiman F, Sasse MF, Fonbah WS, Workman RW, Johnson BE, Carlson SE, Brott BC, Prabhu SD, Leesar MA. Effects of Crushed Ticagrelor Versus Eptifibatide Bolus Plus Clopidogrel in Troponin-Negative Acute Coronary Syndrome Patients Undergoing Percutaneous Coronary Intervention: A Randomized Clinical Trial. J Am Heart Assoc 2019;8:e012844. [PMID: 31766977 DOI: 10.1161/JAHA.119.012844] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
178 Erbel R, Buerke M, Mohr-Kahaly S, Oelert H, Uebis R. [Therapy of cardiogenic shock : A success story of German cardiology]. Herz 2019;44:22-8. [PMID: 30627739 DOI: 10.1007/s00059-018-4773-4] [Reference Citation Analysis]
179 Rothenbühler M, Valgimigli M, Odutayo A, Frigoli E, Leonardi S, Vranckx P, Turturo M, Moretti L, Amico F, Uguccioni L, Contarini M, Gómez-hospital JA, Mainar V, Creaco M, Petronio AS, Cremonesi A, Tamburino C, Fresco C, Bonmassari R, Díaz Fernández JF, Romagnoli E, Beyersmann J, Heg D, Jüni P. Association of acute kidney injury and bleeding events with mortality after radial or femoral access in patients with acute coronary syndrome undergoing invasive management: secondary analysis of a randomized clinical trial. European Heart Journal 2019;40:1226-32. [DOI: 10.1093/eurheartj/ehy860] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
180 Verheugt FW. Antithrombotic Therapy to Reduce Ischemic Events in Acute Coronary Syndromes Patients Undergoing Percutaneous Coronary Intervention. Interventional Cardiology Clinics 2017;6:131-40. [DOI: 10.1016/j.iccl.2016.08.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
181 McAlister C, Smyth D. Shifting Paradigms and Financing a Revolution: Providing Transcatheter Valves in the Public Health System. A View from Aotearoa New Zealand. Interv Cardiol 2021;16:e04. [PMID: 33897830 DOI: 10.15420/icr.2020.03] [Reference Citation Analysis]
182 Pararajasingam G, Løgstrup BB, Høfsten DE, Christophersen TB, Auscher S, Hangaard J, Egstrup K. Dysglycemia and increased left ventricle mass in normotensive patients admitted with a first myocardial infarction: prognostic implications of dysglycemia during 14 years of follow-up. BMC Cardiovasc Disord 2019;19:103. [PMID: 31046690 DOI: 10.1186/s12872-019-1084-5] [Reference Citation Analysis]
183 Dézsi CA, Dézsi BB, Dézsi AD. Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence. Eur J Gen Pract 2017;23:196-201. [PMID: 28743214 DOI: 10.1080/13814788.2017.1350645] [Cited by in Crossref: 13] [Cited by in F6Publishing: 6] [Article Influence: 3.3] [Reference Citation Analysis]
184 Bueno H, Pocock S, Medina J, Danchin N, Annemans L, Licour M, Gregson J, Vega AM, van de Werf F. Relación entre las situaciones clínicas que llevan al tratamiento exclusivamente farmacológico del SCASEST y su pronóstico. Revista Española de Cardiología 2017;70:817-24. [DOI: 10.1016/j.recesp.2016.11.046] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.4] [Reference Citation Analysis]
185 Ran P, Yang JQ, Li J, Li G, Wang Y, Qiu J, Zhong Q, Wang Y, Wei XB, Huang JL, Siu CW, Zhou YL, Zhao D, Yu DQ, Chen JY. A risk score to predict in-hospital mortality in patients with acute coronary syndrome at early medical contact: results from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome (CCC-ACS) Project. Ann Transl Med 2021;9:167. [PMID: 33569469 DOI: 10.21037/atm-21-31] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
186 Kaura A, Sterne JAC, Trickey A, Abbott S, Mulla A, Glampson B, Panoulas V, Davies J, Woods K, Omigie J, Shah AD, Channon KM, Weber JN, Thursz MR, Elliott P, Hemingway H, Williams B, Asselbergs FW, O'Sullivan M, Lord GM, Melikian N, Johnson T, Francis DP, Shah AM, Perera D, Kharbanda R, Patel RS, Mayet J. Invasive versus non-invasive management of older patients with non-ST elevation myocardial infarction (SENIOR-NSTEMI): a cohort study based on routine clinical data. Lancet 2020;396:623-34. [PMID: 32861307 DOI: 10.1016/S0140-6736(20)30930-2] [Cited by in Crossref: 20] [Cited by in F6Publishing: 2] [Article Influence: 10.0] [Reference Citation Analysis]
187 Silvain J, Rakowski T, Lattuca B, Liu Z, Bolognese L, Goldstein P, Hamm C, Tanguay J, ten Berg J, Widimsky P, Miller D, Portal J, Collet J, Vicaut E, Montalescot G, Dudek D. Interval From Initiation of Prasugrel to Coronary Angiography in Patients With Non–ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology 2019;73:906-14. [DOI: 10.1016/j.jacc.2018.11.055] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
188 Larson EA, German DM, Shatzel J, DeLoughery TG. Anticoagulation in the cardiac patient: A concise review. Eur J Haematol 2019;102:3-19. [PMID: 30203452 DOI: 10.1111/ejh.13171] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
189 Li DD, Wang XY, Xi SZ, Liu J, Qin LA, Jing J, Yin T, Chen YD. Relationship between ADP-induced platelet-fibrin clot strength and anti-platelet responsiveness in ticagrelor treated ACS patients. J Geriatr Cardiol 2016;13:282-9. [PMID: 27403136 DOI: 10.11909/j.issn.1671-5411.2016.04.012] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
190 Chen S, Stone GW. Circadian influences, time of hospitalization, and prognosis in acute myocardial infarction. European Heart Journal 2019;40:1222-5. [DOI: 10.1093/eurheartj/ehz015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
191 Kavsak PA, Cerasuolo JO, Ko DT, Ma J, Sherbino J, Mondoux SE, Perez R, Seow H, Worster A. High-Sensitivity Cardiac Troponin I vs a Clinical Chemistry Score for Predicting All-Cause Mortality in an Emergency Department Population. CJC Open 2020;2:296-302. [PMID: 32695979 DOI: 10.1016/j.cjco.2020.03.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
192 Marques-alves P, Espírito-santo N, Baptista R, Teixeira R, Martins R, Gonçalves F, Pego M. Two-dimensional speckle-tracking global longitudinal strain in high-sensitivity troponin-negative low-risk patients with unstable angina: a “resting ischemia test”? Int J Cardiovasc Imaging 2018;34:561-8. [DOI: 10.1007/s10554-017-1269-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
193 Orrem HL, Nilsson PH, Pischke SE, Kleveland O, Yndestad A, Ekholt K, Damås JK, Espevik T, Bendz B, Halvorsen B, Gregersen I, Wiseth R, Andersen GØ, Ueland T, Gullestad L, Aukrust P, Barratt-Due A, Mollnes TE. IL-6 Receptor Inhibition by Tocilizumab Attenuated Expression of C5a Receptor 1 and 2 in Non-ST-Elevation Myocardial Infarction. Front Immunol 2018;9:2035. [PMID: 30258440 DOI: 10.3389/fimmu.2018.02035] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.5] [Reference Citation Analysis]
194 Bainey KR, Durham D, Zheng Y, Westerhout CM, Kaul P, Welsh RC. Utilization and Costs of Noninvasive Cardiac Tests After Acute Coronary Syndromes: Insights From the Alberta COAPT Study. CJC Open 2019;1:76-83. [PMID: 32159087 DOI: 10.1016/j.cjco.2019.01.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
195 Burlacu A, Genovesi S, Basile C, Ortiz A, Mitra S, Kirmizis D, Kanbay M, Davenport A, van der Sande F, Covic A; EUDIAL Working Group of ERA-EDTA. Coronary artery disease in dialysis patients: evidence synthesis, controversies and proposed management strategies. J Nephrol 2021;34:39-51. [PMID: 32472526 DOI: 10.1007/s40620-020-00758-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
196 Mueller C, Giannitsis E, Lindahl B. In reply. Ann Emerg Med 2016;67:794-5. [PMID: 27217136 DOI: 10.1016/j.annemergmed.2016.02.037] [Reference Citation Analysis]
197 Kang SH, Baek H, Cho J, Kim S, Hwang H, Lee W, Park JJ, Yoon YE, Yoon CH, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ, Yoo S, Suh JW. Management of cardiovascular disease using an mHealth tool: a randomized clinical trial. NPJ Digit Med 2021;4:165. [PMID: 34862449 DOI: 10.1038/s41746-021-00535-z] [Reference Citation Analysis]
198 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Effect of statin treatment in patients with acute myocardial infarction with prediabetes and type 2 diabetes mellitus: A retrospective observational registry study. Medicine (Baltimore) 2021;100:e24733. [PMID: 33578620 DOI: 10.1097/MD.0000000000024733] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
199 Sattler K, El-Battrawy I, Zhao Z, Schrottenberg C, Yücel G, Lan H, Li X, Lang S, Zimmermann WH, Cyganek L, Utikal J, Wieland T, Ravens U, Bieback K, Borggrefe M, Zhou X, Akin I. Serum of patients with acute myocardial infarction prevents inflammation in iPSC-cardiomyocytes. Sci Rep 2019;9:5651. [PMID: 30948775 DOI: 10.1038/s41598-019-42079-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
200 Sivri S, Sokmen E, Celik M, Ozbek SC, Yildirim A, Boduroglu Y. Usefulness of white blood cell count to mean platelet volume ratio in the prediction of SYNTAX score in patients with non-ST elevation myocardial infarction. Pak J Med Sci 2019;35:824-9. [PMID: 31258602 DOI: 10.12669/pjms.35.3.1017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
201 Wallentin L, Eriksson N, Olszowka M, Grammer TB, Hagström E, Held C, Kleber ME, Koenig W, März W, Stewart RAH, White HD, Åberg M, Siegbahn A. Plasma proteins associated with cardiovascular death in patients with chronic coronary heart disease: A retrospective study. PLoS Med 2021;18:e1003513. [PMID: 33439866 DOI: 10.1371/journal.pmed.1003513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
202 Neumann JT, Blankenberg S, Westermann D. Be more sensitive, please - using cardiac troponin assays for diagnosing AMI. Heart 2016;102:1251-2. [PMID: 27325589 DOI: 10.1136/heartjnl-2016-309484] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
203 Lippi G, Plebani M. Integrated diagnostics: the future of laboratory medicine? Biochem Med (Zagreb) 2020;30:010501. [PMID: 31839719 DOI: 10.11613/BM.2020.010501] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
204 Carrero JJ, Varenhorst C, Jensevik K, Szummer K, Lagerqvist B, Evans M, Spaak J, Held C, James S, Jernberg T. Long-term versus short-term dual antiplatelet therapy was similarly associated with a lower risk of death, stroke, or infarction in patients with acute coronary syndrome regardless of underlying kidney disease. Kidney Int 2017;91:216-26. [PMID: 27865441 DOI: 10.1016/j.kint.2016.09.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
205 Janssens GN, van der Hoeven NW, Lemkes JS, Everaars H, van de Ven PM, Marques KM, Nap A, van Leeuwen MA, Appelman Y, Knaapen P, Verouden NJ, Allaart CP, Brinckman SL, Saraber CE, Plomp KJ, Timmer JR, Kedhi E, Hermanides RS, Meuwissen M, Schaap J, van der Weerdt AP, van Rossum AC, Nijveldt R, van Royen N. 1-Year Outcomes of Delayed Versus Immediate Intervention in Patients With Transient ST-Segment Elevation Myocardial Infarction. JACC: Cardiovascular Interventions 2019;12:2272-82. [DOI: 10.1016/j.jcin.2019.07.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
206 Norum J, Hansen TM, Hovland A, Balteskard L, Haug B, Olsen F, Trovik T. Calculating the 30-day Survival Rate in Acute Myocardial Infarction: Should we Use the Treatment Chain or the Hospital Catchment Model? Heart Int 2017;12:heartint. [PMID: 30263101 DOI: 10.5301/heartint.5000238] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
207 Gray AJ, Roobottom C, Smith JE, Goodacre S, Oatey K, O'Brien R, Storey RF, Na L, Lewis SC, Thokala P, Newby DE. The RAPID-CTCA trial (Rapid Assessment of Potential Ischaemic Heart Disease with CTCA) - a multicentre parallel-group randomised trial to compare early computerised tomography coronary angiography versus standard care in patients presenting with suspected or confirmed acute coronary syndrome: study protocol for a randomised controlled trial. Trials 2016;17:579. [PMID: 27923390 DOI: 10.1186/s13063-016-1717-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
208 Osman M, Benjamin MM, Balla S, Kheiri B, Bianco C, Sengupta PP, Daggubati R, Malla M, Liu SV, Mamas M, Patel B. Index admission and thirty-day readmission outcomes of patients with cancer presenting with STEMI. Cardiovasc Revasc Med 2021:S1553-8389(21)00203-7. [PMID: 33888417 DOI: 10.1016/j.carrev.2021.04.015] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
209 Zeymer U, Rao SV, Montalescot G. Anticoagulation in coronary intervention. Eur Heart J 2016;37:3376-85. [DOI: 10.1093/eurheartj/ehw061] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 3.7] [Reference Citation Analysis]
210 Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio AL, De Caterina R, Zimarino M, Roffi M, Kjeldsen K, Atar D, Kaski JC, Sechtem U, Tornvall P; WG on Cardiovascular Pharmacotherapy. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J. 2017;38:143-153. [PMID: 28158518 DOI: 10.1093/eurheartj/ehw149] [Cited by in Crossref: 76] [Cited by in F6Publishing: 119] [Article Influence: 25.3] [Reference Citation Analysis]
211 Looi JL, Poppe K, Lee M, Gilmore J, Webster M, To A, Kerr AJ. A Score to differentiate Takotsubo syndrome from non-ST-elevation myocardial nfarction in women at the bedside. Open Heart 2020;7:e001197. [PMID: 32201588 DOI: 10.1136/openhrt-2019-001197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
212 Twerenbold R, Costabel JP, Nestelberger T, Campos R, Wussler D, Arbucci R, Cortes M, Boeddinghaus J, Baumgartner B, Nickel CH, Bingisser R, Badertscher P, Puelacher C, du Fay de Lavallaz J, Wildi K, Rubini Giménez M, Walter J, Meier M, Hafner B, Lopez Ayala P, Lohrmann J, Troester V, Koechlin L, Zimmermann T, Gualandro DM, Reichlin T, Lambardi F, Resi S, Alves de Lima A, Trivi M, Mueller C. Outcome of Applying the ESC 0/1-hour Algorithm in Patients With Suspected Myocardial Infarction. Journal of the American College of Cardiology 2019;74:483-94. [DOI: 10.1016/j.jacc.2019.05.046] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 16.7] [Reference Citation Analysis]
213 Shah SR, Kiemeneij F, Khuddus MA. Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site. Catheter Cardiovasc Interv 2021;97:278-81. [DOI: 10.1002/ccd.28772] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
214 Leistner DM, Dietrich S, Erbay A, Steiner J, Abdelwahed Y, Siegrist PT, Schindler M, Skurk C, Haghikia A, Sinning D, Riedel M, Landmesser U, Stähli BE. Association of left ventricular end‐diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes. Catheter Cardiovasc Interv 2020;96. [DOI: 10.1002/ccd.28839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
215 Doshi R, Vadher A, Mithawala P, Shah P. Oral antiplatelets in primary and secondary prevention of myocardial infarction: a review. Ir J Med Sci 2019;188:453-67. [PMID: 30178075 DOI: 10.1007/s11845-018-1897-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
216 Sinnaeve PR, Van de Werf F. Clopidogrel instead of prasugrel or ticagrelor after 1 month in stabilized ACS patients: back to square one for DAPT? European Heart Journal 2017;38:3079-81. [DOI: 10.1093/eurheartj/ehx253] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
217 Pareek N, Kordis P, Webb I, Noc M, MacCarthy P, Byrne J. Contemporary Management of Out-of-hospital Cardiac Arrest in the Cardiac Catheterisation Laboratory: Current Status and Future Directions. Interv Cardiol 2019;14:113-23. [PMID: 31867056 DOI: 10.15420/icr.2019.3.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
218 Cenko E, Ricci B, Kedev S, Vasiljevic Z, Dorobantu M, Gustiene O, Knežević B, Miličić D, Dilic M, Manfrini O, Koller A, Badimon L, Bugiardini R. Invasive versus conservative strategy in acute coronary syndromes: The paradox in women's outcomes. Int J Cardiol 2016;222:1110-5. [PMID: 27514628 DOI: 10.1016/j.ijcard.2016.07.211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
219 Syyli N, Hautamäki M, Antila K, Mahdiani S, Eskola M, Lehtimäki T, Nikus K, Lyytikäinen LP, Oksala N, Hernesniemi J. Left ventricular ejection fraction adds value over the GRACE score in prediction of 6-month mortality after ACS: the MADDEC study. Open Heart 2019;6:e001007. [PMID: 31328004 DOI: 10.1136/openhrt-2019-001007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
220 Gabet A, Danchin N, Puymirat E, Tuppin P, Olié V. Early and late case fatality after hospitalization for acute coronary syndrome in France, 2010-2015. Arch Cardiovasc Dis 2019;112:754-64. [PMID: 31718932 DOI: 10.1016/j.acvd.2019.09.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
221 Stähli BE, Wischnewsky MB, Jakob P, Klingenberg R, Obeid S, Heg D, Räber L, Windecker S, Roffi M, Mach F, Gencer B, Nanchen D, Jüni P, Landmesser U, Matter CM, Lüscher TF, Maier W. Predictive value of the age, creatinine, and ejection fraction (ACEF) score in patients with acute coronary syndromes. Int J Cardiol 2018;270:7-13. [PMID: 29885826 DOI: 10.1016/j.ijcard.2018.05.134] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
222 Hally KE, La Flamme AC, Harding SA, Larsen PD. The effects of aspirin and ticagrelor on Toll-like receptor (TLR)-mediated platelet activation: results of a randomized, cross-over trial. Platelets 2019;30:599-607. [PMID: 29869943 DOI: 10.1080/09537104.2018.1479520] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
223 Chichareon P, Modolo R, van Klaveren D, Takahashi K, Kogame N, Chang CC, Katagiri Y, Tomaniak M, Asano T, Spitzer E, Buszman P, Prokopczuk J, Fath-Ordoubadi F, Buysschaert I, Anderson R, Oldroyd KG, Merkely B, Garg S, Wykrzykowska JJ, Piek JJ, Jüni P, Hamm C, Steg PG, Valgimigli M, Vranckx P, Windecker S, Onuma Y, Serruys PW. Predictive ability of ACEF and ACEF II score in patients undergoing percutaneous coronary intervention in the GLOBAL LEADERS study. Int J Cardiol 2019;286:43-50. [PMID: 30846254 DOI: 10.1016/j.ijcard.2019.02.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
224 Savarese G, Savonitto S, Lund LH, Paolillo S, Marciano C, Dellegrottaglie S, Parente A, Trimarco B, Luscher TF, Perrone-filardi P. Efficacy and safety of prolonged dual antiplatelet therapy: a meta-analysis of 15 randomized trials enrolling 85 265 patients. Eur Heart J Cardiovasc Pharmacother 2016;2:218-28. [DOI: 10.1093/ehjcvp/pvw011] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 2.2] [Reference Citation Analysis]
225 van Dongen DN, Ottervanger JP, Tolsma R, Fokkert M, van der Sluis A, van 't Hof AWJ, Badings E, Slingerland RJ. In-Hospital Healthcare Utilization, Outcomes, and Costs in Pre-Hospital-Adjudicated Low-Risk Chest-Pain Patients. Appl Health Econ Health Policy 2019;17:875-82. [PMID: 31388939 DOI: 10.1007/s40258-019-00502-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
226 Henriksson R, Björklund F, Mooe T. The introduction of ticagrelor is associated with lower rates of recurrent ischemic stroke after myocardial infarction. PLoS One 2019;14:e0216404. [PMID: 31059535 DOI: 10.1371/journal.pone.0216404] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
227 Traby L, Kaider A, Kollars M, Eichinger S, Wolzt M, Kyrle PA. Effects of clopidogrel with or without aspirin on the generation of extracellular vesicles in the microcirculation and in venous blood: A randomized placebo controlled trial. Thromb Res 2018;167:149-55. [PMID: 29857271 DOI: 10.1016/j.thromres.2018.05.021] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
228 Vrints CJ. Triage, diagnosis and management of acute chest pain syndromes, atypical and high-risk subtypes of acute coronary artery syndromes. European Heart Journal: Acute Cardiovascular Care 2018;7:589-90. [DOI: 10.1177/2048872618810252] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
229 Cai Q, Wang J, Li H, Li C, Wu X, Lu X. Measurement of Left Ventricular Volumes and Ejection Fraction in Patients with Regional Wall Motion Abnormalities Using an Automated 3D Quantification Algorithm. Ultrasound Med Biol 2018;44:2274-82. [PMID: 30122311 DOI: 10.1016/j.ultrasmedbio.2018.07.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
230 Panchavati S, Lam C, Zelin NS, Pellegrini E, Barnes G, Hoffman J, Garikipati A, Calvert J, Mao Q, Das R. Retrospective validation of a machine learning clinical decision support tool for myocardial infarction risk stratification. Healthc Technol Lett 2021;8:139-47. [PMID: 34938570 DOI: 10.1049/htl2.12017] [Reference Citation Analysis]
231 Stewart RAH, Jones P, Dicker B, Jiang Y, Smith T, Swain A, Kerr A, Scott T, Smyth D, Ranchord A, Edmond J, Than M, Webster M, White HD, Devlin G. High flow oxygen and risk of mortality in patients with a suspected acute coronary syndrome: pragmatic, cluster randomised, crossover trial. BMJ 2021;372:n355. [PMID: 33653685 DOI: 10.1136/bmj.n355] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
232 Deubner N, Greiss H, Neumann T. [Emergency treatment of tachycardias]. Med Klin Intensivmed Notfmed 2017;112:265-81. [PMID: 28342096 DOI: 10.1007/s00063-017-0268-y] [Reference Citation Analysis]
233 Van der Stuijt W, Kuipers RS. Rupturing Abdominal Aneurysm Presenting as Acute Coronary Syndrome. Cureus 2020;12:e9296. [PMID: 32832293 DOI: 10.7759/cureus.9296] [Reference Citation Analysis]
234 Kavsak PA, Andruchow JE, Mcrae AD, Worster A. Profile of Roche’s Elecsys Troponin T Gen 5 STAT blood test (a high-sensitivity cardiac troponin assay) for diagnosing myocardial infarction in the emergency department. Expert Review of Molecular Diagnostics 2018;18:481-9. [DOI: 10.1080/14737159.2018.1476141] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
235 Wienbergen H, Fach A, Erdmann J, Katalinic A, Eisemann N, Krawitz P, Maj C, Borisov O, Munz M, Noethen M, Meyer-saraei R, Osteresch R, Schmucker J, Linke A, Eitel I, Hambrecht R, Langer H. New technologies for intensive prevention programs after myocardial infarction: rationale and design of the NET-IPP trial. Clin Res Cardiol 2021;110:153-61. [DOI: 10.1007/s00392-020-01695-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
236 Correia C, Galvão Braga C, Martins J, Arantes C, Abreu G, Quina C, Salgado A, Álvares Pereira M, Costa J, Marques J. Multivessel vs. culprit-only revascularization in patients with non-ST-elevation acute coronary syndromes and multivessel coronary disease. Rev Port Cardiol (Engl Ed) 2018;37:143-54. [PMID: 29486987 DOI: 10.1016/j.repc.2017.05.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
237 Aursulesei V, Costache II. Anticoagulation in chronic kidney disease: from guidelines to clinical practice. Clin Cardiol 2019;42:774-82. [PMID: 31102275 DOI: 10.1002/clc.23196] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 7.3] [Reference Citation Analysis]
238 Andersen CF, Bang C, Lauridsen KG, Frederiksen CA, Schmidt M, Jensen T, Hornung N, Løfgren B. Single troponin measurement to rule-out acute myocardial infarction in early presenters. Int J Cardiol 2021:S0167-5273(21)01215-8. [PMID: 34391791 DOI: 10.1016/j.ijcard.2021.08.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
239 Marano R, Rovere G, Savino G, Flammia FC, Carafa MRP, Steri L, Merlino B, Natale L. CCTA in the diagnosis of coronary artery disease. Radiol Med 2020;125:1102-13. [PMID: 32964325 DOI: 10.1007/s11547-020-01283-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
240 de Knegt MC, Linde JJ, Fuchs A, Nordestgaard BG, Køber LV, Hove JD, Kofoed KF. Reproducibility of coronary atherosclerotic plaque characteristics in populations with low, intermediate, and high prevalence of coronary artery disease by multidetector computer tomography: a guide to reliable visual coronary plaque assessments. Int J Cardiovasc Imaging 2016;32:1555-66. [PMID: 27378095 DOI: 10.1007/s10554-016-0932-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
241 Sperry AE, Williams M, Atluri P, Szeto WY, Cevasco M, Bermudez CA, Acker MA, Ibrahim M. The Surgeon's Role in Cardiogenic Shock. Curr Heart Fail Rep 2021;18:240-51. [PMID: 33956313 DOI: 10.1007/s11897-021-00514-1] [Reference Citation Analysis]
242 Collinson P. Troponin measurement in patients with suspected acute coronary syndromes: walking beyond the wall. European Heart Journal - Quality of Care and Clinical Outcomes 2018;4:8-9. [DOI: 10.1093/ehjqcco/qcx034] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
243 Hartikainen TS, Sörensen NA, Haller PM, Goßling A, Lehmacher J, Zeller T, Blankenberg S, Westermann D, Neumann JT. Clinical application of the 4th Universal Definition of Myocardial Infarction. Eur Heart J 2020;41:2209-16. [PMID: 32077925 DOI: 10.1093/eurheartj/ehaa035] [Cited by in Crossref: 27] [Cited by in F6Publishing: 22] [Article Influence: 27.0] [Reference Citation Analysis]
244 Li M, Tang X, Liu X, Cui X, Lian M, Zhao M, Peng H, Han X. Targeted miR-21 loaded liposomes for acute myocardial infarction. J Mater Chem B 2020;8:10384-91. [PMID: 33112352 DOI: 10.1039/d0tb01821j] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
245 Jha S, Zeijlon R, Shekka Espinosa A, Alkhoury J, Oras J, Omerovic E, Redfors B. Clinical management in the takotsubo syndrome. Expert Review of Cardiovascular Therapy 2018;17:83-93. [DOI: 10.1080/14779072.2019.1556098] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
246 Scirica BM, Bergmark BA, Morrow DA, Antman EM, Bonaca MP, Murphy SA, Sabatine MS, Braunwald E, Wiviott SD. Nonculprit Lesion Myocardial Infarction Following Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome. Journal of the American College of Cardiology 2020;75:1095-106. [DOI: 10.1016/j.jacc.2019.12.067] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
247 Zeymer U, Widimsky P, Danchin N, Lettino M, Bardaji A, Barrabes JA, Cequier A, Claeys MJ, De Luca L, Dörler J, Erlinge D, Erne P, Goldstein P, Koul SM, Lemesle G, Lüscher TF, Matter CM, Montalescot G, Radovanovic D, Sendón JL, Tousek P, Weidinger F, Weston CFM, Zaman A, Andell P, Li J, Jukema JW. P2Y12 receptor inhibitors in patients with non-ST-elevation acute coronary syndrome in the real world: use, patient selection, and outcomes from contemporary European registries. Eur Heart J Cardiovasc Pharmacother 2016;2:229-43. [DOI: 10.1093/ehjcvp/pvw005] [Cited by in Crossref: 41] [Cited by in F6Publishing: 33] [Article Influence: 6.8] [Reference Citation Analysis]
248 Eggers KM, Jernberg T, Lindahl B. Unstable Angina in the Era of Cardiac Troponin Assays with Improved Sensitivity-A Clinical Dilemma. Am J Med 2017;130:1423-1430.e5. [PMID: 28647406 DOI: 10.1016/j.amjmed.2017.05.037] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
249 de Hoog VC, Lim SH, Bank IE, Gijsberts CM, Ibrahim IB, Kuan WS, Ooi SB, Chua TS, Tai ES, Gao F, Pasterkamp G, den Ruijter HM, Doevendans PA, Wildbergh TX, Mosterd A, Richards AM, de Kleijn DP, Timmers L. HEART score performance in Asian and Caucasian patients presenting to the emergency department with suspected acute coronary syndrome. European Heart Journal: Acute Cardiovascular Care 2018;7:591-601. [DOI: 10.1177/2048872617700870] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
250 Flores-blanco PJ, Cambronero-sánchez F, Raposeiras-roubin S, Abu-assi E, Leithold G, Cobas-paz R, Rodríguez Serrano AI, Calvo-iglesias F, Valdés M, Januzzi JL, Iñiguez-romo A, Manzano-fernández S. Asociación entre las escalas de riesgo isquémico y hemorrágico y el uso de los nuevos inhibidores del P2Y 12 en pacientes con síndrome coronario agudo. Revista Española de Cardiología 2018;71:538-44. [DOI: 10.1016/j.recesp.2017.09.024] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
251 Cuisset T, Deharo P, Quilici J, Johnson TW, Deffarges S, Bassez C, Bonnet G, Fourcade L, Mouret JP, Lambert M, Verdier V, Morange PE, Alessi MC, Bonnet JL. Benefit of switching dual antiplatelet therapy after acute coronary syndrome: the TOPIC (timing of platelet inhibition after acute coronary syndrome) randomized study. Eur Heart J. 2017;38:3070-3078. [PMID: 28510646 DOI: 10.1093/eurheartj/ehx175] [Cited by in Crossref: 175] [Cited by in F6Publishing: 135] [Article Influence: 43.8] [Reference Citation Analysis]
252 Zheng N, Yin F, Yu Q, Zhong J, Yang J, Xu Z, Su J, Chen X. Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel. J Clin Lab Anal 2021;35:e23713. [PMID: 33501709 DOI: 10.1002/jcla.23713] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
253 Banerjee D, Perrett C, Banerjee A. Troponins, Acute Coronary Syndrome and Renal Disease: From Acute Kidney Injury Through End-stage Kidney Disease. Eur Cardiol 2019;14:187-90. [PMID: 31933690 DOI: 10.15420/ecr.2019.28.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
254 Dai Y, Tian Q, Si J, Sun Z, Shali S, Xu L, Ren D, Chang S, Dong X, Zhao H, Mei Z, Zheng Y, Ge J. Circulating metabolites from the choline pathway and acute coronary syndromes in a Chinese case-control study. Nutr Metab (Lond) 2020;17:39. [PMID: 32489394 DOI: 10.1186/s12986-020-00460-0] [Reference Citation Analysis]
255 Jiang C, Wu S, Wang M, Zhao X, Li H. J-curve relationship between admission SBP and 2-year cardiovascular mortality in older patients admitted for acute coronary syndrome. J Hypertens 2021;39:926-34. [PMID: 33201050 DOI: 10.1097/HJH.0000000000002737] [Reference Citation Analysis]
256 Lupu L, Shepshelovich D, Banai S, Hershkoviz R, Isakov O. Effect of Ticagrelor on Reducing the Risk of Gram-Positive Infections in Patients With Acute Coronary Syndrome. The American Journal of Cardiology 2020;130:56-63. [DOI: 10.1016/j.amjcard.2020.06.016] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
257 Kayani WT, Tanavin T, Jneid H. Managing Acute Coronary Syndromes in Older Adults With Chronic Kidney Disease: Are We There Yet? J Am Heart Assoc 2020;9:e016909. [PMID: 32519562 DOI: 10.1161/JAHA.120.016909] [Reference Citation Analysis]
258 Montenegro Sá F, Carvalho R, Santos L, Ruivo C, Antunes A, Belo A, Soares F, Morais J; Portuguese Registry of Acute Coronary Syndromes. Dual antiplatelet therapy in myocardial infarction with non-obstructive coronary artery disease - insights from a nationwide registry. Rev Port Cardiol (Engl Ed) 2020;39:679-84. [PMID: 33234352 DOI: 10.1016/j.repc.2020.05.008] [Reference Citation Analysis]
259 Rashid M, Fischman DL, Gulati M, Tamman K, Potts J, Kwok CS, Ensor J, Shoaib A, Mansour H, Zaman A, Savage MP, Mamas MA. Temporal trends and inequalities in coronary angiography utilization in the management of non-ST-Elevation acute coronary syndromes in the U.S. Sci Rep 2019;9:240. [PMID: 30659213 DOI: 10.1038/s41598-018-36504-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
260 Kubena P, Špinar J, Dastych M, Lokaj P, Pařenica J. Diagnostic and prognostic biomarkers in acute coronary syndrome. Vnitř Lék 2017;63:935-44. [DOI: 10.36290/vnl.2017.171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
261 Beal SG, Winchester DE, Wilkerson G, Harris N, Allen B. Comparison of Patient Results on a New High-Sensitivity Troponin I Assay with a Conventional Assay, Focusing on Clinically Relevant Cutpoints. J Appl Lab Med 2020;5:597-9. [PMID: 32445354 DOI: 10.1093/jalm/jfaa014] [Reference Citation Analysis]
262 Napp LC, Cammann VL, Jaguszewski M, Szawan KA, Wischnewsky M, Gili S, Knorr M, Heiner S, Citro R, Bossone E, D'Ascenzo F, Neuhaus M, Franke J, Sorici-Barb I, Noutsias M, Burgdorf C, Koenig W, Kherad B, Sarcon A, Rajan L, Michels G, Pfister R, Cuneo A, Jacobshagen C, Karakas M, Pott A, Meyer P, Arroja JD, Banning A, Cuculi F, Kobza R, Fischer TA, Vasankari T, Airaksinen KEJ, Hauck C, Paolini C, Bilato C, Imori Y, Kato K, Kobayashi Y, Opolski G, Budnik M, Dworakowski R, MacCarthy P, Kaiser C, Osswald S, Galiuto L, Dichtl W, Chan C, Bridgman P, Beug D, Delmas C, Lairez O, El-Battrawy I, Akin I, Gilyarova E, Shilova A, Gilyarov M, Horowitz JD, Polednikova K, Tousek P, Widimský P, Winchester DE, Galuszka J, Ukena C, Poglajen G, Carrilho-Ferreira P, Di Mario C, Prasad A, Rihal CS, Schulze PC, Bianco M, Crea F, Borggrefe M, Maier LS, Pinto FJ, Braun-Dullaeus RC, Rottbauer W, Katus HA, Hasenfuß G, Tschöpe C, Pieske BM, Thiele H, Schunkert H, Böhm M, Felix SB, Münzel T, Bax JJ, Bauersachs J, Braunwald E, Lüscher TF, Ruschitzka F, Ghadri JR, Templin C. Coexistence and outcome of coronary artery disease in Takotsubo syndrome. Eur Heart J 2020;41:3255-68. [PMID: 32484517 DOI: 10.1093/eurheartj/ehaa210] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 12.0] [Reference Citation Analysis]
263 Tran DT, Welsh RC, Ohinmaa A, Thanh NX, Kaul P. Resource Use and Burden of Hospitalization, Outpatient, Physician, and Drug Costs in Short- and Long-term Care After Acute Myocardial Infarction. Can J Cardiol 2018;34:1298-306. [PMID: 30170782 DOI: 10.1016/j.cjca.2018.05.022] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
264 Schmucker J, Fach A, Mata Marin LA, Retzlaff T, Osteresch R, Kollhorst B, Hambrecht R, Pohlabeln H, Wienbergen H. Efficacy and Safety of Ticagrelor in Comparison to Clopidogrel in Elderly Patients With ST-Segment-Elevation Myocardial Infarctions. J Am Heart Assoc 2019;8:e012530. [PMID: 31538856 DOI: 10.1161/JAHA.119.012530] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 4.7] [Reference Citation Analysis]
265 Baber U, Dangas G, Angiolillo DJ, Cohen DJ, Sharma SK, Nicolas J, Briguori C, Cha JY, Collier T, Dudek D, Džavik V, Escaned J, Gil R, Gurbel P, Hamm CW, Henry T, Huber K, Kastrati A, Kaul U, Kornowski R, Krucoff M, Kunadian V, Marx SO, Mehta S, Moliterno D, Ohman EM, Oldroyd K, Sardella G, Sartori S, Shlofmitz R, Steg PG, Weisz G, Witzenbichler B, Han Y, Pocock S, Gibson CM, Mehran R. Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS. European Heart Journal 2020;41:3533-45. [DOI: 10.1093/eurheartj/ehaa670] [Cited by in Crossref: 26] [Cited by in F6Publishing: 18] [Article Influence: 13.0] [Reference Citation Analysis]
266 Mair J. Circulating micro ribonucleic acids in cardiovascular disease: a look beyond myocardial injury. Ann Transl Med 2016;4:S30. [PMID: 27867998 DOI: 10.21037/atm.2016.10.67] [Cited by in Crossref: 12] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
267 López HV, Vivas MF, Ruiz RN, Martínez JR, Navaridas BG, Villa MG, Lázaro CL, Rubio RJ, Ortiz AM, Lacal LA, Diéguez AM. Association between post-procedural hyperoxia and poor functional outcome after mechanical thrombectomy for ischemic stroke: an observational study. Ann Intensive Care 2019;9:59. [PMID: 31127402 DOI: 10.1186/s13613-019-0533-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
268 Shoaib A, Rashid M, Berry C, Curzen N, Kontopantelis E, Timmis A, Ahmad A, Kinnaird T, Mamas MA. Clinical Characteristics, Management Strategies, and Outcomes of Non-ST-Segment-Elevation Myocardial Infarction Patients With and Without Prior Coronary Artery Bypass Grafting. J Am Heart Assoc 2021;10:e018823. [PMID: 34612049 DOI: 10.1161/JAHA.120.018823] [Reference Citation Analysis]
269 Montefusco A, De Filippo O, Gili S, Mancone M, Calcagno S, Cirillo P, Esposito G, Poli A, Ferrara E, Smolka G, Wanha W, Palmieri C, Pastormerlo LE, Baumbach A, Sganzerla P, Tamburino C, Bruno F, Secco GG, Nicolino A, Yew KL, di Palma G, Wojakowski W, Sardella G, Rinaldi M, Cortese B, D'Ascenzo F. Safety and effectiveness of the self-aPposing, bAlloon-delivered, siRolimus-eluting stent for the Treatment of the coronary Artery disease: SPARTA, a multicenter experience. Coron Artery Dis 2020;31:27-34. [PMID: 31658146 DOI: 10.1097/MCA.0000000000000790] [Reference Citation Analysis]
270 Giannitsis E, Clifford P, Slagman A, Ruedelstein R, Liebetrau C, Hamm C, Honnart D, Huber K, Vollert JO, Simonelli C, Schröder M, Wiemer JC, Mueller-Hennessen M, Schroer H, Kastner K, Möckel M. Multicentre cross-sectional observational registry to monitor the safety of early discharge after rule-out of acute myocardial infarction by copeptin and troponin: the Pro-Core registry. BMJ Open 2019;9:e028311. [PMID: 31340965 DOI: 10.1136/bmjopen-2018-028311] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
271 Gencer B, Mach F. Lipid management in ACS: Should we go lower faster? Atherosclerosis 2018;275:368-75. [PMID: 30015301 DOI: 10.1016/j.atherosclerosis.2018.06.871] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
272 Jayanti S, Juergens C, Makris A, Hennessy A, Nguyen P. The Learning Curves for Transradial and Ultrasound-Guided Arterial Access: An Analysis of the SURF Trial. Heart Lung Circ 2021;30:1329-36. [PMID: 33722490 DOI: 10.1016/j.hlc.2021.02.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
273 Patel KK, Arnold SV, Jones PG, Qintar M, Alexander KP, Spertus JA. Relation of Age and Health-Related Quality of Life to Invasive Versus Ischemia-Guided Management of Patients with Non-ST Elevation Myocardial Infarction. Am J Cardiol 2018;121:789-95. [PMID: 29397885 DOI: 10.1016/j.amjcard.2017.12.034] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
274 Adamo M, Ariotti S, Costa F, Curello S, Moschovitis A, de Vries T, White HD, Windecker S, Valgimigli M. Phosphate- or Citrate-Buffered Tirofiban Versus Unfractionated Heparin and its Impact on Thrombocytopenia and Clinical Outcomes in Patients With Acute Coronary Syndrome. JACC: Cardiovascular Interventions 2016;9:1667-76. [DOI: 10.1016/j.jcin.2016.05.031] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
275 Jneid H. Merits of Invasive Strategy in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome. J Am Heart Assoc 2017;6:e005773. [PMID: 28528325 DOI: 10.1161/JAHA.117.005773] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
276 Ahrens I, Averkov O, Zúñiga EC, Fong AYY, Alhabib KF, Halvorsen S, Abdul Kader MABSK, Sanz-Ruiz R, Welsh R, Yan H, Aylward P. Invasive and antiplatelet treatment of patients with non-ST-segment elevation myocardial infarction: Understanding and addressing the global risk-treatment paradox. Clin Cardiol 2019;42:1028-40. [PMID: 31317575 DOI: 10.1002/clc.23232] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
277 Sousa-uva M, Neumann F, Ahlsson A, Alfonso F, Banning AP, Benedetto U, Byrne RA, Collet J, Falk V, Head SJ, Jüni P, Kastrati A, Koller A, Kristensen SD, Niebauer J, Richter DJ, Seferović PM, Sibbing D, Stefanini GG, Windecker S, Yadav R, Zembala MO, Wijns W, Glineur D, Aboyans V, Achenbach S, Agewall S, Andreotti F, Barbato E, Baumbach A, Brophy J, Bueno H, Calvert PA, Capodanno D, Davierwala PM, Delgado V, Dudek D, Freemantle N, Funck-brentano C, Gaemperli O, Gielen S, Gilard M, Gorenek B, Haasenritter J, Haude M, Ibanez B, Iung B, Jeppsson A, Katritsis D, Knuuti J, Kolh P, Leite-moreira A, Lund LH, Maisano F, Mehilli J, Metzler B, Montalescot G, Pagano D, Petronio AS, Piepoli MF, Popescu BA, Sádaba R, Shlyakhto E, Silber S, Simpson IA, Sparv D, Tavilla G, Thiele H, Tousek P, Van Belle E, Vranckx P, Witkowski A, Zamorano JL, Roffi M, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, Mcdonagh TA, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Sousa-uva M, Simpson IA, Zamorano JL, Pagano D, Freemantle N, Sousa-uva M, Chettibi M, Sisakian H, Metzler B, İbrahimov F, Stelmashok VI, Postadzhiyan A, Skoric B, Eftychiou C, Kala P, Terkelsen CJ, Magdy A, Eha J, Niemelä M, Kedev S, Motreff P, Aladashvili A, Mehilli J, Kanakakis I, Becker D, Gudnason T, Peace A, Romeo F, Bajraktari G, Kerimkulova A, Rudzītis A, Ghazzal Z, Kibarskis A, Pereira B, Xuereb RG, Hofma SH, Steigen TK, Witkowski A, de Oliveira EI, Mot S, Duplyakov D, Zavatta M, Beleslin B, Kovar F, Bunc M, Ojeda S, Witt N, Jeger R, Addad F, Akdemir R, Parkhomenko A, Henderson R; ESC Scientific Document Group. 2018 ESC/EACTS Guidelines on myocardial revascularization. European Journal of Cardio-Thoracic Surgery 2019;55:4-90. [DOI: 10.1093/ejcts/ezy289] [Cited by in Crossref: 208] [Cited by in F6Publishing: 154] [Article Influence: 52.0] [Reference Citation Analysis]
278 Cook B, McCord J, Hudson M, Al-Darzi W, Moyer M, Jacobsen G, Nowak R. Baseline High Sensitivity Cardiac Troponin I Level Below Limit of Quantitation Rules Out Acute Myocardial Infarction in the Emergency Department. Crit Pathw Cardiol 2021;20:4-9. [PMID: 32639243 DOI: 10.1097/HPC.0000000000000230] [Reference Citation Analysis]
279 Aimo A, Vergaro G, Passino C, Clerico A. Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure. Crit Rev Clin Lab Sci 2021;:1-16. [PMID: 34196254 DOI: 10.1080/10408363.2021.1942782] [Reference Citation Analysis]
280 Pollack CV, Amin A, Wang T, Deitelzweig S, Cohen M, Slattery D, Fanikos J, DiLascia C, Tuder R, Kaatz S. Contemporary NSTEMI management: the role of the hospitalist. Hosp Pract (1995) 2020;48:1-11. [PMID: 31815570 DOI: 10.1080/21548331.2020.1701329] [Reference Citation Analysis]
281 Chen CW, Hsieh YC, Hsieh MH, Lin YK, Huang CY, Yeh JS. Predictive Power of In-Hospital and Long-Term Mortality of the GRACE, TIMI, Revised CADILLAC and PAMI Score in NSTEMI Patients with Diabetes - Data from TSOC ACS-DM Registry. Acta Cardiol Sin 2020;36:595-602. [PMID: 33235415 DOI: 10.6515/ACS.202011_36(6).20200326A] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
282 Kusunose K. Radiomics in Echocardiography: Deep Learning and Echocardiographic Analysis. Curr Cardiol Rep 2020;22:89. [PMID: 32648059 DOI: 10.1007/s11886-020-01348-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
283 Parker WAE, Storey RF. Novel approaches to P2Y12 inhibition and aspirin dosing. Platelets 2021;32:7-14. [PMID: 31957518 DOI: 10.1080/09537104.2020.1714574] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
284 Gulati M, Levy PD, Mukherjee D, Amsterdam E, Bhatt DL, Birtcher KK, Blankstein R, Boyd J, Bullock-Palmer RP, Conejo T, Diercks DB, Gentile F, Greenwood JP, Hess EP, Hollenberg SM, Jaber WA, Jneid H, Joglar JA, Morrow DA, O'Connor RE, Ross MA, Shaw LJ; Writing Committee Members. 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol 2021;78:e187-285. [PMID: 34756653 DOI: 10.1016/j.jacc.2021.07.053] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
285 Amann U, Kirchberger I, Heier M, Thilo C, Kuch B, Meisinger C. Medication use in long-term survivors from the MONICA/KORA Myocardial Infarction Registry. Eur J Intern Med 2018;47:62-8. [PMID: 28826823 DOI: 10.1016/j.ejim.2017.08.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
286 Lim AY, Park TK, Cho SW, Oh MS, Lee da H, Seong CS, Gwag HB, Yang JH, Song YB, Hahn JY. Clinical implications of low-dose aspirin on vasospastic angina patients without significant coronary artery stenosis; a propensity score-matched analysis. Int J Cardiol. 2016;221:161-166. [PMID: 27400315 DOI: 10.1016/j.ijcard.2016.06.195] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
287 Shapiro SZ, Sabacinski KA, Mantripragada K, Shah SS, Stein AA, Echeverry NB, MacKinnon GA, Snelling BM. Access-Site Complications in Mechanical Thrombectomy for Acute Ischemic Stroke: A Review of Prospective Trials. AJNR Am J Neuroradiol 2020;41:477-81. [PMID: 32079599 DOI: 10.3174/ajnr.A6423] [Cited by in Crossref: 4] [Article Influence: 2.0] [Reference Citation Analysis]
288 Huang B, Qian Y, Xie S, Ye X, Chen H, Chen Z, Zhang L, Xu J, Hu H, Ma S, Héroux P, Wang D, Shen HM, Wu Y, Xia D. Ticagrelor inhibits the NLRP3 inflammasome to protect against inflammatory disease independent of the P2Y12 signaling pathway. Cell Mol Immunol 2021;18:1278-89. [PMID: 32523112 DOI: 10.1038/s41423-020-0444-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
289 Domingues C, Ferreira MJV, Ferreira JM, Marinho AV, Alves PM, Ferreira C, Fonseca I, Gonçalves L. Prognostic Value of Isolated Elevated Troponin I Levels in Patients without Acute Coronary Syndrome Admitted to the Emergency Department. Arq Bras Cardiol 2021;116:928-37. [PMID: 34008817 DOI: 10.36660/abc.20190356] [Reference Citation Analysis]
290 Adamski P, Ostrowska M, Sikora J, Obońska K, Buszko K, Krintus M, Sypniewska G, Marszałł MP, Koziński M, Kubica J. Comparison of Ticagrelor Pharmacokinetics and Pharmacodynamics in STEMI and NSTEMI Patients (PINPOINT): protocol for a prospective, observational, single-centre study. BMJ Open 2017;7:e013218. [PMID: 28446521 DOI: 10.1136/bmjopen-2016-013218] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
291 Al Said S, Ellscheid M, Beltsios ET, Frey N. Non-Vitamin K Antagonist Oral Anticoagulants in Coronary Artery Disease. Hamostaseologie 2021. [PMID: 34662918 DOI: 10.1055/a-1606-7523] [Reference Citation Analysis]
292 Joo S, Kim S, Choi J, Park HK, Beom JW, Lee J, Chae SC, Kim H, Kim YJ, Cho MC, Kim CJ, Rha S, Yoon J, Jeong MH. Effect of beta-blocker therapy in patients with or without left ventricular systolic dysfunction after acute myocardial infarction. European Heart Journal - Cardiovascular Pharmacotherapy 2020. [DOI: 10.1093/ehjcvp/pvaa029] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
293 Alnsasra H, Zahger D, Geva D, Matetzky S, Beigel R, Iakobishvili Z, Alcalai R, Atar S, Shimony A. Contemporary Determinants of Delayed Benchmark Timelines in Acute Myocardial Infarction in Men and Women. Am J Cardiol 2017;120:1715-9. [PMID: 28864323 DOI: 10.1016/j.amjcard.2017.07.085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
294 Safi S, Sethi NJ, Nielsen EE, Feinberg J, Jakobsen JC, Gluud C. Beta-blockers for suspected or diagnosed acute myocardial infarction. Cochrane Database Syst Rev 2019;12:CD012484. [PMID: 31845756 DOI: 10.1002/14651858.CD012484.pub2] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
295 Zeitouni M, Kerneis M, Nafee T, Collet J, Silvain J, Montalescot G. Anticoagulation in Acute Coronary Syndrome-State of the Art. Progress in Cardiovascular Diseases 2018;60:508-13. [DOI: 10.1016/j.pcad.2018.01.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
296 Xu Z, Sun Y, Xu T, Shi Y, Liang L, Liu P, Ge J. MGUS Predicts Worse Prognosis in Patients with Coronary Artery Disease. J Cardiovasc Transl Res 2020;13:806-12. [PMID: 31900894 DOI: 10.1007/s12265-019-09950-w] [Reference Citation Analysis]
297 Spaich S, Kern H, Zelniker TA, Stiepak J, Gabel M, Popp E, Katus HA, Preusch MR. Feasibility of CardioSecur®, a Mobile 4-Electrode/22-Lead ECG Device, in the Prehospital Emergency Setting. Front Cardiovasc Med 2020;7:551796. [PMID: 33195450 DOI: 10.3389/fcvm.2020.551796] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
298 Dupuy AM, Bargnoux AS, Roubille F, Cristol JP. Letter in reply to the letter to the editor of Geerts N and Schanhorst V with the title "Roche Troponin T hs-STAT meets all expert opinion analytical laboratory practice recommendations for the use of the differential diagnosis of acute coronary syndrome". Clin Chem Lab Med 2021;59:e125-7. [PMID: 32739903 DOI: 10.1515/cclm-2020-0469] [Reference Citation Analysis]
299 Abi Khalil C, Omar OM, Al Suwaidi J, Taheri S. Aspirin Use and Cardiovascular Outcome in Patients With Type 2 Diabetes Mellitus and Heart Failure: A Population-Based Cohort Study. J Am Heart Assoc 2018;7:e010033. [PMID: 30608202 DOI: 10.1161/JAHA.118.010033] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
300 Korjian S, Braunwald E, Daaboul Y, Verheugt F, Bode C, Tendera M, Jain P, Plotnikov A, Burton P, Gibson CM. Safety and efficacy of rivaroxaban for the secondary prevention following acute coronary syndromes among biomarker-positive patients: Insights from the ATLAS ACS 2-TIMI 51 trial. Eur Heart J Acute Cardiovasc Care 2019;8:186-93. [PMID: 29249166 DOI: 10.1177/2048872617745003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
301 Schiele F, Aktaa S, Rossello X, Ahrens I, Claeys MJ, Collet JP, Fox KAA, Gale CP, Huber K, Iakobishvili Z, Keys A, Lambrinou E, Leonardi S, Lettino M, Masoudi FA, Price S, Quinn T, Swahn E, Thiele H, Timmis A, Tubaro M, Vrints CJM, Walker D, Bueno H, Halvorsen S, Jernberg T, Jortveit J, Blöndal M, Ibanez B, Hassager C; ESC Scientific Document Group. 2020 Update of the quality indicators for acute myocardial infarction: a position paper of the Association for Acute Cardiovascular Care: the study group for quality indicators from the ACVC and the NSTE-ACS guideline group. Eur Heart J Acute Cardiovasc Care 2021;10:224-33. [PMID: 33550362 DOI: 10.1093/ehjacc/zuaa037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
302 Afolabi A, Hu S, Wang C, Zhu Y, Mustafina I, Lin L, Zheng G, Zhe C, Jia H, Hou J, Yu B. Role of Optical Coherence Tomography in Diagnosis and Treatment of Patients with Acute Coronary Syndrome. Cardiovascular Innovations and Applications 2017;2:229-35. [DOI: 10.15212/cvia.2016.0054] [Reference Citation Analysis]
303 Guedeney P, Collet JP. Antithrombotic Therapy in Acute Coronary Syndromes: Current Evidence and Ongoing Issues Regarding Early and Late Management. Thromb Haemost 2021;121:854-66. [PMID: 33506483 DOI: 10.1055/s-0040-1722188] [Reference Citation Analysis]
304 Otsuki H, Arashi H, Yamaguchi J, Kawada-Watanabe E, Ogawa H, Hagiwara N. Effect of Ezetimibe + Pitavastatin on Cardiovascular Outcomes in Patients with ST-Segment Elevation Myocardial Infarction (from the HIJ-PROPER Study). Am J Cardiol 2020;132:15-21. [PMID: 32773226 DOI: 10.1016/j.amjcard.2020.06.069] [Reference Citation Analysis]
305 Karauzum I, Karauzum K, Acar B, Hanci K, Bildirici HIU, Kilic T, Ural E. Predictive Value of Lymphocyte-to-monocyte Ratio in Patients with Contrast-induced Nephropathy After Percutaneous Coronary Intervention for Acute Coronary Syndrome. J Transl Int Med 2021;9:123-30. [PMID: 34497751 DOI: 10.2478/jtim-2021-0024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
306 Popovic B, Sorbets E, Abtan J, Cohen M, Pollack CV Jr, Bode C, Wiviott SD, Sabatine MS, Mehta SR, Ruzyllo W, Rao SV, French WJ, Kerkar P, Kiss RG, Estrada JLN, Elbez Y, Ducrocq G, Steg PG; TAO investigators. Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy. Eur Heart J Acute Cardiovasc Care 2020;:2048872619896205. [PMID: 33081496 DOI: 10.1177/2048872619896205] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
307 Desch S. Revascularization strategies in cardiogenic shock after acute myocardial infarction: . Current Opinion in Critical Care 2019;25:379-83. [DOI: 10.1097/mcc.0000000000000623] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
308 Meyers HP, Smith SW. Prospective, real-world evidence showing the gap between ST elevation myocardial infarction (STEMI) and occlusion MI (OMI). International Journal of Cardiology 2019;293:48-9. [DOI: 10.1016/j.ijcard.2019.07.043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
309 Witberg G, Bathish J, Bental T, Leshem-Lev D, Assali A, Kornowski R, Lev E. The effect of cessation of 2nd generation P2Y12 inhibitor therapy on platelet reactivity in patients 1 year after acute myocardial infarction. J Thromb Thrombolysis 2018;46:351-8. [PMID: 29922880 DOI: 10.1007/s11239-018-1701-7] [Reference Citation Analysis]
310 Behnes M, Mashayekhi K, Weiß C, Nienaber C, Lang S, Reiser L, Bollow A, Taton G, Reichelt T, Ellguth D, Engelke N, Schupp T, Ansari U, El-Battrawy I, Rusnak J, Akin M, Borggrefe M, Akin I. Prognostic Impact of Acute Myocardial Infarction in Patients Presenting With Ventricular Tachyarrhythmias and Aborted Cardiac Arrest. J Am Heart Assoc 2018;7:e010004. [PMID: 30371335 DOI: 10.1161/JAHA.118.010004] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
311 Garadah TS, Thani KB, Sulibech L, Jaradat AA, Al Alawi ME, Amin H. Risk Stratification and in Hospital Morality in Patients Presenting with Acute Coronary Syndrome (ACS) in Bahrain. Open Cardiovasc Med J 2018;12:7-17. [PMID: 29541260 DOI: 10.2174/1874192401812010007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
312 Furtado RHM, Nicolau JC, Guo J, Im K, White JA, Sabatine MS, Newby LK, Giugliano RP. Morphine and Cardiovascular Outcomes Among Patients With Non-ST-Segment Elevation Acute Coronary Syndromes Undergoing Coronary Angiography. J Am Coll Cardiol 2020;75:289-300. [PMID: 31976867 DOI: 10.1016/j.jacc.2019.11.035] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
313 De Innocentiis C, Zimarino M, De Caterina R. Is Complete Revascularisation Mandated for all Patients with Multivessel Coronary Artery Disease? Interv Cardiol 2018;13:45-50. [PMID: 29593837 DOI: 10.15420/icr.2017:23:1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.2] [Reference Citation Analysis]
314 Jeong JH, Seo YH, Ahn JY, Kim KH, Seo JY, Chun KY, Lim YS, Park PW. Performance of Copeptin for Early Diagnosis of Acute Myocardial Infarction in an Emergency Department Setting. Ann Lab Med 2020;40:7-14. [PMID: 31432633 DOI: 10.3343/alm.2020.40.1.7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
315 Morawiec B, Fournier S, Tapponnier M, Prior JO, Monney P, Dunet V, Lauriers N, Recordon F, Trana C, Iglesias JF, Kawecki D, Boulat O, Bardy D, Lamsidri S, Eeckhout E, Hugli O, Muller O. Performance of highly sensitive cardiac troponin T assay to detect ischaemia at PET-CT in low-risk patients with acute coronary syndrome: a prospective observational study. BMJ Open 2017;7:e014655. [PMID: 28698323 DOI: 10.1136/bmjopen-2016-014655] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
316 Farquharson B, Abhyankar P, Smith K, Dombrowski SU, Treweek S, Dougall N, Williams B, Johnston M. Reducing delay in patients with acute coronary syndrome and other time-critical conditions: a systematic review to identify the behaviour change techniques associated with effective interventions. Open Heart 2019;6:e000975. [PMID: 30997136 DOI: 10.1136/openhrt-2018-000975] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
317 Lott C, Truhlář A, Alfonzo A, Barelli A, González-Salvado V, Hinkelbein J, Nolan JP, Paal P, Perkins GD, Thies KC, Yeung J, Zideman DA, Soar J. [Cardiac arrest under special circumstances]. Notf Rett Med 2021;:1-77. [PMID: 34127910 DOI: 10.1007/s10049-021-00891-z] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
318 Bobadilla RV. Duration of Dual Antiplatelet Therapy in the Post-Acute Coronary Syndrome Patient. J Cardiovasc Nurs 2018;33:248-54. [PMID: 29251650 DOI: 10.1097/JCN.0000000000000452] [Reference Citation Analysis]
319 Brașoveanu AM, Cruce R, Mogoantă L, Cârlig V. The Treatment of Arterial Hypertension. Curr Health Sci J 2019;45:358-65. [PMID: 32110437 DOI: 10.12865/CHSJ.45.04.03] [Reference Citation Analysis]
320 Alaour B, Liew F, Kaier TE. Cardiac Troponin - diagnostic problems and impact on cardiovascular disease. Annals of Medicine 2018;50:655-65. [DOI: 10.1080/07853890.2018.1530450] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
321 Zanchin C, Ueki Y, Losdat S, Fahrni G, Daemen J, Ondracek AS, Häner JD, Stortecky S, Otsuka T, Siontis GCM, Rigamonti F, Radu M, Spirk D, Kaiser C, Engstrom T, Lang I, Koskinas KC, Räber L. In vivo relationship between near-infrared spectroscopy-detected lipid-rich plaques and morphological plaque characteristics by optical coherence tomography and intravascular ultrasound: a multimodality intravascular imaging study. Eur Heart J Cardiovasc Imaging 2021;22:824-34. [PMID: 31990323 DOI: 10.1093/ehjci/jez318] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
322 Schernthaner C, Paar V, Wernly B, Pistulli R, Rohm I, Jung C, Figulla HR, Yilmaz A, Cadamuro J, Haschke-Becher E, Schulze PC, Hoppe UC, Lichtenauer M, Kretzschmar D. Elevated plasma levels of interleukin-16 in patients with acute myocardial infarction. Medicine (Baltimore) 2017;96:e8396. [PMID: 29095267 DOI: 10.1097/MD.0000000000008396] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
323 Hu YC, Yao WJ, Jin DX, Zhang JX, Wang L, Zhang R, Xu JH, Cong HL. Bivalirudin in patients undergoing percutaneous coronary intervention and independent predictors of postoperative adverse events in these patients: A real world retrospective study. Medicine (Baltimore) 2021;100:e25003. [PMID: 33725878 DOI: 10.1097/MD.0000000000025003] [Reference Citation Analysis]
324 Gaede L, Möllmann H. [The elderly patient with acute coronary syndrome]. Dtsch Med Wochenschr 2021;146:48-57. [PMID: 33395727 DOI: 10.1055/a-1212-9393] [Reference Citation Analysis]
325 Nadarajah R, Gale C. The management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: key points from the ESC 2020 Clinical Practice Guidelines for the general and emergency physician. Clin Med (Lond) 2021;21:e206-11. [PMID: 33762388 DOI: 10.7861/clinmed.2020-0879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
326 Tomaszewski CA, Nestler D, Shah KH, Sudhir A, Brown MD, Brown MD, Wolf SJ, Byyny R, Diercks DB, Gemme SR, Gerardo CJ, Godwin SA, Hahn SA, Harrison NE, Hatten BW, Haukoos JS, Kaji A, Kwok H, Lo BM, Mace SE, Nazarian DJ, Proehl JA, Promes SB, Shah KH, Shih RD, Silvers SM, Smith MD, Thiessen ME, Tomaszewski CA, Valente JH, Wall SP, Cantrill SV, Hirshon JM, Schulz T, Whitson RR. Clinical Policy: Critical Issues in the Evaluation and Management of Emergency Department Patients With Suspected Non–ST-Elevation Acute Coronary Syndromes. Annals of Emergency Medicine 2018;72:e65-e106. [DOI: 10.1016/j.annemergmed.2018.07.045] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 6.3] [Reference Citation Analysis]
327 Yang L, Wang H, Zhang Y, Han T, Wang W. The Prognostic Value of Lipoprotein-Associated Phospholipase A2 in the Long-Term Care of Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention. Clin Appl Thromb Hemost 2018;24:822-7. [PMID: 29121808 DOI: 10.1177/1076029617737837] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
328 Peiró ÓM, Cediel G, Bonet G, Rojas S, Quintern V, Carrasquer A, González-Del-Hoyo M, Sanz E, Bardají A. Soluble urokinase plasminogen activator receptor as a long-term prognostic biomarker in acute coronary syndromes. Biomarkers 2020;25:402-9. [PMID: 32551985 DOI: 10.1080/1354750X.2020.1778090] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
329 Liu Y, Li CP, Lu PJ, Wang XY, Xiao JY, Gao MD, Wang JX, Li XW, Zhang N, Li CJ, Ma J, Gao J. Percutaneous coronary intervention assisted by invasive mechanical ventilation and intra-aortic balloon pump for acute myocardial infarction with cardiogenic shock: Retrospective cohort study and meta-analyses. Bosn J Basic Med Sci 2020;20:514-23. [PMID: 31782697 DOI: 10.17305/bjbms.2019.4500] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
330 Yang Q, Wang Y, Liu J, Liu J, Hao Y, Smith SC, Huo Y, Fonarow GC, Ma C, Ge J, Taubert KA, Morgan L, Guo Y, Wang W, Zhou Y, Zhao D. Invasive Management Strategies and Antithrombotic Treatments in Patients With Non–ST-Segment–Elevation Acute Coronary Syndrome in China: Findings From the Improving CCC Project (Care for Cardiovascular Disease in China). Circ Cardiovasc Interv 2017;10. [DOI: 10.1161/circinterventions.116.004750] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 2.8] [Reference Citation Analysis]
331 Riedlinger D, Möckel M, Müller C, Holert F, Searle J, von Recum J, Slagman A. High-sensitivity cardiac troponin T for diagnosis of NSTEMI in the elderly emergency department patient: a clinical cohort study. Biomarkers 2018;23:551-7. [PMID: 29619842 DOI: 10.1080/1354750X.2018.1460763] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
332 Prejean SP, Din M, Reyes E, Hage FG. Guidelines in review: Comparison of the 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes and the 2015 ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. J Nucl Cardiol 2018;25:769-76. [DOI: 10.1007/s12350-017-1137-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.2] [Reference Citation Analysis]
333 Degli Esposti L, Perrone V, Veronesi C, Buda S, Rossini R; Local Health Unit group. All-cause mortality, cardiovascular events, and health care costs after 12 months of dual platelet aggregation inhibition after acute myocardial infarction in real-world patients: findings from the Platelet-aggregation Inhibition: Persistence with treatment and cardiovascular Events in Real world (PIPER) study. Vasc Health Risk Manag 2018;14:383-92. [PMID: 30538488 DOI: 10.2147/VHRM.S162004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
334 Kraus D, von Jeinsen B, Tzikas S, Palapies L, Zeller T, Bickel C, Fette G, Lackner KJ, Drechsler C, Neumann JT, Baldus S, Blankenberg S, Münzel T, Wanner C, Zeiher AM, Keller T. Cardiac Troponins for the Diagnosis of Acute Myocardial Infarction in Chronic Kidney Disease. J Am Heart Assoc 2018;7:e008032. [PMID: 30371308 DOI: 10.1161/JAHA.117.008032] [Cited by in Crossref: 19] [Cited by in F6Publishing: 9] [Article Influence: 6.3] [Reference Citation Analysis]
335 Giannitsis E, Biener M, Hund H, Mueller-hennessen M, Vafaie M, Gandowitz J, Riedle C, Löhr J, Katus HA, Stoyanov KM. Management and outcomes of patients with unstable angina with undetectable, normal, or intermediate hsTnT levels. Clin Res Cardiol 2020;109:476-87. [DOI: 10.1007/s00392-019-01529-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
336 Sandoval Y, Apple FS, Smith SW. High-sensitivity cardiac troponin assays and unstable angina. European Heart Journal: Acute Cardiovascular Care 2018;7:120-8. [DOI: 10.1177/2048872616658591] [Cited by in Crossref: 29] [Cited by in F6Publishing: 26] [Article Influence: 4.8] [Reference Citation Analysis]
337 Boeddinghaus J, Twerenbold R, Nestelberger T, Badertscher P, Wildi K, Puelacher C, du Fay de Lavallaz J, Keser E, Rubini Giménez M, Wussler D, Kozhuharov N, Rentsch K, Miró Ò, Martin-sanchez FJ, Morawiec B, Stefanelli S, Geigy N, Keller DI, Reichlin T, Mueller C, Sanchez AY, Breidthardt T, Mueller D, Sazgary L, Marbot S, Sabti Z, Flores D, Mahfouz R, Osswald S, Schaerli N, Freese M, Stelzig C, Meissner K, Kulangara C, Shrestha S, Grimm K, Hartmann B, Ferel I, López B, Fuenzalida C, Adrada ER, Ganovská E, Lohrmann J, Kloos W, Buser A, von Eckardstein A, Muzyk P, Nowalany-kozielska E, Kawecki D, Parenica J; for the APACE Investigators. Clinical Validation of a Novel High-Sensitivity Cardiac Troponin I Assay for Early Diagnosis of Acute Myocardial Infarction. Clinical Chemistry 2018;64:1347-60. [DOI: 10.1373/clinchem.2018.286906] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 13.3] [Reference Citation Analysis]
338 Reed GW, Rossi JE, Cannon CP. Acute myocardial infarction. Lancet. 2017;389:197-210. [PMID: 27502078 DOI: 10.1016/s0140-6736(16)30677-8] [Cited by in Crossref: 307] [Cited by in F6Publishing: 142] [Article Influence: 51.2] [Reference Citation Analysis]
339 Hollander JE. High-Sensitivity Troponin: Time to Implement. Ann Emerg Med 2018;72:665-7. [PMID: 30243545 DOI: 10.1016/j.annemergmed.2018.07.025] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
340 Wang X, Tian L, Sun Q. Diagnostic and prognostic value of circulating miRNA-499 and miRNA-22 in acute myocardial infarction. J Clin Lab Anal 2020;34:2410-7. [PMID: 32529742 DOI: 10.1002/jcla.23332] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
341 Bom MJ, van der Heijden DJ, Kedhi E, van der Heyden J, Meuwissen M, Knaapen P, Timmer SA, van Royen N. Early Detection and Treatment of the Vulnerable Coronary Plaque: Can We Prevent Acute Coronary Syndromes? Circ: Cardiovascular Imaging 2017;10. [DOI: 10.1161/circimaging.116.005973] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 6.6] [Reference Citation Analysis]
342 Rath D, Geisler T. Optimal antiplatelet and anticoagulation strategies in acute coronary syndromes. Herz 2020;45:528-36. [PMID: 32507904 DOI: 10.1007/s00059-020-04947-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
343 Maras P, Doimo S, Altinier A, Della Mattia A, Scudeller L, Sinagra G, Klersy C. ‘PERFSCORE’ – a multidimensional score: a simple way to predict the success of cardiac rehabilitation. Journal of Cardiovascular Medicine 2017;18:617-24. [DOI: 10.2459/jcm.0000000000000518] [Cited by in Crossref: 8] [Article Influence: 1.6] [Reference Citation Analysis]
344 Rozenbaum Z, Elis A, Shuvy M, Vorobeichik D, Shlomo N, Shlezinger M, Goldenberg I, kimhi O, Pereg D. CHA2DS2-VASc score and clinical outcomes of patients with acute coronary syndrome. European Journal of Internal Medicine 2016;36:57-61. [DOI: 10.1016/j.ejim.2016.09.010] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 3.7] [Reference Citation Analysis]
345 Cainzos-Achirica M, Rebordosa C, Vela E, Cleries M, Matsushita K, Plana E, Rivero-Ferrer E, Enjuanes C, Jimenez-Marrero S, Garcia-Rodriguez LA, Comin-Colet J, Perez-Gutthann S. Challenges of evaluating chronic heart failure and acute heart failure events in research studies using large health care databases. Am Heart J 2018;202:76-83. [PMID: 29902694 DOI: 10.1016/j.ahj.2018.05.005] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
346 Parsonage WA, Mueller C, Greenslade JH, Wildi K, Pickering J, Than M, Aldous S, Boeddinghaus J, Hammett CJ, Hawkins T, Nestelberger T, Reichlin T, Reidt S, Rubin Gimenez M, Tate JR, Twerenbold R, Ungerer JP, Cullen L. Validation of NICE diagnostic guidance for rule out of myocardial infarction using high-sensitivity troponin tests. Heart 2016;102:1279-86. [PMID: 27288278 DOI: 10.1136/heartjnl-2016-309270] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
347 Volpe M, Battistoni A, Gallo G, Coluccia R, De Caterina R. Aspirin and the Primary Prevention of Cardiovascular Diseases: An Approach Based on Individualized, Integrated Estimation of Risk. High Blood Press Cardiovasc Prev 2017;24:331-9. [DOI: 10.1007/s40292-017-0213-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
348 Oliveros E, Brailovsky Y, Aggarwal V. Overview of Options for Mechanical Circulatory Support. Interv Cardiol Clin 2021;10:147-56. [PMID: 33745665 DOI: 10.1016/j.iccl.2020.12.009] [Reference Citation Analysis]
349 Fournier S, Iten L, Marques-vidal P, Boulat O, Bardy D, Beggah A, Calderara R, Morawiec B, Lauriers N, Monney P, Iglesias JF, Pascale P, Harbaoui B, Eeckhout E, Muller O. Circadian rhythm of blood cardiac troponin T concentration. Clin Res Cardiol 2017;106:1026-32. [DOI: 10.1007/s00392-017-1152-8] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 5.6] [Reference Citation Analysis]
350 Martinsson A, Li X, Torp-Pedersen C, Zöller B, Andell P, Andreasen C, Gislason G, Køber L, Sundquist K, Smith JG, Andersson C. Outcomes associated with dual antiplatelet therapy after myocardial infarction in patients with aortic stenosis. Int J Cardiol 2019;281:140-5. [PMID: 30722957 DOI: 10.1016/j.ijcard.2019.01.063] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
351 Gager GM, Jilma B, Winter MP, Hengstenberg C, Lang IM, Toma A, Prüller F, Wallner M, Kolesnik E, von Lewinski D, Siller-Matula JM. Ticagrelor and prasugrel are independent predictors of improved long-term survival in ACS patients. Eur J Clin Invest 2020;50:e13304. [PMID: 32506444 DOI: 10.1111/eci.13304] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
352 Kaier TE, Twerenbold R, Puelacher C, Marjot J, Imambaccus N, Boeddinghaus J, Nestelberger T, Badertscher P, Sabti Z, Giménez MR, Wildi K, Hillinger P, Grimm K, Loeffel S, Shrestha S, Widmer DF, Cupa J, Kozhuharov N, Miró Ò, Martín-Sánchez FJ, Morawiec B, Rentsch K, Lohrmann J, Kloos W, Osswald S, Reichlin T, Weber E, Marber M, Mueller C. Direct Comparison of Cardiac Myosin-Binding Protein C With Cardiac Troponins for the Early Diagnosis of Acute Myocardial Infarction. Circulation 2017;136:1495-508. [PMID: 28972002 DOI: 10.1161/CIRCULATIONAHA.117.028084] [Cited by in Crossref: 41] [Cited by in F6Publishing: 15] [Article Influence: 8.2] [Reference Citation Analysis]
353 Orenes-Piñero E, Ruiz-Nodar JM, Esteve-Pastor MA, Quintana-Giner M, Rivera-Caravaca JM, Veliz A, Valdés M, Macías M, Pernias-Escrig V, Vicente-Ibarra N, Carrillo L, Sandín-Rollán M, Candela E, Lozano T, Marín F. Therapeutic management and one-year outcomes in elderly patients with acute coronary syndrome. Oncotarget 2017;8:80182-91. [PMID: 29113294 DOI: 10.18632/oncotarget.21260] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
354 Schneider VS, Böhm F, Blum K, Riedel M, Abdelwahed YS, Klotsche J, Steiner JK, Heuberger A, Skurk C, Mochmann HC, Lauten A, Fröhlich G, Rauch-Kröhnert U, Haghikia A, Sinning D, Stähli BE, Landmesser U, Leistner DM. Impact of real-time angiographic co-registered optical coherence tomography on percutaneous coronary intervention: the OPTICO-integration II trial. Clin Res Cardiol 2021;110:249-57. [PMID: 32889633 DOI: 10.1007/s00392-020-01739-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
355 Kubica A, Kosobucka A, Niezgoda P, Adamski P, Buszko K, Lesiak M, Wojakowski W, Gasior M, Gorący J, Kleinrok A, Nadolny K, Navarese E, Kubica J. ANalgesic Efficacy and safety of MOrphiNe versus methoxyflurane in patients with acute myocardial infarction: the rationale and design of the ANEMON-SIRIO 3 study: a multicentre, open-label, phase II, randomised clinical trial. BMJ Open 2021;11:e043330. [PMID: 33649058 DOI: 10.1136/bmjopen-2020-043330] [Reference Citation Analysis]
356 Veličković VM, Rochau U, Conrads-frank A, Kee F, Blankenberg S, Siebert U. Systematic assessment of decision-analytic models evaluating diagnostic tests for acute myocardial infarction based on cardiac troponin assays. Expert Review of Pharmacoeconomics & Outcomes Research 2018;18:619-40. [DOI: 10.1080/14737167.2018.1512857] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
357 Adamson PD, McAllister D, Pilbrow A, Pickering JW, Poppe K, Shah A, Whalley G, Ellis C, Mills NL, Newby DE, Pemberton C, Troughton RW, Doughty RN, Richards AM. Convalescent troponin and cardiovascular death following acute coronary syndrome. Heart 2019;105:1717-24. [PMID: 31337669 DOI: 10.1136/heartjnl-2019-315084] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
358 Chang XW, Zhang SY, Wang H, Zhang MM, Zheng WF, Ma HF, Gu YF, Wei JH, Qiu CG. Combined value of red blood cell distribution width and global registry of acute coronary events risk score on predicting long-term major adverse cardiac events in STEMI patients undergoing primary PCI. Oncotarget 2018;9:13971-80. [PMID: 29568409 DOI: 10.18632/oncotarget.24128] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
359 Caporale R, Geraci G, Gulizia MM, Borzi M, Colivicchi F, Menozzi A, Musumeci G, Scherillo M, Ledda A, Tarantini G, Gerometta P, Casolo G, Formigli D, Romeo F, Di Bartolomeo R. Consensus Document of the Italian Association of Hospital Cardiologists (ANMCO), Italian Society of Cardiology (SIC), Italian Association of Interventional Cardiology (SICI-GISE) and Italian Society of Cardiac Surgery (SICCH): clinical approach to pharmacologic pre-treatment for patients undergoing myocardial revascularization procedures. Eur Heart J Suppl 2017;19:D151-62. [PMID: 28751841 DOI: 10.1093/eurheartj/sux010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
360 Lin Z, Lim SH, Chua SJT, Tai ES, Chan YH, Richards AM. High-sensitivity troponin T and long-term adverse cardiac events among patients presenting with suspected acute coronary syndrome in Singapore. Singapore Med J 2019;60:418-26. [PMID: 30773602 DOI: 10.11622/smedj.2019013] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
361 Cotoban AG, Udroiu CA, Vina R, Vinereanu D. Antithrombotic Strategies in Invasively Managed Patients with Non-ST Elevation Acute Coronary Syndromes and Non-Valvular Atrial Fibrillation in Romania. Maedica (Bucur) 2021;16:6-15. [PMID: 34221150 DOI: 10.26574/maedica.2020.16.1.6] [Reference Citation Analysis]
362 Bjørnsen LP, Naess-pleym LE, Dale J, Grenne B, Wiseth R. Description of chest pain patients in a Norwegian emergency department. Scandinavian Cardiovascular Journal 2019;53:28-34. [DOI: 10.1080/14017431.2019.1583362] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
363 Tsarouchas A, Mouselimis D, Bakogiannis C, Gkasdaris G, Dimitriadis G, Zioutas D, Papadopoulos CE. Spontaneous Epidural Hematoma of the Cervical Spine Following Thrombolysis in a Patient with STEMI-Two Medical Specialties Facing a Rare Dilemma. J Neurosci Rural Pract 2020;11:191-5. [PMID: 32140027 DOI: 10.1055/s-0039-3400182] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
364 Roos A, Sartipy U, Ljung R, Holzmann MJ. Relation of Chronic Myocardial Injury and Non-ST-Segment Elevation Myocardial Infarction to Mortality. Am J Cardiol 2018;122:1989-95. [PMID: 30314814 DOI: 10.1016/j.amjcard.2018.09.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
365 Naber CK, Urban P, Ong PJ, Valdes-Chavarri M, Abizaid AA, Pocock SJ, Fabbiocchi F, Dubois C, Copt S, Greene S, Morice MC; LEADERS FREE Investigators. Biolimus-A9 polymer-free coated stent in high bleeding risk patients with acute coronary syndrome: a Leaders Free ACS sub-study. Eur Heart J 2017;38:961-9. [PMID: 27190095 DOI: 10.1093/eurheartj/ehw203] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
366 Hung J, Roos A, Kadesjö E, McAllister DA, Kimenai DM, Shah ASV, Anand A, Strachan FE, Fox KAA, Mills NL, Chapman AR, Holzmann MJ. Performance of the GRACE 2.0 score in patients with type 1 and type 2 myocardial infarction. Eur Heart J 2021;42:2552-61. [PMID: 32516805 DOI: 10.1093/eurheartj/ehaa375] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 7.0] [Reference Citation Analysis]
367 Kim YH, Her AY, Jeong MH, Kim BK, Hong SJ, Kim S, Ahn CM, Kim JS, Ko YG, Choi D, Hong MK, Jang Y. Impacts of renin-angiotensin system inhibitors on two-year clinical outcomes in diabetic and dyslipidemic acute myocardial infarction patients after a successful percutaneous coronary intervention using newer-generation drug-eluting stents. Medicine (Baltimore) 2020;99:e21289. [PMID: 32791710 DOI: 10.1097/MD.0000000000021289] [Reference Citation Analysis]
368 Bueno H, Pocock S, Danchin N, Annemans L, Gregson J, Medina J, Van de Werf F. International patterns of dual antiplatelet therapy duration after acute coronary syndromes. Heart 2017;103:132-8. [PMID: 27504002 DOI: 10.1136/heartjnl-2016-309509] [Cited by in Crossref: 34] [Cited by in F6Publishing: 22] [Article Influence: 5.7] [Reference Citation Analysis]
369 Haller PM, Beer BN, Tonkin AM, Blankenberg S, Neumann JT. Role of Cardiac Biomarkers in Epidemiology and Risk Outcomes. Clin Chem 2021;67:96-106. [PMID: 33225348 DOI: 10.1093/clinchem/hvaa228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
370 Zhang S, Xu K, Mei L, Zhu H, Li J, Wang F, Yang L, Zhang J, Fan Y, Zou F, Niles K, Eikelboom JW, Li C. Reversal of the antiplatelet effect of ticagrelor by simulated platelet transfusion. Transfusion 2019;59:1850-6. [PMID: 30802336 DOI: 10.1111/trf.15219] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
371 Wang Z, Wang J, Cao D, Han L. Correlation of neutrophil-to-lymphocyte ratio with the prognosis of non-ST-segment elevation in patients with acute coronary syndrome undergoing selective percutaneous coronary intervention. J Int Med Res 2020;48:300060520959510. [PMID: 33050747 DOI: 10.1177/0300060520959510] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
372 Kavsak PA, Neumann JT, Cullen L, Than M, Shortt C, Greenslade JH, Pickering JW, Ojeda F, Ma J, Clayton N, Sherbino J, Hill SA, McQueen M, Westermann D, Sörensen NA, Parsonage WA, Griffith L, Mehta SR, Devereaux PJ, Richards M, Troughton R, Pemberton C, Aldous S, Blankenberg S, Worster A. Clinical chemistry score versus high-sensitivity cardiac troponin I and T tests alone to identify patients at low or high risk for myocardial infarction or death at presentation to the emergency department. CMAJ 2018;190:E974-84. [PMID: 30127037 DOI: 10.1503/cmaj.180144] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
373 Im J, Kawada-Watanabe E, Yamaguchi J, Arashi H, Otsuki H, Matsui Y, Sekiguchi H, Fujii S, Mori F, Ogawa H, Hagiwara N. Baseline low-density lipoprotein cholesterol predicts the benefit of adding ezetimibe on statin in statin-naïve acute coronary syndrome. Sci Rep 2021;11:7480. [PMID: 33820931 DOI: 10.1038/s41598-021-87098-x] [Reference Citation Analysis]
374 Suzuki T, Lyon A, Saggar R, Heaney LM, Aizawa K, Cittadini A, Mauro C, Citro R, Limongelli G, Ferrara F, Vriz O, Morley-Smith A, Calabrò P, Bossone E. Editor's Choice-Biomarkers of acute cardiovascular and pulmonary diseases. Eur Heart J Acute Cardiovasc Care 2016;5:416-33. [PMID: 27221957 DOI: 10.1177/2048872616652309] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
375 Tajsic M, Járai R, Koch J, Stangl K, Wojta J, Dreger H, Huber K. Midregional pro-A-type natriuretic peptide as part of a dual biomarker strategy for the early rule out of non-ST segment elevation acute coronary syndrome – The WilCop study. International Journal of Cardiology 2018;273:243-8. [DOI: 10.1016/j.ijcard.2018.09.084] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
376 Liu R, Lyu SZ, Zhao GQ, Zheng W, Wang X, Zhao XD, Zhou SH, Zhen L, Nie SP. Comparison of the performance of the CRUSADE, ACUITY-HORIZONS, and ACTION bleeding scores in ACS patients undergoing PCI: insights from a cohort of 4939 patients in China. J Geriatr Cardiol 2017;14:93-9. [PMID: 28491083 DOI: 10.11909/j.issn.1671-5411.2017.02.011] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
377 Gencer B, Rigamonti F, Nanchen D, Klingenberg R, Räber L, Moutzouri E, Auer R, Carballo D, Heg D, Windecker S, Lüscher TF, Matter CM, Rodondi N, Mach F, Roffi M. Prognostic values of fasting hyperglycaemia in non-diabetic patients with acute coronary syndrome: A prospective cohort study. European Heart Journal. Acute Cardiovascular Care 2020;9:589-98. [DOI: 10.1177/2048872618777819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
378 Zafirovska B, Antov S, Kostov J, Spiroski I, Vasilev I, Jovkovski A, Kitanoski D, Petkoska D, Bertrand OF, Kedev S. Benefit of routine preprocedural radial artery angiography in STEMI patients. Catheter Cardiovasc Interv 2019;93:25-31. [DOI: 10.1002/ccd.27711] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
379 Joseph JP, Redwood SR. Timing of coronary angioplasty in patients with non-ST-segment elevation acute coronary syndromes. Eur Heart J Qual Care Clin Outcomes 2017;3:6-8. [PMID: 28927184 DOI: 10.1093/ehjqcco/qcw059] [Reference Citation Analysis]
380 Perings S, Smetak N, Kelm M, Gremmler U, Darius H, Senges J, Münzel T, Giannitsis E, Katus H. Kriterien der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. für „Brustschmerz-Ambulanzen“: Update 2016. Kardiologe 2016;10:301-6. [DOI: 10.1007/s12181-016-0074-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
381 Yndigegn T, Hofmann R, Jernberg T, Gale CP. Registry-based randomised clinical trial: efficient evaluation of generic pharmacotherapies in the contemporary era. Heart 2018;104:1562-7. [PMID: 29666176 DOI: 10.1136/heartjnl-2017-312322] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
382 Cea Soriano L, Soriano-Gabarró M, García Rodríguez LA. Incidence of colorectal cancer in new users and non-users of low-dose aspirin without existing cardiovascular disease: A cohort study using The Health Improvement Network. Int J Cardiol 2017;248:376-81. [PMID: 28942878 DOI: 10.1016/j.ijcard.2017.06.052] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
383 Waldsperger H, Biener M, Stoyanov KM, Vafaie M, Katus HA, Giannitsis E, Mueller-Hennessen M. Prognostic Value of Elevated Copeptin and High-Sensitivity Cardiac Troponin T in Patients with and without Acute Coronary Syndrome: The ConTrACS Study. J Clin Med 2020;9:E3627. [PMID: 33187192 DOI: 10.3390/jcm9113627] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
384 Twerenbold R, Jaeger C, Rubini Gimenez M, Wildi K, Reichlin T, Nestelberger T, Boeddinghaus J, Grimm K, Puelacher C, Moehring B, Pretre G, Schaerli N, Campodarve I, Rentsch K, Steuer S, Osswald S, Mueller C. Impact of high-sensitivity cardiac troponin on use of coronary angiography, cardiac stress testing, and time to discharge in suspected acute myocardial infarction. Eur Heart J 2016;37:3324-32. [PMID: 27357358 DOI: 10.1093/eurheartj/ehw232] [Cited by in Crossref: 85] [Cited by in F6Publishing: 69] [Article Influence: 14.2] [Reference Citation Analysis]
385 Fladseth K, Kristensen A, Mannsverk J, Trovik T, Schirmer H. Pre-test characteristics of unstable angina patients with obstructive coronary artery disease confirmed by coronary angiography. Open Heart 2018;5:e000888. [PMID: 30487980 DOI: 10.1136/openhrt-2018-000888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
386 Chen PY, Liu YH, Duan CY, Fan HL, Zeng LH, Guo W, Jiang L, Wei XB, He WF, Tao S, Guo ZQ, Chen JY, Tan N, He PC. Association of in-hospital intensive statins dosage and death in arteriosclerotic cardiovascular disease with percutaneous coronary intervention: insights of multicentre cohort from China. Eur J Clin Pharmacol 2020;76:1755-63. [PMID: 32700000 DOI: 10.1007/s00228-020-02966-1] [Reference Citation Analysis]
387 Bhattad VB, Gaddam S, Lassiter MA, Jagadish PS, Ardeshna D, Cave B, Khouzam RN. Intravenous cangrelor as a peri-procedural bridge with applied uses in ischemic events. Ann Transl Med 2019;7:408. [PMID: 31660307 DOI: 10.21037/atm.2019.07.64] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
388 Miki R, Takeuchi M, Imai T, Seki T, Tanaka S, Nakamura M, Kawakami K. Association of intensive care unit admission and mortality in patients with acute myocardial infarction. Journal of Cardiology 2019;74:109-15. [DOI: 10.1016/j.jjcc.2019.01.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
389 Rasmussen MB, Stengaard C, Sørensen JT, Riddervold IS, Søndergaard HM, Niemann T, Dodt KK, Frost L, Jensen T, Raungaard B, Hansen TM, Giebner M, Rasmussen C, Bøtker HE, Kristensen SD, Maeng M, Christiansen EH, Terkelsen CJ. Comparison of Acute Versus Subacute Coronary Angiography in Patients With NON-ST-Elevation Myocardial Infarction (from the NONSTEMI Trial). The American Journal of Cardiology 2019;124:825-32. [DOI: 10.1016/j.amjcard.2019.06.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
390 Noble S, Roffi M. Routine beta-blocker administration following acute myocardial infarction: why still an unsolved issue? J Thorac Dis 2017;9:4191-4. [PMID: 29268468 DOI: 10.21037/jtd.2017.10.25] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
391 Atıcı A, Barman HA, Erturk E, Baycan OF, Fidan S, Demirel KC, Asoglu R, Demir K, Ozturk F, Elitok A, Okuyan E, Sahin I. Multilayer longitudinal strain can help predict the development of no-reflow in patients with acute coronary syndrome without ST elevation. Int J Cardiovasc Imaging 2019;35:1811-21. [PMID: 31093895 DOI: 10.1007/s10554-019-01623-8] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
392 Wein B, Coslovsky M, Jabbari R, Galatius S, Pfisterer M, Kaiser C. Prasugrel vs. clopidogrel in contemporary Western European patients with acute coronary syndromes receiving drug-eluting stents: Comparative cost-effectiveness analysis from the BASKET-PROVE cohorts. Int J Cardiol 2017;248:20-7. [PMID: 28823409 DOI: 10.1016/j.ijcard.2017.07.102] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
393 Bainey KR, Welsh RC, Alemayehu W, Westerhout CM, Traboulsi D, Anderson T, Brass N, Armstrong PW, Kaul P. Population-level incidence and outcomes of myocardial infarction with non-obstructive coronary arteries (MINOCA): Insights from the Alberta contemporary acute coronary syndrome patients invasive treatment strategies (COAPT) study. Int J Cardiol 2018;264:12-7. [PMID: 29655952 DOI: 10.1016/j.ijcard.2018.04.004] [Cited by in Crossref: 52] [Cited by in F6Publishing: 40] [Article Influence: 13.0] [Reference Citation Analysis]
394 Bardaji A, Barrabés JA, Ribera A, Bueno H, Fernández-Ortiz A, Marrugat J, Oristrell G, Ferreira-González I. Revascularisation in older adult patients with non-ST-segment elevation acute coronary syndrome: effect and impact on 6-month mortality. Eur Heart J Acute Cardiovasc Care 2020;9:358-66. [PMID: 31084380 DOI: 10.1177/2048872619849922] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
395 Park CS, Yang HM, Ki YJ, Kang J, Han JK, Park KW, Kang HJ, Koo BK, Kim CJ, Cho MC, Kim YJ, Chae SC, Jeong MH, Kim HS; KAMIR-NIH Registry. Left Ventricular Ejection Fraction 1 Year After Acute Myocardial Infarction Identifies the Benefits of the Long-Term Use of β-Blockers: Analysis of Data From the KAMIR-NIH Registry. Circ Cardiovasc Interv 2021;14:e010159. [PMID: 33877862 DOI: 10.1161/CIRCINTERVENTIONS.120.010159] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
396 Marin TS, Walsh S, May N, Jones M, Gray R, Muir-Cochrane E, Clark RA. Screening for depression and anxiety among patients with acute coronary syndrome in acute care settings: a scoping review. JBI Evid Synth 2020;18:1932-69. [PMID: 32813429 DOI: 10.11124/JBISRIR-D-19-00316] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
397 Hoedemaker NPG, Damman P, Woudstra P, Hirsch A, Windhausen F, Tijssen JG, de Winter RJ; ICTUS investigators. Ten-year outcomes of an early invasive or a selective invasive strategy in non-ST-segment elevation acute coronary syndrome patients with and without diabetes mellitus: a subgroup analysis of the ICTUS trial. Coron Artery Dis 2020;31:95-7. [PMID: 31658152 DOI: 10.1097/MCA.0000000000000820] [Reference Citation Analysis]
398 Colivicchi F, Gulizia MM, Arca M, Abrignani MG, Perna GP, Mureddu GF, Nardi F, Riccio C; Italian Association of Hospital Cardiologists (ANMCO). ANMCO Scientific Statement: clinical management of hypercholesterolaemia in patients with acute coronary syndromes. Eur Heart J Suppl 2017;19:D64-9. [PMID: 28751835 DOI: 10.1093/eurheartj/sux018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
399 Shabbir A, Fan L, Fraser G, Cassar MP, Swinburn J. One-Hour High Sensitivity Troponin Testing: A Safe and Effective Triage Tool for the Emergency Department. Critical Pathways in Cardiology: A Journal of Evidence-Based Medicine 2019;18:16-8. [DOI: 10.1097/hpc.0000000000000162] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
400 Park J, Lee SH, Jeong DS, Lee YT, Kim Y, Lee SO, Lee SM, Lee JH, Min JJ, Choi JH, Gwon HC, Carriere K, Ahn J, Kim WS. Association Between β-Blockers and Outcome of Coronary Artery Bypass Grafting: Before and After 1 Year. Ann Thorac Surg 2021;111:69-75. [PMID: 32565089 DOI: 10.1016/j.athoracsur.2020.04.127] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
401 Chaulin A. Cardiac Troponins: Contemporary Biological Data and New Methods of Determination. Vasc Health Risk Manag 2021;17:299-316. [PMID: 34113117 DOI: 10.2147/VHRM.S300002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
402 Ahn KT, Seong SW, Choi UL, Jin SA, Kim JH, Lee JH, Choi SW, Jeong MH, Chae SC, Kim YJ, Kim CJ, Kim HS, Cho MC, Gwon HC, Jeong JO, Seong IW; Korea Acute Myocardial Infarction Registry - National Institute of Health (KAMIR-NIH) Investigators. Comparison of 1-year clinical outcomes between prasugrel and ticagrelor versus clopidogrel in type 2 diabetes patients with acute myocardial infarction underwent successful percutaneous coronary intervention. Medicine (Baltimore) 2019;98:e14833. [PMID: 30882670 DOI: 10.1097/MD.0000000000014833] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
403 Zeymer U, Annemans L, Danchin N, Pocock S, Newsome S, Van de Werf F, Medina J, Bueno H. Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry. European Heart Journal: Acute Cardiovascular Care 2019;8:121-9. [DOI: 10.1177/2048872618769057] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 3.5] [Reference Citation Analysis]
404 Udell JA, Koh M, Qiu F, Austin PC, Wijeysundera HC, Bagai A, Yan AT, Goodman SG, Tu JV, Ko DT. Outcomes of Women and Men With Acute Coronary Syndrome Treated With and Without Percutaneous Coronary Revascularization. J Am Heart Assoc 2017;6:e004319. [PMID: 28108465 DOI: 10.1161/JAHA.116.004319] [Cited by in Crossref: 26] [Cited by in F6Publishing: 12] [Article Influence: 5.2] [Reference Citation Analysis]
405 Lambrakis K, French JK, Scott IA, Briffa T, Brieger D, Farkouh ME, White H, Chuang A(, Tiver K, Quinn S, Kaambwa B, Horsfall M, Morton E, Chew DP. The appropriateness of coronary investigation in myocardial injury and type 2 myocardial infarction (ACT-2): A randomized trial design. American Heart Journal 2019;208:11-20. [DOI: 10.1016/j.ahj.2018.09.016] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 8.3] [Reference Citation Analysis]
406 Ferlini M, Musumeci G, Grieco N, Rossini R, De Servi S, Mafrici A, Sponzilli C, Demarchi A, Assanelli EM, Camisasca P, Chizzola G, Corrada E, Farina A, Pedrinazzi C, Lettieri C, Oltrona Visconti L. The paradox of clopidogrel use in patients with acute coronary syndromes and diabetes: insight from the Diabetes and Acute Coronary Syndrome Registry. Coronary Artery Disease 2018;29:309-15. [DOI: 10.1097/mca.0000000000000601] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
407 Cho J, Park IB, Lee K, Ahn TH, Park WB, Kim JH, Ahn Y, Jeong MH, Lee DH; Other Korea Acute Myocardial Infarction Registry (KAMIR) and Korea Working Group on Myocardial Infarction (KorMI) Investigators. Statin has more protective effects in AMI patients with higher plasma BNP or NT-proBNP level, but not with lower left ventricular ejection fraction. J Cardiol 2018;71:375-81. [PMID: 29158023 DOI: 10.1016/j.jjcc.2017.10.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
408 Hoedemaker NPG, Damman P, Woudstra P, Hirsch A, Windhausen F, Tijssen JGP, de Winter RJ; ICTUS Investigators. Early Invasive Vs Selective Strategy for Non-ST-Segment Elevation Acute Coronary Syndrome: The ICTUS Trial. J Am Coll Cardiol. 2017;69:1883-1893. [PMID: 28408018 DOI: 10.1016/j.jacc.2017.02.023] [Cited by in Crossref: 22] [Cited by in F6Publishing: 14] [Article Influence: 4.4] [Reference Citation Analysis]
409 Thiele H, Ohman EM, de Waha-thiele S, Zeymer U, Desch S. Management of cardiogenic shock complicating myocardial infarction: an update 2019. European Heart Journal 2019;40:2671-83. [DOI: 10.1093/eurheartj/ehz363] [Cited by in Crossref: 129] [Cited by in F6Publishing: 106] [Article Influence: 43.0] [Reference Citation Analysis]
410 Rupprecht HJ, Geeren M, Geeren M, Weilemann S, Schuster HP. [Acute coronary syndrome without ST-elevation (NSTE-ACS)]. Herz 2019;44:10-5. [PMID: 30627742 DOI: 10.1007/s00059-018-4776-1] [Reference Citation Analysis]
411 Arslan M, Dedic A, Boersma E, Dubois EA. Serial high-sensitivity cardiac troponin T measurements to rule out acute myocardial infarction and a single high baseline measurement for swift rule-in: A systematic review and meta-analysis. Eur Heart J Acute Cardiovasc Care 2020;9:14-22. [PMID: 30618277 DOI: 10.1177/2048872618819421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
412 Howell S, Hoeks S, West R, Wheatcroft S, Hoeft A, Leva B, Plichon B, Damster S, Momeni M, Watremez C, Kahn D, Dincq A, Danila A, Wittmann M, Struck R, Rüddel T, Kessler F, Rasche S, Matsota P, Hasani A, Gudaityte J, Karbonskiene A, Ferreira R, Carvalho S, Tomescu D, Martac C, Grintescu I, Mirea L, Serrano L, Serrano L, Sierra P, Sabaté S, Hernando D, Matute P, Trashorras M, Suñé M, Sarmiento L, Hervias A, González O, Hermina A, González O, Hermina A, Navarro Perez R, Orts M, Fernandez-garcia R, Sanchez Pérez D, Sepulveda Gil I, Monedero P, Hidalgo F, Mbongo C, Pont A, Reyes H, Bartolo C, Galera S, Valentijn T, Stolker R, Tugrul M, Emre Demirel E, Hough M, Griffiths K, Birch S, Beardow Z, Elliot S, Thompson J, Bowrey S, Northey M, Melson H, Telford R, Nadolski M, Potter A, Fuller D, Rose A, Varma S, Simeson K, Pettit J, Smith N, Martinson V, Sleight L, Naylor C, Watt P, Raymode P, Dunk N, Twohey L, Hollos L, Davies S, Gibson A, Coleman Z, Tamm T, Joscak J, Zsisku L, Zuleika M, Carvalho P, Collyer T, Ryan J, Colling K, Dharmarajah S, Krishnan A, Paddle J, Fouracres A, Arnell K, Muhammad K. Prospective observational cohort study of the association between antiplatelet therapy, bleeding and thrombosis in patients with coronary stents undergoing noncardiac surgery. British Journal of Anaesthesia 2019;122:170-9. [DOI: 10.1016/j.bja.2018.09.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
413 Heiniger PS, Holy EW, Maier W, Nietlispach F, Ruschitzka F, Stähli BE. [Therapeutic Strategies in Patients with Stable Coronary Artery Disease: The Role of Coronary Revascularization]. Praxis (Bern 1994) 2019;108:401-9. [PMID: 31039710 DOI: 10.1024/1661-8157/a003216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
414 Gulizia MM, Colivicchi F, Abrignani MG, Ambrosetti M, Aspromonte N, Barile G, Caporale R, Casolo G, Chiuini E, Di Lenarda A, Faggiano P, Gabrielli D, Geraci G, La Manna AG, Maggioni AP, Marchese A, Massari FM, Mureddu GF, Musumeci G, Nardi F, Panno AV, Pedretti RFE, Piredda M, Pusineri E, Riccio C, Rossini R, di Uccio FS, Urbinati S, Varbella F, Zito GB, De Luca L; ESC Scientific Document Group ., Faculty for approval of the Consensus Document . Consensus Document ANMCO/ANCE/ARCA/GICR-IACPR/GISE/SICOA: Long-term Antiplatelet Therapy in Patients with Coronary Artery Disease. Eur Heart J Suppl 2018;20:F1-F74. [PMID: 29867293 DOI: 10.1093/eurheartj/suy019] [Cited by in Crossref: 17] [Cited by in F6Publishing: 10] [Article Influence: 4.3] [Reference Citation Analysis]
415 Paukovitsch M, Schepperle N, Pott A, Buckert D, Moritz Schneider L, Keßler M, Reichart C, Rottbauer W, Markovic S. Impact of bleeding complications after transcatheter mitral valve repair. Int J Cardiol Heart Vasc 2021;32:100707. [PMID: 33457493 DOI: 10.1016/j.ijcha.2020.100707] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
416 Kaier TE, Alaour B, Marber M. Cardiac troponin and defining myocardial infarction. Cardiovasc Res 2021:cvaa331. [PMID: 33458742 DOI: 10.1093/cvr/cvaa331] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
417 Sinning C, Ojeda F, Zeller T, Zengin E, Rupprecht H, Lackner K, Bickel C, Blankenberg S, Schnabel RB, Westermann D. Cardiovascular Mortality in Chest Pain Patients: Comparison of Natriuretic Peptides With Novel Biomarkers of Cardiovascular Stress. Canadian Journal of Cardiology 2016;32:1470-7. [DOI: 10.1016/j.cjca.2016.05.010] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
418 Jobs A, Thiele H. ESC-Leitlinien 2015: Akutes Koronarsyndrom ohne ST-Strecken-Hebung. Herz 2015;40:1027-33. [DOI: 10.1007/s00059-015-4369-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
419 Baker P, Leckie T, Harrington D, Richardson A. Exercise-induced cardiac troponin elevation: An update on the evidence, mechanism and implications. Int J Cardiol Heart Vasc. 2019;22:181-186. [PMID: 30963092 DOI: 10.1016/j.ijcha.2019.03.001] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
420 Möckel M, Landmesser U. Challenges in using high-sensitive troponin reporting in clinical practice—The important role of appropriate use in the context of clinical evaluation. International Journal of Cardiology 2017;245:61-2. [DOI: 10.1016/j.ijcard.2017.07.019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
421 Cook DJ, Webb S, Proudfoot A. Assessment and management of cardiovascular disease in the intensive care unit. Heart 2021:heartjnl-2019-315568. [PMID: 34168006 DOI: 10.1136/heartjnl-2019-315568] [Reference Citation Analysis]
422 Kedev S. Approaching the post-femoral era for coronary angiography and intervention. Cardiovasc Revasc Med 2018;19:910-1. [PMID: 30415970 DOI: 10.1016/j.carrev.2018.10.017] [Reference Citation Analysis]
423 Orvin K, Barac YD, Kornowski R, Perl L, Wasserstrum Y, Rubchevsky V, Sharony R, Snir E, Aravot D, Lev EI. Monitoring platelet reactivity during prasugrel or ticagrelor washout before urgent coronary artery bypass grafting. Coronary Artery Disease 2017;28:465-71. [DOI: 10.1097/mca.0000000000000501] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
424 Capodanno D, Milluzzo RP, Angiolillo DJ. Intravenous antiplatelet therapies (glycoprotein IIb/IIIa receptor inhibitors and cangrelor) in percutaneous coronary intervention: from pharmacology to indications for clinical use. Ther Adv Cardiovasc Dis 2019;13:1753944719893274. [PMID: 31823688 DOI: 10.1177/1753944719893274] [Cited by in Crossref: 22] [Cited by in F6Publishing: 19] [Article Influence: 11.0] [Reference Citation Analysis]
425 Strebel I, Twerenbold R, Boeddinghaus J, Abächerli R, Rubini Giménez M, Wildi K, Grimm K, Puelacher C, Badertscher P, Sabti Z, Breitenbücher D, Jann J, Selman F, du Fay de Lavallaz J, Schaerli N, Nestelberger T, Stelzig C, Freese M, Schumacher L, Osswald S, Mueller C, Reichlin T. Diagnostic value of the cardiac electrical biomarker, a novel ECG marker indicating myocardial injury, in patients with symptoms suggestive of non-ST-elevation myocardial infarction. Ann Noninvasive Electrocardiol 2018;23:e12538. [PMID: 29476571 DOI: 10.1111/anec.12538] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
426 Adamski P, Adamska U, Ostrowska M, Koziński M, Kubica J. New directions for pharmacotherapy in the treatment of acute coronary syndrome. Expert Opin Pharmacother 2016;17:2291-306. [PMID: 27677394 DOI: 10.1080/14656566.2016.1241234] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
427 Gąsecka A, Pluta K, Solarska K, Rydz B, Eyileten C, Postula M, van der Pol E, Nieuwland R, Budnik M, Kochanowski J, Jaguszewski MJ, Szarpak Ł, Mazurek T, Kapłon-Cieślicka A, Opolski G, Filipiak KJ. Plasma Concentrations of Extracellular Vesicles Are Decreased in Patients with Post-Infarct Cardiac Remodelling. Biology (Basel) 2021;10:97. [PMID: 33573196 DOI: 10.3390/biology10020097] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
428 Verdoia M, Schaffer A, Barbieri L, Suryapranata H, De Luca G. Bivalirudina frente a heparina no fraccionada en síndromes coronarios agudos: un metanálisis actualizado de ensayos aleatorizados. Revista Española de Cardiología 2016;69:732-45. [DOI: 10.1016/j.recesp.2016.01.036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
429 Morici N, Molinari V, Cantoni S, Rubboli A, Antolini L, Sacco A, Cattaneo M, Alicandro G, Oreglia JA, Oliva F, Giannattasio C, Brunelli D, La Vecchia C, Valgimigli M, Savonitto S. Long-Term Risk of Major Adverse Cardiovascular Events in Patients With Acute Coronary Syndrome: Prognostic Role of Complete Blood Cell Count. Angiology 2020;71:831-9. [PMID: 32638621 DOI: 10.1177/0003319720938619] [Reference Citation Analysis]
430 Yang JH, Shih HM, Pan YC, Chang SS, Li CY, Yu SH. Early Dual-Antiplatelet Therapy at the Emergency Department Is Associated with Lower In-Hospital Major Adverse Cardiac Event Risk among Patients with Non-ST-Elevation Myocardial Infarction. Cardiol Res Pract 2021;2021:5571822. [PMID: 33968445 DOI: 10.1155/2021/5571822] [Reference Citation Analysis]
431 Montalescot G, Angiolillo DJ. Anticoagulation, the Unknown of the Antithrombotic Equation After Stenting of an Acute Coronary Syndrome. Journal of the American College of Cardiology 2019;73:775-8. [DOI: 10.1016/j.jacc.2018.12.022] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
432 Roversi S, Fabbri LM, Sin DD, Hawkins NM, Agustí A. Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care. Am J Respir Crit Care Med 2016;194:1319-36. [PMID: 27589227 DOI: 10.1164/rccm.201604-0690SO] [Cited by in Crossref: 97] [Cited by in F6Publishing: 45] [Article Influence: 19.4] [Reference Citation Analysis]
433 Guo T, Xi Z, Qiu H, Wang Y, Zheng J, Dou K, Xu B, Qiao S, Yang W, Gao R. Prognostic value of GRACE and CHA2DS2-VASc score among patients with atrial fibrillation undergoing percutaneous coronary intervention. Ann Med 2021;53:2215-24. [PMID: 34791980 DOI: 10.1080/07853890.2021.2004321] [Reference Citation Analysis]
434 Domienik-Karłowicz J, Kupczyńska K, Michalski B, Kapłon-Cieślicka A, Darocha S, Dobrowolski P, Wybraniec M, Wańha W, Jaguszewski M. Fourth universal definition of myocardial infarction. Selected messages from the European Society of Cardiology document and lessons learned from the new guidelines on ST-segment elevation myocardial infarction and non-ST-segment elevation-acute coronary syndrome. Cardiol J 2021;28:195-201. [PMID: 33843035 DOI: 10.5603/CJ.a2021.0036] [Reference Citation Analysis]
435 Branch KRH, Strote J, Gunn M, Maynard C, Kudenchuk PJ, Brusen R, Petek BJ, Sayre MR, Edwards R, Carlbom D, Counts CR, Probstfield JL, Gatewood MO. Early head-to-pelvis computed tomography in out-of-hospital circulatory arrest without obvious etiology. Acad Emerg Med 2021;28:394-403. [PMID: 33606342 DOI: 10.1111/acem.14228] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
436 Engel LC, Landmesser U, Gigengack K, Wurster T, Manes C, Girke G, Jaguszewski M, Skurk C, Leistner DM, Lauten A, Schuster A, Hamm B, Botnar RM, Makowski MR, Bigalke B. Novel Approach for In Vivo Detection of Vulnerable Coronary Plaques Using Molecular 3-T CMR Imaging With an Albumin-Binding Probe. JACC Cardiovasc Imaging 2019;12:297-306. [PMID: 29361487 DOI: 10.1016/j.jcmg.2017.10.026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 3.8] [Reference Citation Analysis]
437 Patrono C, Morais J, Baigent C, Collet JP, Fitzgerald D, Halvorsen S, Rocca B, Siegbahn A, Storey RF, Vilahur G. Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. J Am Coll Cardiol 2017;70:1760-76. [PMID: 28958334 DOI: 10.1016/j.jacc.2017.08.037] [Cited by in Crossref: 79] [Cited by in F6Publishing: 67] [Article Influence: 15.8] [Reference Citation Analysis]
438 Munkhaugen J, Ruddox V, Halvorsen S, Dammen T, Fagerland MW, Hernæs KH, Vethe NT, Prescott E, Jensen SE, Rødevand O, Jortveit J, Bendz B, Schirmer H, Køber L, Bøtker HE, Larsen AI, Vikenes K, Steigen T, Wiseth R, Pedersen T, Edvardsen T, Otterstad JE, Atar D. BEtablocker Treatment After acute Myocardial Infarction in revascularized patients without reduced left ventricular ejection fraction (BETAMI): Rationale and design of a prospective, randomized, open, blinded end point study. American Heart Journal 2019;208:37-46. [DOI: 10.1016/j.ahj.2018.10.005] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
439 Onwordi EN, Gamal A, Zaman A. Anticoagulant Therapy for Acute Coronary Syndromes. Interv Cardiol 2018;13:87-92. [PMID: 29928314 DOI: 10.15420/icr.2017:26:1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
440 Chen R, Liu C, Zhou P, Tan Y, Sheng Z, Li J, Zhou J, Chen Y, Song L, Zhao H, Yan H. Both Low and High Postprocedural hsCRP Associate with Increased Risk of Death in Acute Coronary Syndrome Patients Treated by Percutaneous Coronary Intervention. Mediators Inflamm 2020;2020:9343475. [PMID: 32377168 DOI: 10.1155/2020/9343475] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
441 Kimenai DM, Janssen EBNJ, Eggers KM, Lindahl B, den Ruijter HM, Bekers O, Appelman Y, Meex SJR. Sex-Specific Versus Overall Clinical Decision Limits for Cardiac Troponin I and T for the Diagnosis of Acute Myocardial Infarction: A Systematic Review. Clin Chem 2018;64:1034-43. [PMID: 29844245 DOI: 10.1373/clinchem.2018.286781] [Cited by in Crossref: 27] [Cited by in F6Publishing: 20] [Article Influence: 6.8] [Reference Citation Analysis]
442 Arbel Y, Bennell MC, Goodman SG, Wijeysundera HC. Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention. Can J Cardiol 2018;34:31-7. [PMID: 29275879 DOI: 10.1016/j.cjca.2017.10.004] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
443 Kim C, Shin DH, Ahn CM, Kim JS, Kim BK, Ko YG, Choi D, Hong MK, Park J, Lee H, Choi YJ, Choi YS, Oh SK, Jang Y. The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data. Korean Circ J 2017;47:888-97. [PMID: 29035430 DOI: 10.4070/kcj.2017.0072] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
444 Venge P, van Lippen L, Blaschke S, Christ M, Geier F, Giannitsis E, Hagström E, Hausfater P, Khellaf M, Mair J, Pariente D, Scharnhorst V, Semjonow V. Equal clinical performance of a novel point-of-care cardiac troponin I (cTnI) assay with a commonly used high-sensitivity cTnI assay. Clin Chim Acta 2017;469:119-25. [PMID: 28347675 DOI: 10.1016/j.cca.2017.03.023] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
445 Fosbøl EL, Ju C, Anstrom KJ, Zettler ME, Messenger JC, Waksman R, Effron MB, Baker BA, Cohen DJ, Peterson ED, Wang TY. Early Cessation of Adenosine Diphosphate Receptor Inhibitors Among Acute Myocardial Infarction Patients Treated With Percutaneous Coronary Intervention: Insights From the TRANSLATE-ACS Study (Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome). Circ Cardiovasc Interv 2016;9:e003602. [PMID: 27789517 DOI: 10.1161/CIRCINTERVENTIONS.115.003602] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 2.4] [Reference Citation Analysis]
446 George S, Onwordi ENC, Gamal A, Zaman A. Development of New Antithrombotic Regimens for Patients with Acute Coronary Syndrome. Clin Drug Investig 2019;39:495-502. [PMID: 30972665 DOI: 10.1007/s40261-019-00769-6] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
447 Nilsson T, Lundberg G, Larsson D, Mokhtari A, Ekelund U. Emergency Department Chest Pain Patients With or Without Ongoing Pain: Characteristics, Outcome, and Diagnostic Value of the Electrocardiogram. J Emerg Med 2020;58:874-81. [PMID: 32291126 DOI: 10.1016/j.jemermed.2020.03.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
448 Sunamura M, Ter Hoeve N, van den Berg-Emons RJG, Boersma E, van Domburg RT, Geleijnse ML. Cardiac rehabilitation in patients with acute coronary syndrome with primary percutaneous coronary intervention is associated with improved 10-year survival. Eur Heart J Qual Care Clin Outcomes 2018;4:168-72. [PMID: 29325067 DOI: 10.1093/ehjqcco/qcy001] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
449 Angiolillo DJ, Franchi F, Waksman R, Sweeny JM, Raveendran G, Teng R, Zhao Y, Carlson G, Khan N, Mehran R. Effects of Ticagrelor Versus Clopidogrel in Troponin-Negative Patients With Low-Risk ACS Undergoing Ad Hoc PCI. Journal of the American College of Cardiology 2016;67:603-13. [DOI: 10.1016/j.jacc.2015.11.044] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]
450 Bömicke T, Valina C, Stratz C, Amann M, Neumann F, Hochholzer W. On-clopidogrel platelet reactivity as predictor for long-term clinical outcome in patients after planned discontinuation of clopidogrel. Thromb Haemost 2017;117:1644-50. [DOI: 10.1160/th17-02-0122] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
451 Eggers KM, Lindahl B. Impact of Sex on Cardiac Troponin Concentrations—A Critical Appraisal. Clinical Chemistry 2017;63:1457-64. [DOI: 10.1373/clinchem.2017.271684] [Cited by in Crossref: 25] [Cited by in F6Publishing: 22] [Article Influence: 5.0] [Reference Citation Analysis]
452 Inohara T, Endo A, Melloni C. Unmet Needs in Managing Myocardial Infarction in Patients With Malignancy. Front Cardiovasc Med 2019;6:57. [PMID: 31157239 DOI: 10.3389/fcvm.2019.00057] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
453 Nihei T, Takahashi J, Hao K, Kikuchi Y, Odaka Y, Tsuburaya R, Nishimiya K, Matsumoto Y, Ito K, Miyata S, Sakata Y, Shimokawa H. Prognostic impacts of Rho-kinase activity in circulating leucocytes in patients with vasospastic angina. Eur Heart J 2018;39:952-9. [PMID: 29165549 DOI: 10.1093/eurheartj/ehx657] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
454 Sazonova SI, Atabekov TA, Batalov RE, Mishkina AI, Varlamova JV, Zavadovsky KV, Popov SV. Prediction of appropriate ICD therapy in patients with ischemic heart failure. J Nucl Cardiol 2020. [PMID: 32851586 DOI: 10.1007/s12350-020-02321-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
455 Grant EV, Summapund J, Matlock DD, Vaughan Dickson V, Iqbal S, Patel S, Katz SD, Chaudhry SI, Dodson JA. Patient and Cardiologist Perspectives on Shared Decision Making in the Treatment of Older Adults Hospitalized for Acute Myocardial Infarction. Med Decis Making 2020;40:279-88. [PMID: 32428431 DOI: 10.1177/0272989X20912293] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
456 Kaliyadan AG, Savage MP, Ruggiero N 2nd, Fischman DL. An update on management of the patient presenting with non-ST-elevation acute coronary syndromes. Hosp Pract (1995) 2016;44:173-8. [PMID: 27098650 DOI: 10.1080/21548331.2016.1179119] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
457 Sanchis J, García-blas S, Carratalá A, Valero E, Mollar A, Miñana G, Ruiz V, Balaguer JV, Roqué M, Bosch X, Núñez J. Clinical Evaluation Versus Undetectable High-Sensitivity Troponin for Assessment of Patients With Acute Chest Pain. The American Journal of Cardiology 2016;118:1631-5. [DOI: 10.1016/j.amjcard.2016.08.040] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
458 Gaubert M, Resseguier N, Laine M, Bonello L, Camoin-jau L, Paganelli F. Dabigatran versus vitamin k antagonist: an observational across-cohort comparison in acute coronary syndrome patients with atrial fibrillation. J Thromb Haemost 2018;16:465-73. [DOI: 10.1111/jth.13931] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
459 Aakre KM, Omland T. The rise and fall of the 99th percentile decision limit for cardiac troponins? Int J Cardiol 2019;288:25-6. [PMID: 30955878 DOI: 10.1016/j.ijcard.2019.02.071] [Reference Citation Analysis]
460 Bordoni L, Fedeli D, Piangerelli M, Pelikant-Malecka I, Radulska A, Samulak JJ, Sawicka AK, Lewicki L, Kalinowski L, Olek RA, Gabbianelli R. Gender-Related Differences in Trimethylamine and Oxidative Blood Biomarkers in Cardiovascular Disease Patients. Biomedicines 2020;8:E238. [PMID: 32717906 DOI: 10.3390/biomedicines8080238] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
461 Thiele H. Cardiovascular emergencies in the COVID-19 pandemic. Herz 2020;45:327-8. [PMID: 32328715 DOI: 10.1007/s00059-020-04931-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
462 Kim YH, Her A, Jeong MH, Kim B, Hong S, Kim S, Ahn C, Kim J, Ko Y, Choi D, Hong M, Jang Y. Effect of renin-angiotensin system inhibitors on major clinical outcomes in patients with acute myocardial infarction and prediabetes or diabetes after successful implantation of newer-generation drug-eluting stents. Journal of Diabetes and its Complications 2020;34:107574. [DOI: 10.1016/j.jdiacomp.2020.107574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
463 Montalescot G, Crea F. The year in cardiology 2015: acute coronary syndromes. Eur Heart J 2016;37:221-8. [DOI: 10.1093/eurheartj/ehv686] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
464 Baschin M, Selleng S, Hummel A, Diedrich S, Schroeder HW, Kohlmann T, Westphal A, Greinacher A, Thiele T. Preoperative platelet transfusions to reverse antiplatelet therapy for urgent non‐cardiac surgery: an observational cohort study. J Thromb Haemost 2018;16:709-17. [DOI: 10.1111/jth.13962] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 2.8] [Reference Citation Analysis]
465 von Känel R, Princip M, Schmid JP, Barth J, Znoj H, Schnyder U, Meister-Langraf RE. Association of sleep problems with neuroendocrine hormones and coagulation factors in patients with acute myocardial infarction. BMC Cardiovasc Disord 2018;18:213. [PMID: 30463526 DOI: 10.1186/s12872-018-0947-5] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
466 Yangui F, Touil A, Antit S, Zakhama L, Charfi MR. COPD prevalence in smokers with stable ischemic heart disease: A cross-sectional study in Tunisia. Respir Med 2021;179:106335. [PMID: 33621707 DOI: 10.1016/j.rmed.2021.106335] [Reference Citation Analysis]
467 Weiss TW, Aichinger J, Huber K, Speidl WS, Watzinger N, Zweiker R, Alber HF. Expert position paper on prolonged dual antiplatelet therapy in secondary prevention following myocardial infarction. Wien Klin Wochenschr 2016;128:450-7. [PMID: 27278134 DOI: 10.1007/s00508-016-1016-7] [Cited by in Crossref: 3] [Article Influence: 0.5] [Reference Citation Analysis]
468 Abdeladim S, Elharras M, Elouarradi A, Bensahi I, Oualim S, Merzouk F, Sabry M. Thrombocytopenia induced by glycoprotein (GP) IIb-IIIa antagonists: about two cases. Pan Afr Med J 2021;38:9. [PMID: 33520078 DOI: 10.11604/pamj.2021.38.9.27215] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
469 Kanic V, Kompara G, Vollrath M, Suran D, Kanic Z. Age-Specific Sex-Based Differences in Anemia in Patients with Myocardial Infarction. J Womens Health (Larchmt) 2019;28:1004-10. [PMID: 30632879 DOI: 10.1089/jwh.2018.7211] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
470 Zhu X, Wang K, Jin Y, Wang S, Liu X, Liu H, Zhou P, Yang C, Han Z. Multiplexed fluorometric determination for three microRNAs in acute myocardial infarction by using duplex-specific nuclease and MoS2 nanosheets. Microchim Acta 2020;187. [DOI: 10.1007/s00604-019-3896-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
471 Postalian A, Krajcer Z. Transradial versus transfemoral access: The dispute continues. Catheter Cardiovasc Interv 2020;96:296-7. [PMID: 32797743 DOI: 10.1002/ccd.29143] [Reference Citation Analysis]
472 Golamari R, Gilchrist IC. Collateral Circulation Testing of the Hand- Is it Relevant Now? A Narrative Review. Am J Med Sci 2021;361:702-10. [PMID: 33947584 DOI: 10.1016/j.amjms.2020.12.001] [Reference Citation Analysis]
473 Nowak RM, Christenson RH, Jacobsen G, McCord J, Apple FS, Singer AJ, Limkakeng A Jr, Peacock WF, deFilippi CR. Performance of Novel High-Sensitivity Cardiac Troponin I Assays for 0/1-Hour and 0/2- to 3-Hour Evaluations for Acute Myocardial Infarction: Results From the HIGH-US Study. Ann Emerg Med 2020;76:1-13. [PMID: 32046869 DOI: 10.1016/j.annemergmed.2019.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
474 Klingenberg R, Aghlmandi S, Liebetrau C, Räber L, Gencer B, Nanchen D, Carballo D, Akhmedov A, Montecucco F, Zoller S, Brokopp C, Heg D, Jüni P, Marti Soler H, Marques-Vidal PM, Vollenweider P, Dörr O, Rodondi N, Mach F, Windecker S, Landmesser U, von Eckardstein A, Hamm CW, Matter CM, Lüscher TF. Cysteine-rich angiogenic inducer 61 (Cyr61): a novel soluble biomarker of acute myocardial injury improves risk stratification after acute coronary syndromes. Eur Heart J 2017;38:3493-502. [PMID: 29155984 DOI: 10.1093/eurheartj/ehx640] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 7.5] [Reference Citation Analysis]
475 Keller K, Hobohm L, Münzel T, Lankeit M, Konstantinides S, Ostad MA. Impact of Systemic Atherosclerosis on Clinical Characteristics and Short-term Outcomes in Patients with Deep Venous Thrombosis or Thrombophlebitis. Am J Med Sci 2021:S0002-9629(21)00317-7. [PMID: 34551354 DOI: 10.1016/j.amjms.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
476 Toner L, Koshy AN, Hamilton GW, Clark D, Farouque O, Yudi MB. Acute coronary syndromes undergoing percutaneous coronary intervention in the COVID-19 era: comparable case volumes but delayed symptom onset to hospital presentation. Eur Heart J Qual Care Clin Outcomes 2020;6:225-6. [PMID: 32379888 DOI: 10.1093/ehjqcco/qcaa038] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 10.5] [Reference Citation Analysis]
477 Sattler K, El-Battrawy I, Gietzen T, Kummer M, Lang S, Zhou XB, Behnes M, Borggrefe M, Akin I. Improved Outcome of Cardiogenic Shock Triggered by Takotsubo Syndrome Compared With Myocardial Infarction. Can J Cardiol. 2020;36:860-867. [PMID: 32249068 DOI: 10.1016/j.cjca.2019.10.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
478 Breidthardt T, Brunner-Schaub N, Balmelli C, Insenser JJS, Burri-Winkler K, Geigy N, Mundorff L, Exadaktylos A, Scholz J, Haaf P, Hamel C, Frey D, Delport K, Peacock WF, Freese M, DiSomma S, Todd J, Rentsch K, Bingisser R, Mueller C, Walter J, Twerenbold R, Nestelberger T, Boeddinghaus J, Badertscher P, du Fay de Lavallaz J, Puelacher C, Wildi K; BASEL VII Investigators. Inflammatory Biomarkers and Clinical Judgment in the Emergency Diagnosis of Urgent Abdominal Pain. Clin Chem 2019;65:302-12. [PMID: 30518662 DOI: 10.1373/clinchem.2018.296491] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
479 Chenevier-Gobeaux C, Sebbane M, Meune C, Lefebvre S, Dupuy AM, Lefèvre G, Peschanski N, Ray P. Is high-sensitivity troponin, alone or in combination with copeptin, sensitive enough for ruling out NSTEMI in very early presenters at admission? A post hoc analysis performed in emergency departments. BMJ Open 2019;9:e023994. [PMID: 31209082 DOI: 10.1136/bmjopen-2018-023994] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
480 Faxén J, Hall M, Gale CP, Sundström J, Lindahl B, Jernberg T, Szummer K. A user-friendly risk-score for predicting in-hospital cardiac arrest among patients admitted with suspected non ST-elevation acute coronary syndrome - The SAFER-score. Resuscitation 2017;121:41-8. [PMID: 28993178 DOI: 10.1016/j.resuscitation.2017.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
481 Pareek N, Kordis P, Beckley-Hoelscher N, Pimenta D, Kocjancic ST, Jazbec A, Nevett J, Fothergill R, Kalra S, Lockie T, Shah AM, Byrne J, Noc M, MacCarthy P. A practical risk score for early prediction of neurological outcome after out-of-hospital cardiac arrest: MIRACLE2. Eur Heart J 2020;41:4508-17. [PMID: 32731260 DOI: 10.1093/eurheartj/ehaa570] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
482 Araújo C, Laszczyńska O, Viana M, Dias P, Maciel MJ, Moreira I, Azevedo A. Calidad del cuidado y mortalidad a 30 días de mujeres y varones con infarto agudo de miocardio. Revista Española de Cardiología 2019;72:543-52. [DOI: 10.1016/j.recesp.2018.05.016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 5] [Article Influence: 3.7] [Reference Citation Analysis]
483 Lønborg J, Engstrøm T, Ahtarovski KA, Nepper-christensen L, Helqvist S, Vejlstrup N, Kyhl K, Schoos MM, Ghotbi A, Göransson C, Bertelsen L, Holmvang L, Pedersen F, Jørgensen E, Saunamäki K, Clemmensen P, De Backer O, Kløvgaard L, Høfsten DE, Køber L, Kelbæk H. Myocardial Damage in Patients With Deferred Stenting After STEMI. Journal of the American College of Cardiology 2017;69:2794-804. [DOI: 10.1016/j.jacc.2017.03.601] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 5.0] [Reference Citation Analysis]
484 Summaria F, Sgueglia GA, D'Errico F, De Santis A, Piccioni F, Gioffrè G, Gaspardone A. Safety and Efficacy of Triple Therapeutic Targets with Rivaroxaban after Acute Myocardial Infarction Complicated by Left Ventricular Thrombi in a Case of Nonvalvular Atrial Fibrillation. Case Rep Cardiol 2018;2018:6503435. [PMID: 29692936 DOI: 10.1155/2018/6503435] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
485 Batra G, Friberg L, Erlinge D, James S, Jernberg T, Svennblad B, Wallentin L, Oldgren J. Antithrombotic therapy after myocardial infarction in patients with atrial fibrillation undergoing percutaneous coronary intervention. European Heart Journal - Cardiovascular Pharmacotherapy 2018;4:36-45. [DOI: 10.1093/ehjcvp/pvx033] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
486 Ikemura N, Sawano M, Ueda I, Fukuda K, Kohsaka S. Consequence of reimbursement policy alteration for urgent PCI in Japan. Lancet 2018;391:2208-9. [PMID: 29893216 DOI: 10.1016/S0140-6736(18)30857-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
487 Valina C, Neumann F, Menichelli M, Mayer K, Wöhrle J, Bernlochner I, Aytekin A, Richardt G, Witzenbichler B, Sibbing D, Cassese S, Angiolillo DJ, Kufner S, Liebetrau C, Hamm CW, Xhepa E, Hapfelmeier A, Sager HB, Wustrow I, Joner M, Trenk D, Laugwitz K, Schunkert H, Schüpke S, Kastrati A. Ticagrelor or Prasugrel in Patients With Non–ST-Segment Elevation Acute Coronary Syndromes. Journal of the American College of Cardiology 2020;76:2436-46. [DOI: 10.1016/j.jacc.2020.09.584] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 7.5] [Reference Citation Analysis]
488 Ochiumi Y, Suzuki Y. Observation of early strut coverage after polymer-free biolimus-A9 coated stent by optical frequency domain imaging. J Cardiol Cases 2019;19:145-7. [PMID: 31073345 DOI: 10.1016/j.jccase.2018.09.006] [Reference Citation Analysis]
489 Charpentier S, Beaune S, Joly LM, Khoury A, Duchateau FX, Briot R, Renaud B, Ageron FX; IRU Network. Management of chest pain in the French emergency healthcare system: the prospective observational EPIDOULTHO study. Eur J Emerg Med 2018;25:404-10. [PMID: 28723703 DOI: 10.1097/MEJ.0000000000000481] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 3.7] [Reference Citation Analysis]
490 Marwan M, Achenbach S, Korosoglou G, Schmermund A, Schneider S, Bruder O, Hausleiter J, Schroeder S, Barth S, Kerber S, Leber A, Moshage W, Senges J. German cardiac CT registry: indications, procedural data and clinical consequences in 7061 patients undergoing cardiac computed tomography. Int J Cardiovasc Imaging 2018;34:807-19. [PMID: 29197025 DOI: 10.1007/s10554-017-1282-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
491 Garcia-garcia HM, Mcfadden EP, Farb A, Mehran R, Stone GW, Spertus J, Onuma Y, Morel M, van Es G, Zuckerman B, Fearon WF, Taggart D, Kappetein A, Krucoff MW, Vranckx P, Windecker S, Cutlip D, Serruys PW; Academic Research Consortium. Standardized End Point Definitions for Coronary Intervention Trials. European Heart Journal 2018;39:2192-207. [DOI: 10.1093/eurheartj/ehy223] [Cited by in Crossref: 81] [Cited by in F6Publishing: 63] [Article Influence: 20.3] [Reference Citation Analysis]
492 van Dijk VF, Quast ABE, Schaap J, Balt JC, Kelder JC, Wijffels MCEF, de Groot JR, Boersma LVA. ICD implantation for secondary prevention in patients with ventricular arrhythmia in the setting of acute cardiac ischemia and a history of myocardial infarction. J Cardiovasc Electrophysiol 2020;31:536-43. [PMID: 31944462 DOI: 10.1111/jce.14357] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
493 Keykhaei M, Ashraf H, Rashedi S, Farrokhpour H, Heidari B, Zokaei S, Bagheri S, Foroumadi R, Asgarian S, Amirian A, Saleh SK, James S. Differences in the 2020 ESC Versus 2015 ESC and 2014 ACC/AHA Guidelines on the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation. Curr Atheroscler Rep 2021;23:77. [PMID: 34671860 DOI: 10.1007/s11883-021-00976-7] [Reference Citation Analysis]
494 Kähkönen O, Oikarinen A, Vähänikkilä H, Kyngäs H. Association between perceived health and adherence to treatment after percutaneous coronary intervention: A long-term follow-up study. J Adv Nurs 2021. [PMID: 34636444 DOI: 10.1111/jan.15069] [Reference Citation Analysis]
495 Chi TY, Liu Y, Zhu HM, Zhang M. Thromboelastography-derived parameters for the prediction of acute thromboembolism following non-steroidal anti-inflammatory drug-induced gastrointestinal bleeding: A retrospective study. Exp Ther Med 2018;16:2257-66. [PMID: 30186466 DOI: 10.3892/etm.2018.6468] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
496 Kim I, Kim MC, Park KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Park JC, Cho MC, Kim JJ, Kim YJ, Ahn Y. Prognostic significance of non-chest pain symptoms in patients with non-ST-segment elevation myocardial infarction. Korean J Intern Med 2018;33:1111-8. [PMID: 29117666 DOI: 10.3904/kjim.2017.071] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
497 Waldo SW, Gokhale M, O'Donnell CI, Plomondon ME, Valle JA, Armstrong EJ, Schofield R, Fihn SD, Maddox TM. Temporal Trends in Coronary Angiography and Percutaneous Coronary Intervention: Insights From the VA Clinical Assessment, Reporting, and Tracking Program. JACC Cardiovasc Interv 2018;11:879-88. [PMID: 29747919 DOI: 10.1016/j.jcin.2018.02.035] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 10.0] [Reference Citation Analysis]
498 Lorente V, Aboal J, Garcia C, Sans-Roselló J, Sambola A, Andrea R, Tomás C, Bonet G, Viñas D, El Ouaddi N, Montero S, Cantalapiedra J, Pujol M, Hernández I, Pérez-Rodriguez M, Llaó I, Sánchez-Salado JC, Gual M, Ariza-Solé A. Anemia in patients with high-risk acute coronary syndromes admitted to Intensive Cardiac Care Units. J Geriatr Cardiol 2020;17:35-42. [PMID: 32133035 DOI: 10.11909/j.issn.1671-5411.2020.01.006] [Reference Citation Analysis]
499 Cea Soriano L, Gaist D, Soriano-gabarró M, García Rodríguez LA. Incidence of intracranial bleeds in new users of low-dose aspirin: a cohort study using The Health Improvement Network. J Thromb Haemost 2017;15:1055-64. [DOI: 10.1111/jth.13686] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
500 Feistritzer H, Nanos M, Eitel I, Jobs A, de Waha-thiele S, Meyer-saraei R, Freund A, Stiermaier T, Abdel-wahab M, Lurz P, Reinstadler SJ, Reindl M, Klug G, Metzler B, Desch S, Thiele H. Determinants and prognostic value of cardiac magnetic resonance imaging-derived infarct characteristics in non-ST-elevation myocardial infarction. European Heart Journal - Cardiovascular Imaging 2020;21:67-76. [DOI: 10.1093/ehjci/jez165] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
501 Dou Q, Wang W, Wang H, Ma Y, Hai S, Lin X, Liu Y, Zhang X, Wu J, Dong B. Prognostic value of frailty in elderly patients with acute coronary syndrome: a systematic review and meta-analysis. BMC Geriatr 2019;19:222. [PMID: 31416442 DOI: 10.1186/s12877-019-1242-8] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
502 Adamski P, Buszko K, Sikora J, Niezgoda P, Fabiszak T, Ostrowska M, Barańska M, Karczmarska-Wódzka A, Navarese EP, Kubica J. Determinants of high platelet reactivity in patients with acute coronary syndromes treated with ticagrelor. Sci Rep 2019;9:3924. [PMID: 30850677 DOI: 10.1038/s41598-019-40628-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
503 Zalewski J, Undas A. Antithrombotic management in patients with percutaneous coronary intervention requiring oral anticoagulation. Postepy Kardiol Interwencyjnej 2016;12:290-302. [PMID: 27980542 DOI: 10.5114/aic.2016.63626] [Reference Citation Analysis]
504 Yu X, Li Y, Wang Q, Liang M, Xu K, Han Y. "One-Time" versus Staged Multivessel Intervention in Intermediate to Very High-Risk Patients with Non-ST-Segment Elevation Acute Coronary Syndromes. Korean Circ J 2016;46:774-83. [PMID: 27826335 DOI: 10.4070/kcj.2016.46.6.774] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
505 Safi M, Ahmed H, Al-Azab M, Xia YL, Shan X, Al-Radhi M, Al-Danakh A, Shopit A, Liu J. PD-1/PDL-1 Inhibitors and Cardiotoxicity; Molecular, Etiological and Management Outlines. J Adv Res 2021;29:45-54. [PMID: 33842004 DOI: 10.1016/j.jare.2020.09.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
506 Koechlin L, Troester V, Mueller C. Validity of a Novel Point-of-Care Troponin Assay for Single-Test Rule-Out of Acute Myocardial Infarction. JAMA Cardiol 2019;4:298. [PMID: 30725104 DOI: 10.1001/jamacardio.2018.4840] [Reference Citation Analysis]
507 Gibson CM, Mack MJ, Lee VT, Schneider DJ, Sellke FW, Ohman EM, Thourani VH, Doros G, Kroger H, Cutlip DE, Deliargyris EN. Rationale and Design of the Safe and Timely Antithrombotic Removal - Ticagrelor (STAR-T) Trial: A Prospective, Multi-center, Double-blind, Randomized Controlled Trial Evaluating Reductions in Postoperative Bleeding with Intraoperative Removal of Ticagrelor by the DrugSorb™-ATR Device in Patients Undergoing Cardiothoracic Surgery within 48hrs from Last Ticagrelor Dose. Am Heart J 2021:S0002-8703(21)00442-7. [PMID: 34736855 DOI: 10.1016/j.ahj.2021.10.188] [Reference Citation Analysis]
508 Linder M, Andersen M. Patient characteristics and safety outcomes in new users of ticagrelor and clopidogrel-An observational cohort study in Sweden. Pharmacoepidemiol Drug Saf 2021. [PMID: 34802175 DOI: 10.1002/pds.5387] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
509 Sharma H, Radhakrishnan A, Nightingale P, Brown S, May J, O'Connor K, Shakeel I, Zia N, Doshi SN, Townend JN, Myerson SG, Kirchhof P, Ludman PF, Adnan Nadir M, Steeds RP. The characteristics of mitral regurgitation: Data from patients admitted following acute myocardial infarction. Data Brief 2021;39:107451. [PMID: 34703851 DOI: 10.1016/j.dib.2021.107451] [Reference Citation Analysis]
510 Tan LL, Lyon AR. Role of Biomarkers in Prediction of Cardiotoxicity During Cancer Treatment. Curr Treat Options Cardiovasc Med 2018;20:55. [PMID: 29923056 DOI: 10.1007/s11936-018-0641-z] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 8.8] [Reference Citation Analysis]
511 Du BB, Wang XT, Li XD, Li PP, Chen WW, Li SM, Yang P. Treatment of severe upper gastrointestinal bleeding caused by Mallory-Weiss syndrome after primary coronary intervention for acute inferior wall myocardial infarction: A case report. World J Clin Cases 2019; 7(24): 4407-4413 [PMID: 31911925 DOI: 10.12998/wjcc.v7.i24.4407] [Reference Citation Analysis]
512 Bevins NJ, Chae H, Hubbard JA, Castillo EM, Tolia VM, Daniels LB, Fitzgerald RL. Emergency Department Management of Chest Pain With a High-Sensitivity Troponin-Enabled 0/1-Hour Rule-Out Algorithm. Am J Clin Pathol 2021:aqab192. [PMID: 34893795 DOI: 10.1093/ajcp/aqab192] [Reference Citation Analysis]
513 Alquézar-Arbé A, Sionis A, Ordoñez-Llanos J. Cardiac troponins: 25 years on the stage and still improving their clinical value. Crit Rev Clin Lab Sci 2017;54:551-71. [PMID: 29226754 DOI: 10.1080/10408363.2017.1410777] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
514 Chen K, Breitner S, Wolf K, Hampel R, Meisinger C, Heier M, von Scheidt W, Kuch B, Peters A, Schneider A; KORA Study Group. Temporal variations in the triggering of myocardial infarction by air temperature in Augsburg, Germany, 1987-2014. Eur Heart J 2019;40:1600-8. [PMID: 30859207 DOI: 10.1093/eurheartj/ehz116] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 12.5] [Reference Citation Analysis]
515 Andersen LS, Lorentzen V, Beedholm K. From Suspicion to Recognition-Being a Bystander to a Relative Affected by Acute Coronary Syndrome. Qual Health Res 2022;32:307-16. [PMID: 34866472 DOI: 10.1177/10497323211050911] [Reference Citation Analysis]
516 Sgueglia GA, Gioffrè G, De Santis A, Piccioni F, Summaria F, Di Giorgio A, D'Errico F, Gaspardone A. Concept and practice of transradial 5 French percutaneous treatment of coronary bifurcation lesions. Catheter Cardiovasc Interv 2019;93:390-7. [PMID: 30298559 DOI: 10.1002/ccd.27844] [Reference Citation Analysis]
517 Kaboré EG, Yameogo NV, Seghda A, Kagambèga L, Kologo J, Millogo G, Tall/Thiam A, Samadoulougou AK, Zabsonré P. [Evolution profiles of acute coronary syndromes and GRACE, TIMI and SRI risk scores in Burkina Faso. A monocentric study of 111 patients]. Ann Cardiol Angeiol (Paris) 2019;68:107-14. [PMID: 30683480 DOI: 10.1016/j.ancard.2018.09.007] [Reference Citation Analysis]
518 van der Hagen EAE, Cobbaert CM, Meijer R, Thelen MHM. Fast 0/1-h algorithm for detection of NSTEMI: are current high-sensitivity cardiac troponin assays fit for purpose? An EQA-based evaluation. Clin Chem Lab Med 2019;57:1999-2007. [PMID: 31326959 DOI: 10.1515/cclm-2019-0253] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
519 Chen JY, He PC, Liu YH, Wei XB, Jiang L, Guo W, Duan CY, Guo YS, Yu XP, Li J, Li WS, Zhou YL, Lin CY, Luo JF, Yu DQ, Chen ZJ, Chen W, Chen YY, Guo ZQ, Geng QS, Tan N. Association of Parenteral Anticoagulation Therapy With Outcomes in Chinese Patients Undergoing Percutaneous Coronary Intervention for Non-ST-Segment Elevation Acute Coronary Syndrome. JAMA Intern Med 2019;179:186-94. [PMID: 30592483 DOI: 10.1001/jamainternmed.2018.5953] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
520 Tegn N, Eek C, Abdelnoor M, Aaberge L, Endresen K, Skårdal R, Berg ES, Gullestad L, Bendz B. Patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris randomised to an invasive versus conservative strategy: angiographic and procedural results from the After Eighty study. Open Heart 2020;7:e001256. [PMID: 32719073 DOI: 10.1136/openhrt-2020-001256] [Reference Citation Analysis]
521 Body R, Morris N, Collinson P. Single test rule-out of acute myocardial infarction using the limit of detection of a new high-sensitivity troponin I assay. Clin Biochem 2020;78:4-9. [PMID: 32135083 DOI: 10.1016/j.clinbiochem.2020.02.014] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
522 Alabas OA, Hall M, Dondo TB, Rutherford MJ, Timmis AD, Batin PD, Deanfield JE, Hemingway H, Gale CP. Long-term excess mortality associated with diabetes following acute myocardial infarction: a population-based cohort study. J Epidemiol Community Health 2017;71:25-32. [PMID: 27307468 DOI: 10.1136/jech-2016-207402] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 3.2] [Reference Citation Analysis]
523 Yi-Dan H, Ying-Xin Z, Shi-Wei Y, Yu-Jie Z. High-Energy Phosphates and Ischemic Heart Disease: From Bench to Bedside. Front Cardiovasc Med 2021;8:675608. [PMID: 34395552 DOI: 10.3389/fcvm.2021.675608] [Reference Citation Analysis]
524 Thygesen K, Jaffe AS. Should myocardial infarction type 2 be regarded as two separate entities? European Heart Journal 2019;40:2810-2. [DOI: 10.1093/eurheartj/ehz451] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
525 Viana M, Borges A, Araújo C, Rocha A, Ribeiro AI, Laszczyńska O, Dias P, Maciel MJ, Moreira I, Lunet N, Azevedo A. Inequalities in access to cardiac rehabilitation after an acute coronary syndrome: the EPiHeart cohort. BMJ Open 2018;8:e018934. [PMID: 29301762 DOI: 10.1136/bmjopen-2017-018934] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
526 Dahlgren C, Geary L, Hasselström J, Rehnberg C, Schenck-Gustafsson K, Wändell P, Euler MV. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study. BMJ Open 2017;7:e015723. [PMID: 28939569 DOI: 10.1136/bmjopen-2016-015723] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
527 Parco C, Brockmeyer M, Kosejian L, Quade J, Tröstler J, Bader S, Lin Y, Karathanos A, Krieger T, Heinen Y, Schulze V, Icks A, Jung C, Kelm M, Wolff G. Modern NCDR and ACTION risk models outperform the GRACE model for prediction of in-hospital mortality in acute coronary syndrome in a German cohort. Int J Cardiol 2021;329:28-35. [PMID: 33412182 DOI: 10.1016/j.ijcard.2020.12.085] [Reference Citation Analysis]
528 Kibirige D, Atuhe D, Kampiire L, Kiggundu DS, Donggo P, Nabbaale J, Mwebaze RM, Kalyesubula R, Lumu W. Access to medicines and diagnostic tests integral in the management of diabetes mellitus and cardiovascular diseases in Uganda: insights from the ACCODAD study. Int J Equity Health. 2017;16:154. [PMID: 28836972 DOI: 10.1186/s12939-017-0651-6] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
529 Mulder BA, Ten Berg J, Ten Cate H, van Es N, Hemels MEW, Kappelle LJ, Bearda Bakker HB, de Borst GJ, Drenth DJ, Geersing GJ, Rienstra M. Complex clinical scenarios with the use of direct oral anticoagulants in patients with atrial fibrillation: a multidisciplinary expert advisory board. Neth Heart J 2020;28:504-13. [PMID: 32394366 DOI: 10.1007/s12471-020-01424-y] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
530 Ozturk F, Atici A, Barman HA. Can Glypican-6 Level Predict Ejection Fraction Decline After Myocardial Infarction? Angiology 2021;72:582-8. [PMID: 33094648 DOI: 10.1177/0003319720968376] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
531 Stengaard C, Sørensen JT, Rasmussen MB, Søndergaard HM, Dodt KK, Niemann T, Frost L, Jensen T, Hansen TM, Riddervold IS, Rasmussen C, Giebner M, Aarøe J, Maeng M, Christiansen EH, Kristensen SD, Bøtker HE, Terkelsen CJ. Editor’s Choice-Acute versus subacute angiography in patients with non-ST-elevation myocardial infarction – the NONSTEMI trial phase I. European Heart Journal: Acute Cardiovascular Care 2014;6:490-9. [DOI: 10.1177/2048872616648468] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
532 Schmidt FP, Schmitt C, Hochadel M, Giannitsis E, Darius H, Maier LS, Schmitt C, Heusch G, Voigtländer T, Mudra H, Gori T, Senges J, Münzel T. Invasive treatment of NSTEMI patients in German Chest Pain Units – Evidence for a treatment paradox. International Journal of Cardiology 2018;255:15-9. [DOI: 10.1016/j.ijcard.2017.11.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
533 Wongsalap Y, Kengkla K, Poolpun D, Saokaew S. Trends in optimal medical therapy at discharge and clinical outcomes in patients with acute coronary syndrome in Thailand. J Cardiol 2021;77:669-76. [PMID: 33455848 DOI: 10.1016/j.jjcc.2020.12.015] [Reference Citation Analysis]
534 Zhao G, Zhou M, Ma C, Huo Y, Smith SC Jr, Fonarow GC, Ge J, Han Y, Liu J, Hao Y, Liu J, Wang X, Taubert KA, Morgan L, Zhao D, Nie S; CCC‐ACS Investigators. In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project. J Am Heart Assoc 2018;7:e008100. [PMID: 29602767 DOI: 10.1161/JAHA.117.008100] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
535 Zhao Q, Zhang TY, Cheng YJ, Ma Y, Xu YK, Yang JQ, Zhou YJ. Prognostic Significance of Relative Hyperglycemia after Percutaneous Coronary Intervention in Patients with and without Recognized Diabetes. Curr Vasc Pharmacol 2021;19:91-101. [PMID: 32183677 DOI: 10.2174/1570161118666200317145540] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
536 De Rosa R, Palmerini T, De Servi S, Belmonte M, Crimi G, Cornara S, Calabrò P, Cattaneo M, Maffeo D, Toso A, Bartorelli A, Palmieri C, De Carlo M, Capodanno D, Genereux P, Angiolillo D, Piscione F, Galasso G. High on-treatment platelet reactivity and outcome in elderly with non ST-segment elevation acute coronary syndrome - Insight from the GEPRESS study. International Journal of Cardiology 2018;259:20-5. [DOI: 10.1016/j.ijcard.2018.01.057] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
537 Jiménez Díaz VA, Hovasse T, Íñiguez A, Copt S, Byrne J, Brunel P, Morice MC, Abizaid A, Tespilli M, Walters D, Ortiz Sáez A, Bastos Fernández G, Stoll HP, Urban P. Impact of vascular access on outcome after PCI in patients at high bleeding risk: a pre-specified sub-analysis of the LEADERS FREE trial. Rev Esp Cardiol (Engl Ed) 2020;73:536-45. [PMID: 31563471 DOI: 10.1016/j.rec.2019.07.010] [Reference Citation Analysis]
538 Abushouk AI, Yunusa I, Elmehrath AO, Elmatboly AM, Fayek SH, Abdelfattah OM, Saad A, Isogai T, Shekhar S, Kalra A, Reed GW, Puri R, Kapadia S. Quality Assessment of Published Systematic Reviews in High Impact Cardiology Journals: Revisiting the Evidence Pyramid. Front Cardiovasc Med 2021;8:671569. [PMID: 34179136 DOI: 10.3389/fcvm.2021.671569] [Reference Citation Analysis]
539 Gili S, Iannaccone M, Colombo F, Montefusco A, Amabile N, Calcagno S, Capodanno D, Scalone G, Rognoni A, Omedè P, Ugo F, Cavallo E, Mancone M, Mangiameli A, Boccuzzi G, Hiansen J, Motreff P, Toutouzas K, Garbo R, Sardella G, Tamburino C, D'Amico M, Moretti C, Templin C, Gaita F, Souteyrand G, Niccoli G, D'Ascenzo F. Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry. Eur Heart J Cardiovasc Imaging 2018;19:524-31. [PMID: 28605473 DOI: 10.1093/ehjci/jex102] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 5.0] [Reference Citation Analysis]
540 Maeder MT, Mueller C, Schoch OD, Ammann P, Rickli H. Biomarkers of cardiovascular stress in obstructive sleep apnea. Clinica Chimica Acta 2016;460:152-63. [DOI: 10.1016/j.cca.2016.06.046] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 2.3] [Reference Citation Analysis]
541 Cullen LA, Mills NL. Point: The Use of Sex-Specific Cutpoints for High-Sensitivity Cardiac Troponin Assays. Clinical Chemistry 2017;63:261-3. [DOI: 10.1373/clinchem.2016.254672] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 4.4] [Reference Citation Analysis]
542 Jones R, Barratt J, Brettell E, Cockwell P, Dalton R, Deeks J, Eaglestone G, Pellatt-higgins T, Kalra P, Khunti K, Morris F, Ottridge R, Sitch A, Stevens P, Sharpe C, Sutton A, Taal M, Lamb E; on behalf of the eGFR-C Study Group. Biological variation of cardiac troponins in chronic kidney disease. Ann Clin Biochem 2020;57:162-9. [DOI: 10.1177/0004563220906431] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
543 Hizoh I, Gulyas Z, Domokos D, Banhegyi G, Majoros Z, Major L, Ratkai T, Kiss RG. A novel risk model including vascular access site for predicting 30-day mortality after primary PCI: The ALPHA score. Cardiovasc Revasc Med 2017;18:33-9. [PMID: 28029531 DOI: 10.1016/j.carrev.2016.10.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
544 Viana-Tejedor A, Ariza-Solé A, Martínez-Sellés M, Mena MJ, Vila M, García C, García Acuña JM, Bañeras J, García Rubira JC, Pérez PJ, Querol CT, Pastor G, Andrea R, Osorio PL, Alonso N, Martínez C, Pérez Rodríguez M, Noriega FJ, Ferrera C, Salinas P, Gil IN, Ortiz AF, Macaya C. Role of coronary angiography in patients with a non-diagnostic electrocardiogram following out of hospital cardiac arrest: Rationale and design of the multicentre randomized controlled COUPE trial. Eur Heart J Acute Cardiovasc Care 2020;9:S131-7. [PMID: 31237435 DOI: 10.1177/2048872618813843] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
545 Chan Pin Yin D, Azzahhafi J, James S. Risk Assessment Using Risk Scores in Patients with Acute Coronary Syndrome. J Clin Med 2020;9:E3039. [PMID: 32967247 DOI: 10.3390/jcm9093039] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
546 Kayani WT, Khan MR, Deshotels MR, Jneid H. Challenges and Controversies in the Management of ACS in Elderly Patients. Curr Cardiol Rep 2020;22:51. [PMID: 32500287 DOI: 10.1007/s11886-020-01298-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
547 Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’gara PT, Sabatine MS, Smith PK, Smith SC. 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation 2016;134. [DOI: 10.1161/cir.0000000000000404] [Cited by in Crossref: 551] [Cited by in F6Publishing: 230] [Article Influence: 91.8] [Reference Citation Analysis]
548 Sharma A, Garg A, Elmariah S, Drachman D, Obiagwu C, Vallakati A, Sharma SK, Lavie CJ, Mukherjee D, Waksman R, Stefanini GG, Feres F, Marmur JD, Helft G. Duration of Dual Antiplatelet Therapy Following Drug-Eluting Stent Implantation in Diabetic and Non-Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Prog Cardiovasc Dis 2018;60:500-7. [PMID: 29277295 DOI: 10.1016/j.pcad.2017.12.003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
549 Aakre KM, Kleiven Ø, Skadberg Ø, Bjørkavoll-Bergseth MF, Melberg T, Strand H, Hagve TA, Ørn S. The copeptin response after physical activity is not associated with cardiac biomarkers or asymptomatic coronary artery disease: The North Sea Race Endurance Exercise Study (NEEDED) 2013. Clin Biochem 2018;52:8-12. [PMID: 29079359 DOI: 10.1016/j.clinbiochem.2017.10.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
550 Anroedh S, Hilvo M, Akkerhuis KM, Kauhanen D, Koistinen K, Oemrawsingh R, Serruys P, van Geuns RJ, Boersma E, Laaksonen R, Kardys I. Plasma concentrations of molecular lipid species predict long-term clinical outcome in coronary artery disease patients. J Lipid Res 2018;59:1729-37. [PMID: 29858423 DOI: 10.1194/jlr.P081281] [Cited by in Crossref: 53] [Cited by in F6Publishing: 35] [Article Influence: 13.3] [Reference Citation Analysis]
551 Qin Y, Wu X, Wang J, Li Y, Ding X, Guo D, Jiang Z, Zhu W, Cai Q, Lu X. Value of territorial work efficiency estimation in non-ST-segment-elevation acute coronary syndrome: a study with non-invasive left ventricular pressure-strain loops. Int J Cardiovasc Imaging 2021;37:1255-65. [PMID: 33226551 DOI: 10.1007/s10554-020-02110-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
552 Chinwong S, Doungsong K, Channaina P, Phrommintikul A, Chinwong D. Association between medication adherence and cardiovascular outcomes among acute coronary syndrome patients. Res Social Adm Pharm 2021;17:1631-5. [PMID: 33455883 DOI: 10.1016/j.sapharm.2021.01.003] [Reference Citation Analysis]
553 Dondo TB, Hall M, Timmis AD, Yan AT, Batin PD, Oliver G, Alabas OA, Norman P, Deanfield JE, Bloor K, Hemingway H, Gale CP. Geographic variation in the treatment of non-ST-segment myocardial infarction in the English National Health Service: a cohort study. BMJ Open 2016;6:e011600. [PMID: 27406646 DOI: 10.1136/bmjopen-2016-011600] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
554 Roos A, Bandstein N, Lundbäck M, Hammarsten O, Ljung R, Holzmann MJ. Stable High-Sensitivity Cardiac Troponin T Levels and Outcomes in Patients With Chest Pain. J Am Coll Cardiol 2017;70:2226-36. [PMID: 29073949 DOI: 10.1016/j.jacc.2017.08.064] [Cited by in Crossref: 67] [Cited by in F6Publishing: 60] [Article Influence: 13.4] [Reference Citation Analysis]
555 Lippi G, Lo Cascio C, Brocco G, Danese E, Montagnana M, Bassi A, Caruso B, Bovo C, Salvagno GL. High-density lipoprotein cholesterol values independently and inversely predict cardiac troponin T and I concentration. Ann Transl Med 2016;4:188. [PMID: 27294084 DOI: 10.21037/atm.2016.03.03] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
556 Bogacki P, Kabłak-Ziembicka A, Bryniarski K, Wrotniak L, Ostrowska-Kaim E, Żmudka K, Przewłocki T. Triple anticoagulation therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention - real life assessment. Postepy Kardiol Interwencyjnej 2016;12:303-13. [PMID: 27980543 DOI: 10.5114/aic.2016.63629] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.3] [Reference Citation Analysis]
557 Hofmann R, Tornvall P, Witt N, Alfredsson J, Svensson L, Jonasson L, Nilsson L. Supplemental oxygen therapy does not affect the systemic inflammatory response to acute myocardial infarction. J Intern Med 2018;283:334-45. [DOI: 10.1111/joim.12716] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
558 Schneider VS, Lübking L, Stähli BE, Skurk C, Lauten A, Mochmann HC, Schauerte P, Riedel M, Steinbeck L, Rauch-Kröhnert U, Klotsche J, Landmesser U, Fröhlich G, Leistner DM. Performance of One- Compared With Two-Catheter Concepts in Transradial Coronary Angiography (from the Randomized Use of Different Diagnostic Catheters-Radial-Trial). Am J Cardiol 2018;122:1647-51. [PMID: 30217374 DOI: 10.1016/j.amjcard.2018.07.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
559 Lanza GA, Melita V, Mencarelli E, De Vita A, Bisignani A, Manfredonia L, Covino M, Crea F. Characteristics and in-hospital outcome of patients with no ST-segment elevation acute coronary syndrome and no obstructive coronary artery disease in the era of high-sensitivity troponins: . Journal of Cardiovascular Medicine 2019;20:210-4. [DOI: 10.2459/jcm.0000000000000771] [Cited by in Crossref: 3] [Article Influence: 1.0] [Reference Citation Analysis]
560 Guo J, Guo L, Tong Z, Wang Z, Dardik A, Gu Y. Three-Year Clinical Results of Carotid Artery Stenting in Treating Patients with Contralateral Carotid Artery Occlusion. J Stroke Cerebrovasc Dis 2018;27:1296-301. [PMID: 29428329 DOI: 10.1016/j.jstrokecerebrovasdis.2017.12.016] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
561 Chapman AR, Adamson PD, Mills NL. Assessment and classification of patients with myocardial injury and infarction in clinical practice. Heart 2017;103:10-8. [PMID: 27806987 DOI: 10.1136/heartjnl-2016-309530] [Cited by in Crossref: 64] [Cited by in F6Publishing: 55] [Article Influence: 10.7] [Reference Citation Analysis]
562 Al-Sadoon I, Wittmann I, Kun S, Ahmann M, Konyi A, Verzár Z. Assessment of serum phenylalanine and tyrosine isomers in patients with ST-segment elevation vs non-ST-segment elevation myocardial infarction. J Clin Lab Anal 2021;35:e23613. [PMID: 33043503 DOI: 10.1002/jcla.23613] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
563 Vafaie M, Katus HA. Accuracy of 0/1-hour algorithm for diagnosis of MI in the elderly: mono-dimensional optimization of troponin cut-offs for individual confounders or precision medicine? Eur Heart J 2018;39:3795-7. [PMID: 30188981 DOI: 10.1093/eurheartj/ehy526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
564 Valgimigli M, Bueno H, Byrne RA, Collet J, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann F, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Levine GN, Badimon L, Vranckx P, Agewall S, Andreotti F, Antman E, Barbato E, Bassand J, Bugiardini R, Cikirikcioglu M, Cuisset T, De Bonis M, Delgado V, Fitzsimons D, Gaemperli O, Galiè N, Gilard M, Hamm CW, Ibanez B, Iung B, James S, Knuuti J, Landmesser U, Leclercq C, Lettino M, Lip G, Piepoli MF, Pierard L, Schwerzmann M, Sechtem U, Simpson IA, Uva MS, Stabile E, Storey RF, Tendera M, Van de Werf F, Verheugt F, Aboyans V, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, Mcdonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL, Windecker S, Aboyans V, Agewall S, Barbato E, Bueno H, Coca A, Collet J, Coman IM, Dean V, Delgado V, Fitzsimons D, Gaemperli O, Hindricks G, Iung B, Jüni P, Katus HA, Knuuti J, Lancellotti P, Leclercq C, Mcdonagh T, Piepoli MF, Ponikowski P, Richter DJ, Roffi M, Shlyakhto E, Simpson IA, Zamorano JL, Roithinger FX, Aliyev F, Stelmashok V, Desmet W, Postadzhiyan A, Georghiou GP, Motovska Z, Grove EL, Marandi T, Kiviniemi T, Kedev S, Gilard M, Massberg S, Alexopoulos D, Kiss RG, Gudmundsdottir IJ, Mcfadden EP, Lev E, De Luca L, Sugraliyev A, Haliti E, Mirrakhimov E, Latkovskis G, Petrauskiene B, Huijnen S, Magri CJ, Cherradi R, Ten Berg JM, Eritsland J, Budaj A, Aguiar CT, Duplyakov D, Zavatta M, Antonijevic NM, Motovska Z, Fras Z, Montoliu AT, Varenhorst C, Tsakiris D, Addad F, Aydogdu S, Parkhomenko A, Kinnaird T; ESC Scientific Document Group, ESC Committee for Practice Guidelines (CPG), ESC National Cardiac Societies. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. European Heart Journal 2018;39:213-60. [DOI: 10.1093/eurheartj/ehx419] [Cited by in Crossref: 1230] [Cited by in F6Publishing: 937] [Article Influence: 246.0] [Reference Citation Analysis]
565 Mohamed MO, Kirchhof P, Vidovich M, Savage M, Rashid M, Kwok CS, Thomas M, El Omar O, Al Ayoubi F, Fischman DL, Mamas MA. Effect of Concomitant Atrial Fibrillation on In-Hospital Outcomes of Non-ST-Elevation-Acute Coronary Syndrome-Related Hospitalizations in the United States. Am J Cardiol 2019;124:465-75. [PMID: 31248589 DOI: 10.1016/j.amjcard.2019.05.040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
566 Kimenai DM, Martens RJH, Kooman JP, Stehouwer CDA, Tan FES, Schaper NC, Dagnelie PC, Schram MT, van der Kallen CJH, Sep SJS, van Suijlen JDE, Kroon AA, Bekers O, van Dieijen-Visser MP, Henry RMA, Meex SJR. Troponin I and T in relation to cardiac injury detected with electrocardiography in a population-based cohort - The Maastricht Study. Sci Rep 2017;7:6610. [PMID: 28747765 DOI: 10.1038/s41598-017-06978-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
567 Rashid M, Curzen N, Kinnaird T, Lawson CA, Myint PK, Kontopantelis E, Mohamed MO, Shoaib A, Gale CP, Timmis A, Mamas MA. Baseline risk, timing of invasive strategy and guideline compliance in NSTEMI: Nationwide analysis from MINAP. International Journal of Cardiology 2020;301:7-13. [DOI: 10.1016/j.ijcard.2019.11.146] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
568 Duma A, Wagner C, Titz M, Maleczek M, Hüpfl M, Weihs VB, Samaha E, Herkner H, Szekeres T, Mittlboeck M, Scott MG, Jaffe AS, Nagele P. High-sensitivity cardiac troponin T in young, healthy adults undergoing non-cardiac surgery. Br J Anaesth 2018;120:291-8. [PMID: 29406178 DOI: 10.1016/j.bja.2017.09.001] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
569 Hu G, Zhou M, Liu J, Smith SC Jr, Ma C, Ge J, Huo Y, Fonarow GC, Hao Y, Liu J, Taubert KA, Morgan L, Yang N, Zeng Y, Han Y, Zhao D; CCC-ACS Investigators. Smoking and Provision of Smoking Cessation Interventions among Inpatients with Acute Coronary Syndrome in China: Findings from the Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome Project. Glob Heart 2020;15:72. [PMID: 33150137 DOI: 10.5334/gh.784] [Reference Citation Analysis]
570 Bhatia S, Arora S, Bhatia SM, Al-Hijji M, Reddy YNV, Patel P, Rihal CS, Gersh BJ, Deshmukh A. Non-ST-Segment-Elevation Myocardial Infarction Among Patients With Chronic Kidney Disease: A Propensity Score-Matched Comparison of Percutaneous Coronary Intervention Versus Conservative Management. J Am Heart Assoc 2018;7:e007920. [PMID: 29525779 DOI: 10.1161/JAHA.117.007920] [Cited by in Crossref: 10] [Cited by in F6Publishing: 2] [Article Influence: 2.5] [Reference Citation Analysis]
571 Davis WT, Montrief T, Koyfman A, Long B. Dysrhythmias and heart failure complicating acute myocardial infarction: An emergency medicine review. Am J Emerg Med 2019;37:1554-61. [PMID: 31060863 DOI: 10.1016/j.ajem.2019.04.047] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
572 Wang Y, Zhen C, Wang R, Wang G. Growth-differentiation factor-15 predicts adverse cardiac events in patients with acute coronary syndrome: A meta-analysis. Am J Emerg Med 2019;37:1346-52. [PMID: 31029521 DOI: 10.1016/j.ajem.2019.04.035] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
573 Gündoğmuş PD, Ölçü EB, Öz A, Tanboğa İH, Orhan AL. The effects of percutaneous coronary intervention on mortality in elderly patients with non-ST-segment elevation myocardial infarction undergoing coronary angiography. Scott Med J 2020;65:81-8. [PMID: 32772677 DOI: 10.1177/0036933020919931] [Reference Citation Analysis]
574 Mauermann E, Bolliger D, Fassl J, Grapow M, Seeberger EE, Seeberger MD, Filipovic M, Lurati Buse GAL. Postoperative High-Sensitivity Troponin and Its Association With 30-Day and 12-Month, All-Cause Mortality in Patients Undergoing On-Pump Cardiac Surgery. Anesth Analg 2017;125:1110-7. [PMID: 28537984 DOI: 10.1213/ANE.0000000000002023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 2.2] [Reference Citation Analysis]
575 Ingram SJ, Mckee G, Quirke MB, Kelly N, Moloney A. Discharge of Non–Acute Coronary Syndrome Chest Pain Patients From Emergency Care to an Advanced Nurse Practitioner–Led Chest Pain Clinic: A Cross-Sectional Study of Referral Source and Final Diagnosis. J Cardiovasc Nurs 2017;32:E1-8. [DOI: 10.1097/jcn.0000000000000374] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
576 Gurbel PA, Jeong Y, Navarese EP, Tantry US. Platelet-Mediated Thrombosis: From Bench to Bedside. Circ Res 2016;118:1380-91. [DOI: 10.1161/circresaha.115.307016] [Cited by in Crossref: 35] [Cited by in F6Publishing: 15] [Article Influence: 5.8] [Reference Citation Analysis]
577 Christenson RH, Duh SH, Mullins KE, LeClair MM, Grigorov IL, Peacock WF. Analytical and clinical characterization of a novel high-sensitivity cardiac troponin assay in a United States population. Clin Biochem 2020;83:28-36. [PMID: 32485169 DOI: 10.1016/j.clinbiochem.2020.05.014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
578 Perelshtein Brezinov O, Klempfner R, Zekry SB, Goldenberg I, Kuperstein R. Prognostic value of ejection fraction in patients admitted with acute coronary syndrome: A real world study. Medicine (Baltimore) 2017;96:e6226. [PMID: 28248882 DOI: 10.1097/MD.0000000000006226] [Cited by in Crossref: 22] [Cited by in F6Publishing: 11] [Article Influence: 4.4] [Reference Citation Analysis]
579 Ferencik M, Hoffmann U, Bamberg F, Januzzi JL. Highly sensitive troponin and coronary computed tomography angiography in the evaluation of suspected acute coronary syndrome in the emergency department. Eur Heart J 2016;37:2397-405. [PMID: 26843275 DOI: 10.1093/eurheartj/ehw005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
580 Doll JA, Li S, Chiswell K, Roe MT, Kosiborod M, Scirica BM, Wang TY. Clopidogrel reloading for patients with acute myocardial infarction already on clopidogrel therapy. European Heart Journal 2018;39:193-200. [DOI: 10.1093/eurheartj/ehx255] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
581 Roczek-Janowska M, Kacprzak M, Dzieciol M, Zielinska M, Chizynski K. Prognostic value of copeptin in patients with acute myocardial infarction treated with percutaneous coronary intervention: a prospective cohort study. J Thorac Dis 2021;13:4094-103. [PMID: 34422339 DOI: 10.21037/jtd-21-359] [Reference Citation Analysis]
582 Lenz M, Krychtiuk KA, Goliasch G, Distelmaier K, Wojta J, Heinz G, Speidl WS. N-terminal pro-brain natriuretic peptide and high-sensitivity troponin T exhibit additive prognostic value for the outcome of critically ill patients. Eur Heart J Acute Cardiovasc Care 2020;9:496-503. [PMID: 29617154 DOI: 10.1177/2048872618768088] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
583 Álvarez Álvarez B, Abou Jokh Casas C, Agra Bermejo R, Cordero A, Cid Álvarez AB, Rodriguez Mañero M, Bouzas Cruz N, García Acuña JM, Salgado Barreiro A, González-juanatey JR. Sex-related differences in long-term mortality and heart failure in a contemporary cohort of patients with NSTEACS. The cardiochus-HSUJ registry. European Journal of Internal Medicine 2020;81:26-31. [DOI: 10.1016/j.ejim.2020.06.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
584 Hoedemaker NPG, Damman P, Ottervanger JP, Dambrink JHE, Gosselink ATM, Kedhi E, Kolkman E, de Winter RJ, van ’t Hof AWJ. Trends in optimal medical therapy prescription and mortality after admission for acute coronary syndrome: a 9-year experience in a real-world setting. European Heart Journal - Cardiovascular Pharmacotherapy 2018;4:102-10. [DOI: 10.1093/ehjcvp/pvy005] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
585 Lebas H, Yahiaoui K, Martos R, Boulaftali Y. Platelets Are at the Nexus of Vascular Diseases. Front Cardiovasc Med 2019;6:132. [PMID: 31572732 DOI: 10.3389/fcvm.2019.00132] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
586 Bertrand MJ, Tanguay JF. Immediate Versus Delayed Invasive Intervention for Non-ST-Segment Elevation Myocardial Infarction Patients (RIDDLE-NSTEMI Study): A Game Changer for Interventional Cardiologists? JACC Cardiovasc Interv 2016;9:1415-6. [PMID: 27388834 DOI: 10.1016/j.jcin.2016.04.032] [Reference Citation Analysis]
587 Capodanno D. Triple antithrombotic therapy after ACS and PCI in patients on chronic oral anticoagulation: update. Heart 2018;104:1976-83. [PMID: 29695514 DOI: 10.1136/heartjnl-2017-312228] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
588 Hee L, Gibbs OJ, Assad JG, Sharma LD, Hopkins A, Juergens CP, Lo S, Mussap CJ. Real-world use of ticagrelor versus clopidogrel in percutaneous coronary intervention-treated ST-elevation myocardial infarction patients: A single-center registry study. J Saudi Heart Assoc 2019;31:151-60. [PMID: 31296977 DOI: 10.1016/j.jsha.2019.05.005] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
589 Zhai Y, He H, Ma X, Xie J, Meng T, Dong Y, Lu J. Meta-analysis of effects of ABCB1 polymorphisms on clopidogrel response among patients with coronary artery disease. Eur J Clin Pharmacol 2017;73:843-54. [DOI: 10.1007/s00228-017-2235-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
590 Liu Y, Liu T, Zhao J, He T, Chen H, Wang J, Zhang W, Ma W, Fan Y, Song X. Phospholipase Cγ2 signalling contributes to the haemostatic effect of Notoginsenoside Ft1. J Pharm Pharmacol 2019;71:878-86. [PMID: 30549041 DOI: 10.1111/jphp.13057] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
591 De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F, Baigent C, Collet JP, Halvorsen S, Huber K, Jespersen J, Kristensen SD, Lip GY, Morais J, Rasmussen LH, Ricci F, Sibbing D, Siegbahn A, Storey RF, Ten Berg J, Verheugt FW, Weitz JI. Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2016;115:685-711. [PMID: 26952877 DOI: 10.1160/TH15-09-0703] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 3.2] [Reference Citation Analysis]
592 Priori SG, Blomström-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, Elliott PM, Fitzsimons D, Hatala R, Hindricks G, Kirchhof P, Kjeldsen K, Kuck KH, Hernandez-Madrid A, Nikolaou N, Norekvål TM, Spaulding C, Van Veldhuisen DJ; Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC)Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace 2015;17:1601-87. [PMID: 26318695 DOI: 10.1093/europace/euv319] [Cited by in Crossref: 77] [Cited by in F6Publishing: 138] [Article Influence: 11.0] [Reference Citation Analysis]
593 Jobs A, Collet JP, Thiele H. Optimal timing of invasive angiography in non-ST-segment elevation acute coronary syndromes-do we need more data? Eur Heart J 2021;42:353-4. [PMID: 33188593 DOI: 10.1093/eurheartj/ehaa930] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
594 Prondzinsky R, Hirsch K, Wachsmuth L, Buerke M, Unverzagt S. Vasopressors for acute myocardial infarction complicated by cardiogenic shock. Med Klin Intensivmed Notfmed 2019;114:21-9. [DOI: 10.1007/s00063-017-0378-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
595 van der Linden N, Klinkenberg LJJ, Bekers O, Loon LJCV, Dieijen-Visser MPV, Zeegers MP, Meex SJR. Prognostic value of basal high-sensitive cardiac troponin levels on mortality in the general population: A meta-analysis. Medicine (Baltimore) 2016;95:e5703. [PMID: 28033267 DOI: 10.1097/MD.0000000000005703] [Cited by in Crossref: 39] [Cited by in F6Publishing: 9] [Article Influence: 7.8] [Reference Citation Analysis]
596 Hagsund T, Olsson SE, Smith JG, Madsen Hardig B, Wagner H. β-blockers after myocardial infarction and 1-year clinical outcome - a retrospective study. BMC Cardiovasc Disord 2020;20:165. [PMID: 32272880 DOI: 10.1186/s12872-020-01441-0] [Reference Citation Analysis]
597 Janssens GN, Lemkes JS, van der Hoeven NW, van Leeuwen MAH, Everaars H, van de Ven PM, Brinckman SL, Timmer JR, Meuwissen M, Meijers JCM, van der Weerdt AP, Ten Cate TJF, Piek JJ, von Birgelen C, Diletti R, Escaned J, van Rossum AC, Nijveldt R, van Royen N. Transient ST-elevation myocardial infarction versus persistent ST-elevation myocardial infarction. An appraisal of patient characteristics and functional outcome. Int J Cardiol 2021;336:22-8. [PMID: 34004231 DOI: 10.1016/j.ijcard.2021.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
598 Nallet O, Gouffran G, Lavie Badie Y. [Troponin elevation in the absence of acute coronary syndrome]. Ann Cardiol Angeiol (Paris) 2016;65:340-5. [PMID: 27693169 DOI: 10.1016/j.ancard.2016.09.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
599 Jenkins AT, Kantorovich A, Burman L. Contemporary Use of Oral Antithrombotic Agents: Focus on Dual and Triple Therapeutic Approaches. Pharmacotherapy 2017;37:1545-64. [PMID: 28981961 DOI: 10.1002/phar.2041] [Reference Citation Analysis]
600 Biesemans L, Cleef LE, Willemsen RTA, Hoorweg BBN, Renier WS, Buntinx F, Glatz JFC, Dinant GJ. Managing chest pain patients in general practice: an interview-based study. BMC Fam Pract 2018;19:80. [PMID: 29859536 DOI: 10.1186/s12875-018-0771-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
601 Malm CJ, Hansson EC, Åkesson J, Andersson M, Hesse C, Shams Hakimi C, Jeppsson A. Preoperative platelet function predicts perioperative bleeding complications in ticagrelor-treated cardiac surgery patients: a prospective observational study. Br J Anaesth 2016;117:309-15. [PMID: 27543525 DOI: 10.1093/bja/aew189] [Cited by in Crossref: 55] [Cited by in F6Publishing: 40] [Article Influence: 13.8] [Reference Citation Analysis]
602 Salbach C, Mueller-Hennessen M, Biener M, Stoyanov K, Preusch M, Kihm L, Merle U, Schnitzler P, Katus HA, Giannitsis E. Interpretation of myocardial injury subtypes in COVID-19 disease per fourth version of Universal Definition of Myocardial Infarction. Biomarkers 2021;26:401-9. [PMID: 33998352 DOI: 10.1080/1354750X.2021.1921031] [Reference Citation Analysis]
603 Montone RA, Niccoli G, Fracassi F, Russo M, Gurgoglione F, Cammà G, Lanza GA, Crea F. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests. Eur Heart J 2018;39:91-8. [PMID: 29228159 DOI: 10.1093/eurheartj/ehx667] [Cited by in Crossref: 22] [Cited by in F6Publishing: 29] [Article Influence: 7.3] [Reference Citation Analysis]
604 Nairoukh Z, Jahangir S, Adjepong D, Malik BH. Distal Radial Artery Access: The Future of Cardiovascular Intervention. Cureus 2020;12:e7201. [PMID: 32269880 DOI: 10.7759/cureus.7201] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
605 Giannitsis E, Mueller-hennessen M, Zeller T, Schuebler A, Aurich M, Biener M, Vafaie M, Stoyanov KM, Ochs M, Riffel J, Mereles D, Blankenberg S, Katus HA. Gender-specific reference values for high-sensitivity cardiac troponin T and I in well-phenotyped healthy individuals and validity of high-sensitivity assay designation. Clinical Biochemistry 2020;78:18-24. [DOI: 10.1016/j.clinbiochem.2019.11.013] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 6.5] [Reference Citation Analysis]
606 Farcaş AD, Mocan M, Anton FP, Diana ML, Chiorescu RM, Stoia MA, Vonica CL, Goidescu CM, Vida-Simiti LA. Short-Term Prognosis Value of sST2 for an Unfavorable Outcome in Hypertensive Patients. Dis Markers 2020;2020:8143737. [PMID: 32089758 DOI: 10.1155/2020/8143737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
607 Jourdi G, Lordkipanidzé M, Philippe A, Bachelot-Loza C, Gaussem P. Current and Novel Antiplatelet Therapies for the Treatment of Cardiovascular Diseases. Int J Mol Sci 2021;22:13079. [PMID: 34884884 DOI: 10.3390/ijms222313079] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
608 White HD, Stewart RAH, Dalby AJ, Stebbins A, Cannon CP, Budaj A, Linhart A, Pais P, Diaz R, Steg PG, Krug-Gourley S, Granger CB, Hochman JS, Koenig W, Harrington RA, Held C, Wallentin L; STABILITY Investigators. In patients with stable coronary heart disease, low-density lipoprotein-cholesterol levels < 70 mg/dL and glycosylated hemoglobin A1c < 7% are associated with lower major cardiovascular events. Am Heart J 2020;225:97-107. [PMID: 32480059 DOI: 10.1016/j.ahj.2020.04.004] [Reference Citation Analysis]
609 Westwood ME, Armstrong N, Worthy G, Fayter D, Ramaekers BLT, Grimm S, Buksnys T, Ross J, Mills NL, Body R, Collinson PO, Timmis A, Kleijnen J. Optimizing the Use of High-Sensitivity Troponin Assays for the Early Rule-out of Myocardial Infarction in Patients Presenting with Chest Pain: A Systematic Review. Clin Chem 2021;67:237-44. [PMID: 33418577 DOI: 10.1093/clinchem/hvaa280] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
610 Khalid U, Jneid H, Deswal A. Higher risk, high yield: renin-angiotensin system blockade after percutaneous coronary intervention in patients with acute coronary syndrome. Rev Esp Cardiol (Engl Ed) 2020;73:104-6. [PMID: 31575483 DOI: 10.1016/j.rec.2019.08.007] [Reference Citation Analysis]
611 Hall M, Dondo TB, Yan AT, Mamas MA, Timmis AD, Deanfield JE, Jernberg T, Hemingway H, Fox KAA, Gale CP. Multimorbidity and survival for patients with acute myocardial infarction in England and Wales: Latent class analysis of a nationwide population-based cohort. PLoS Med 2018;15:e1002501. [PMID: 29509764 DOI: 10.1371/journal.pmed.1002501] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 8.5] [Reference Citation Analysis]
612 Windecker S, Lopes RD, Massaro T, Jones-Burton C, Granger CB, Aronson R, Heizer G, Goodman SG, Darius H, Jones WS, Aschermann M, Brieger D, Cura F, Engstrøm T, Fridrich V, Halvorsen S, Huber K, Kang HJ, Leiva-Pons JL, Lewis BS, Malaga G, Meneveau N, Merkely B, Milicic D, Morais J, Potpara TS, Raev D, Sabaté M, de Waha-Thiele S, Welsh RC, Xavier D, Mehran R, Alexander JH; AUGUSTUS Investigators. Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights From the AUGUSTUS Trial. Circulation 2019;140:1921-32. [PMID: 31557056 DOI: 10.1161/CIRCULATIONAHA.119.043308] [Cited by in Crossref: 35] [Cited by in F6Publishing: 6] [Article Influence: 11.7] [Reference Citation Analysis]
613 Collinson P. Laboratory Medicine is Faced with the Evolution of Medical Practice. J Med Biochem 2017;36:211-5. [PMID: 30564057 DOI: 10.1515/jomb-2017-0032] [Cited by in Crossref: 26] [Cited by in F6Publishing: 13] [Article Influence: 5.2] [Reference Citation Analysis]
614 Kvakkestad KM, Gran JM, Eritsland J, Holst Hansen C, Fossum E, Andersen GØ, Halvorsen S. Long-Term Survival after Invasive or Conservative Strategy in Elderly Patients with non-ST-Elevation Myocardial Infarction: A Prospective Cohort Study. Cardiology 2019;144:79-89. [PMID: 31689705 DOI: 10.1159/000503442] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
615 Mccarthy CP, Donnellan E, Wasfy JH, Bhatt DL, Mcevoy JW. Time-honored treatments for the initial management of acute coronary syndromes: Challenging the status quo. Trends in Cardiovascular Medicine 2017;27:483-91. [DOI: 10.1016/j.tcm.2017.05.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
616 Badings EA, Remkes WS, The SH, Dambrink JE, Tjeerdsma G, Rasoul S, Timmer JR, van der Wielen ML, Lok DJ, Hermanides RS, Van Wijngaarden J, Suryapranata H, van 't Hof AW. Two-year outcome after early or late Intervention in non-ST elevation acute coronary syndrome. Open Heart 2017;4:e000538. [PMID: 28409008 DOI: 10.1136/openhrt-2016-000538] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
617 Jacobs MS, Tieleman RG. Optimal antithrombotic treatment of patients with atrial fibrillation undergoing percutaneous coronary intervention: triple therapy is too much! Neth Heart J 2018;26:334-40. [PMID: 29740755 DOI: 10.1007/s12471-018-1120-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
618 Lemesle G, Laine M, Pankert M, Puymirat E, Cuisset T, Boueri Z, Maillard L, Armero S, Cayla G, Bali L, Motreff P, Peyre JP, Paganelli F, Kerbaul F, Roch A, Michelet P, Baumstarck K, Bonello L. Early versus delayed invasive strategy for intermediate- and high-risk acute coronary syndromes managed without P2Y12 receptor inhibitor pretreatment: Design and rationale of the EARLY randomized trial. Clin Cardiol 2018;41:5-12. [PMID: 29356001 DOI: 10.1002/clc.22852] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
619 Gimbel M, Qaderdan K, Willemsen L, Hermanides R, Bergmeijer T, de Vrey E, Heestermans T, Tjon Joe Gin M, Waalewijn R, Hofma S, den Hartog F, Jukema W, von Birgelen C, Voskuil M, Kelder J, Deneer V, Ten Berg J. Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): the randomised, open-label, non-inferiority trial. Lancet 2020;395:1374-81. [PMID: 32334703 DOI: 10.1016/S0140-6736(20)30325-1] [Cited by in Crossref: 65] [Cited by in F6Publishing: 13] [Article Influence: 32.5] [Reference Citation Analysis]
620 Zhang B, Wang Y, Guo J, Zhang G, Yang B. Nomogram to differentiate between aortic dissection and non-ST segment elevation acute coronary syndrome: a retrospective cohort study. Cardiovasc Diagn Ther 2021;11:457-66. [PMID: 33968623 DOI: 10.21037/cdt-20-935] [Reference Citation Analysis]
621 Zelniker TA, Jarolim P, Silverman MG, Bohula EA, Park J, Bonaca MP, Scirica BM, Morrow DA. Prognostic role of GDF-15 across the spectrum of clinical risk in patients with NSTE-ACS. Clinical Chemistry and Laboratory Medicine (CCLM) 2019;57:1084-92. [DOI: 10.1515/cclm-2018-1081] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
622 Lee JK, Wang IS, Huang CH, Chen YF, Huang NT, Lin CT. Pre-Clinical Tests of an Integrated CMOS Biomolecular Sensor for Cardiac Diseases Diagnosis. Sensors (Basel) 2017;17:E2733. [PMID: 29186872 DOI: 10.3390/s17122733] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
623 Ding YD, Pei YQ, Wang R, Yang JX, Zhao YX, Liu XL, Shen H, Ma Q, Zhang S, Ge HL. Increased plasma lipoprotein-associated phospholipase A2 levels are associated with coronary slow flow. BMC Cardiovasc Disord 2020;20:248. [PMID: 32460702 DOI: 10.1186/s12872-020-01463-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
624 Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, Federici M, Filippatos G, Grobbee DE, Hansen TB, Huikuri HV, Johansson I, Jüni P, Lettino M, Marx N, Mellbin LG, Östgren CJ, Rocca B, Roffi M, Sattar N, Seferović PM, Sousa-Uva M, Valensi P, Wheeler DC; ESC Scientific Document Group. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 2020;41:255-323. [PMID: 31497854 DOI: 10.1093/eurheartj/ehz486] [Cited by in Crossref: 925] [Cited by in F6Publishing: 738] [Article Influence: 925.0] [Reference Citation Analysis]
625 Nudi F, Nudi A, Biondi-Zoccai G, Schillaci O. Bridging the Atlantic gap in clinical guidelines for non-ST-elevation acute coronary syndromes. J Nucl Cardiol 2018;25:780-4. [PMID: 29435859 DOI: 10.1007/s12350-018-1216-9] [Reference Citation Analysis]
626 Isogai T, Matsui H, Tanaka H, Yokogawa N, Fushimi K, Yasunaga H. Treatments and in-hospital mortality in acute myocardial infarction patients with rheumatoid arthritis: a nationwide retrospective cohort study in Japan. Clin Rheumatol 2017;36:995-1004. [PMID: 28124758 DOI: 10.1007/s10067-017-3555-3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
627 Kim HS, Lee KJ, Ha SO, Han SJ, Park KH, Lee SH, Hwang YI, Jang SH, Park S. Brain natriuretic peptide levels predict 6-month mortality in patients with cardiogenic shock who were weaned off extracorporeal membrane oxygenation. Medicine (Baltimore) 2020;99:e21272. [PMID: 32702916 DOI: 10.1097/MD.0000000000021272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
628 Duan KI, Helfrich CD, Rao SV, Neely EL, Sulc CA, Naranjo D, Wong ES. Cost analysis of a coaching intervention to increase use of transradial percutaneous coronary intervention. Implement Sci Commun 2021;2:123. [PMID: 34706775 DOI: 10.1186/s43058-021-00219-5] [Reference Citation Analysis]
629 Wang Y, Ping Yen Yan B, Tomlinson B, Bruce Nichol M, Lee VWY. Clinical and Economic Analysis of Lipid Goal Attainments in Chinese Patients with Acute Coronary Syndrome Who Received Post-Percutaneous Coronary Intervention. J Atheroscler Thromb 2018;25:1255-73. [PMID: 29962381 DOI: 10.5551/jat.44818] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
630 Farhan S, Baber U, Mehran R. Anemia and Acute Coronary Syndrome: Time for Intervention Studies. J Am Heart Assoc 2016;5:e004908. [PMID: 27866165 DOI: 10.1161/JAHA.116.004908] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
631 Morrow AJ, Ford TJ, McEntegart M. Chest pain with a cold. BMJ 2020;371:m3742. [PMID: 33154035 DOI: 10.1136/bmj.m3742] [Reference Citation Analysis]
632 Elad B, Koren O, Slim W, Turgeman Y, Avraham G, Schwartz N, Elias M. Thrombin generation's role in predicting coronary disease severity. PLoS One 2020;15:e0237024. [PMID: 32764787 DOI: 10.1371/journal.pone.0237024] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
633 Kim JY, Kim KH, Cho JY, Sim DS, Yoon HJ, Yoon NS, Hong YJ, Park HW, Kim JH, Ahn Y, Jeong MH, Cho JG, Park JC. D-dimer/troponin ratio in the differential diagnosis of acute pulmonary embolism from non-ST elevation myocardial infarction. Korean J Intern Med 2019;34:1263-71. [PMID: 30685960 DOI: 10.3904/kjim.2018.153] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
634 Liakopoulos OJ, Schlachtenberger G, Wendt D, Choi YH, Slottosch I, Welp H, Schiller W, Martens S, Welz A, Neuhäuser M, Jakob H, Wahlers T, Thielmann M. Early Clinical Outcomes of Surgical Myocardial Revascularization for Acute Coronary Syndromes Complicated by Cardiogenic Shock: A Report From the North-Rhine-Westphalia Surgical Myocardial Infarction Registry. J Am Heart Assoc 2019;8:e012049. [PMID: 31070076 DOI: 10.1161/JAHA.119.012049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
635 Verdoia M, Barbieri L, Parodi G, Bellandi B, Schaffer A, Suryapranata H, De Luca G. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials. Catheter Cardiovasc Interv 2017;90:553-65. [PMID: 28471057 DOI: 10.1002/ccd.26967] [Reference Citation Analysis]
636 Sierra P, Gómez-Luque A, Llau JV, Ferrandis R, Cassinello C, Hidalgo F. Recommendations for perioperative antiplatelet treatment in non-cardiac surgery. Working Group of the Spanish Society of Anaesthesiology-Resuscitation and Pain Therapy, Division of Haemostasis, Transfusion Medicine, and Perioperative Fluid Therapy. Update of the Clinical practice guide 2018. Rev Esp Anestesiol Reanim (Engl Ed) 2019;66:18-36. [PMID: 30166124 DOI: 10.1016/j.redar.2018.07.003] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
637 Tran DT, Welsh RC, Ohinmaa A, Thanh NX, Bagai A, Kaul P. Quality of Acute Myocardial Infarction Care in Canada: A 10-Year Review of 30-Day In-Hospital Mortality and 30-Day Hospital Readmission. Canadian Journal of Cardiology 2017;33:1319-26. [DOI: 10.1016/j.cjca.2017.06.014] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
638 Zabawa C, Cottenet J, Zeller M, Mercier G, Rodwin VG, Cottin Y, Quantin C. Thirty-day rehospitalizations among elderly patients with acute myocardial infarction: Impact of postdischarge ambulatory care. Medicine (Baltimore) 2018;97:e11085. [PMID: 29901621 DOI: 10.1097/MD.0000000000011085] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
639 Visseren FLJ, Mach F, Smulders YM, Carballo D, Koskinas KC, Bäck M, Benetos A, Biffi A, Boavida JM, Capodanno D, Cosyns B, Crawford C, Davos CH, Desormais I, Di Angelantonio E, Franco OH, Halvorsen S, Hobbs FDR, Hollander M, Jankowska EA, Michal M, Sacco S, Sattar N, Tokgozoglu L, Tonstad S, Tsioufis KP, van Dis I, van Gelder IC, Wanner C, Williams B; ESC Scientific Document Group . 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur J Prev Cardiol 2021:zwab154. [PMID: 34558602 DOI: 10.1093/eurjpc/zwab154] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
640 Michel L, Mincu RI, Mrotzek SM, Korste S, Neudorf U, Rassaf T, Totzeck M. Cardiac biomarkers for the detection of cardiotoxicity in childhood cancer-a meta-analysis. ESC Heart Fail 2020;7:423-33. [PMID: 32069386 DOI: 10.1002/ehf2.12589] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
641 Gong IY, Goodman SG, Brieger D, Gale CP, Chew DP, Welsh RC, Huynh T, DeYoung JP, Baer C, Gyenes GT, Udell JA, Fox KAA, Yan AT; Canadian GRACE/GRACE-2 and CANRACE Investigators. GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome. Int J Cardiol 2017;244:24-9. [PMID: 28645803 DOI: 10.1016/j.ijcard.2017.06.055] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
642 Cortese B, Ielasi A, Moscarella E, Loi B, Tarantini G, Pisano F, Durante A, Pasquetto G, Colombo A, Tumminello G, Moretti L, Calabrò P, Mazzarotto P, Varricchio A, Tespili M, Latini RA, Defilippi G, Corrado D, Steffenino G; RAI Investigators. Thirty-Day Outcomes After Unrestricted Implantation of Bioresorbable Vascular Scaffold (from the Prospective RAI Registry). Am J Cardiol 2017;119:1924-30. [PMID: 28438304 DOI: 10.1016/j.amjcard.2017.03.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
643 Mantovani A, Bonapace S, Lunardi G, Salgarello M, Dugo C, Canali G, Byrne CD, Gori S, Barbieri E, Targher G. Association between plasma ceramides and inducible myocardial ischemia in patients with established or suspected coronary artery disease undergoing myocardial perfusion scintigraphy. Metabolism 2018;85:305-12. [PMID: 29777715 DOI: 10.1016/j.metabol.2018.05.006] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
644 Sakalaki M, Barywani S, Rosengren A, Björck L, Fu M. Determinants of suboptimal long-term secondary prevention of acute myocardial infarction: the structural interview method and physical examinations. BMC Cardiovasc Disord 2019;19:243. [PMID: 31694556 DOI: 10.1186/s12872-019-1238-5] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
645 Chen R, Liu C, Zhou P, Tan Y, Sheng Z, Li J, Zhou J, Chen Y, Song L, Zhao H, Yan H. Prognostic Value of D-dimer in patients with acute coronary syndrome treated by percutaneous coronary intervention: a retrospective cohort study. Thromb J 2021;19:30. [PMID: 33962644 DOI: 10.1186/s12959-021-00281-y] [Reference Citation Analysis]
646 Kalarus Z, Svendsen JH, Capodanno D, Dan GA, De Maria E, Gorenek B, Jędrzejczyk-Patej E, Mazurek M, Podolecki T, Sticherling C, Tfelt-Hansen J, Traykov V, Lip GYH, Fauchier L, Boriani G, Mansourati J, Blomström-Lundqvist C, Mairesse GH, Rubboli A, Deneke T, Dagres N, Steen T, Ahrens I, Kunadian V, Berti S. Cardiac arrhythmias in the emergency settings of acute coronary syndrome and revascularization: an European Heart Rhythm Association (EHRA) consensus document, endorsed by the European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Acute Cardiovascular Care Association (ACCA). Europace 2019;21:1603-4. [PMID: 31353412 DOI: 10.1093/europace/euz163] [Cited by in Crossref: 22] [Cited by in F6Publishing: 20] [Article Influence: 11.0] [Reference Citation Analysis]
647 Twerenbold R, Boeddinghaus J, Mueller C. Update on high-sensitivity cardiac troponin in patients with suspected myocardial infarction. European Heart Journal Supplements 2018;20:G2-G10. [DOI: 10.1093/eurheartj/suy020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
648 Keller K, Beule J, Balzer JO, Dippold W. Right bundle branch block and SIQIII-type patterns for risk stratification in acute pulmonary embolism. J Electrocardiol 2016;49:512-8. [PMID: 27083328 DOI: 10.1016/j.jelectrocard.2016.03.020] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
649 Inzitari R, Vencken S, Daghfal D, McAuley K, McDermott A, Galligan M, Doran P. Time-related performance characteristics of high-sensitivity troponin I assay using manufacturer's controls and reagents. Pract Lab Med 2021;25:e00217. [PMID: 33898687 DOI: 10.1016/j.plabm.2021.e00217] [Reference Citation Analysis]
650 Sandoval Y, Jaffe AS. Raising the Bar for Clinical Cardiac Troponin Research Studies and Implementation Science. Circulation 2021;143:2225-8. [PMID: 34097442 DOI: 10.1161/CIRCULATIONAHA.121.054926] [Reference Citation Analysis]
651 Pizarro C, Herweg-Steffens N, Buchenroth M, Schulte W, Schaefer C, Hammerstingl C, Werner N, Nickenig G, Skowasch D. Invasive coronary angiography in patients with acute exacerbated COPD and elevated plasma troponin. Int J Chron Obstruct Pulmon Dis 2016;11:2081-9. [PMID: 27695304 DOI: 10.2147/COPD.S110746] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
652 Gradolí J, Vidal V, Brady AJ, Facila L. Anticoagulation in Patients with Ischaemic Heart Disease and Peripheral Arterial Disease: Clinical Implications of COMPASS Study. Eur Cardiol 2018;13:115-8. [PMID: 30697356 DOI: 10.15420/ecr.2018.12.2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
653 Gupta K, Khan A, Kumar M, Sawalha K, Abozenah M, Singhania R. Readmissions Rates After Myocardial Infarction for Gastrointestinal Bleeding: A National Perspective. Dig Dis Sci 2021;66:751-9. [PMID: 32436123 DOI: 10.1007/s10620-020-06315-1] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
654 Trantalis G, Aggeli K, Toutouzas K, Synetos A, Latsios G, Drakopoulou M, Penesopoulou V, Patsa C, Tousoulis D. The prognostic value of CHA2DS2-VASc and GRACE risk scores in patients with ACS. Hellenic J Cardiol 2019;60:305-8. [PMID: 29601955 DOI: 10.1016/j.hjc.2018.03.001] [Cited by in Crossref: 5] [Article Influence: 1.3] [Reference Citation Analysis]
655 Cha JJ, Son TD, Ha J, Kim JS, Hong SJ, Ahn CM, Kim BK, Ko YG, Choi D, Hong MK, Jang Y. Optical coherence tomography-based machine learning for predicting fractional flow reserve in intermediate coronary stenosis: a feasibility study. Sci Rep 2020;10:20421. [PMID: 33235309 DOI: 10.1038/s41598-020-77507-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
656 Montenegro Sá F, Carvalho R, Ruivo C, Santos LG, Antunes A, Soares F, Belo A, Morais J; Portuguese Registry of Acute Coronary Syndrome Investigators. Beta-blockers for post-acute coronary syndrome mid-range ejection fraction: a nationwide retrospective study. Eur Heart J Acute Cardiovasc Care 2019;8:599-605. [PMID: 30714389 DOI: 10.1177/2048872619827476] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
657 Williams T, Condon J, Davies A, Brown J, Matheson L, Warner T, Savage L, Boyle A, Collins N, Inder K. Nursing-led ultrasound to aid in trans-radial access in cardiac catheterisation: a feasibility study. J Res Nurs 2020;25:159-72. [PMID: 34394621 DOI: 10.1177/1744987119900374] [Reference Citation Analysis]
658 Kim MC, Ahn Y, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Cho JG, Kim D, Lee K, Jeong I, Cho YS, Jung YH, Jeung KW. Benefit of Extracorporeal Membrane Oxygenation before Revascularization in Patients with Acute Myocardial Infarction Complicated by Profound Cardiogenic Shock after Resuscitated Cardiac Arrest. Korean Circ J 2021;51:533-44. [PMID: 34085425 DOI: 10.4070/kcj.2020.0499] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
659 Gilchrist IC, Awuor SO, Davies RE, Ukaigwe AC. Controversies in complex percutaneous coronary intervention: radial versus femoral. Expert Rev Cardiovasc Ther 2017;15:695-704. [PMID: 28730857 DOI: 10.1080/14779072.2017.1358613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
660 Shahid I, Nizam MA, Motiani V, Menezes RG, Naeem U, Siddiqi TJ, Rizwan T, Makhdom F, Ram P, Usman MS. Efficacy and Safety of Oral P2Y12 Inhibitors in Older Patients with Acute Coronary Syndrome: A Frequentist Network Meta-Analysis. Drugs Aging 2021;38:1003-16. [PMID: 34664214 DOI: 10.1007/s40266-021-00896-w] [Reference Citation Analysis]
661 Ohman EM, Roe MT, Steg PG, James SK, Povsic TJ, White J, Rockhold F, Plotnikov A, Mundl H, Strony J, Sun X, Husted S, Tendera M, Montalescot G, Bahit MC, Ardissino D, Bueno H, Claeys MJ, Nicolau JC, Cornel JH, Goto S, Kiss RG, Güray Ü, Park D, Bode C, Welsh RC, Gibson CM. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial. The Lancet 2017;389:1799-808. [DOI: 10.1016/s0140-6736(17)30751-1] [Cited by in Crossref: 124] [Cited by in F6Publishing: 40] [Article Influence: 24.8] [Reference Citation Analysis]
662 Rodwin BA, Lu D, Giaimo A, Annapureddy A, Daggubati R, Curtis J, Sciria CT, Wang TY, Desai NR. Patient and hospital characteristics associated with ticagrelor uptake in acute MI: An analysis of the Chest Pain–MI Registry. International Journal of Cardiology 2020;304:14-20. [DOI: 10.1016/j.ijcard.2020.01.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
663 Tantry US, Navarese EP, Myat A, Chaudhary R, Gurbel PA. Combination oral antithrombotic therapy for the treatment of myocardial infarction: recent developments. Expert Opinion on Pharmacotherapy 2018;19:653-65. [DOI: 10.1080/14656566.2018.1457649] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
664 Stoyanov KM, Hund H, Biener M, Gandowitz J, Riedle C, Löhr J, Mueller-Hennessen M, Vafaie M, Katus HA, Giannitsis E. RAPID-CPU: a prospective study on implementation of the ESC 0/1-hour algorithm and safety of discharge after rule-out of myocardial infarction. Eur Heart J Acute Cardiovasc Care 2020;9:39-51. [PMID: 31298551 DOI: 10.1177/2048872619861911] [Cited by in Crossref: 27] [Cited by in F6Publishing: 21] [Article Influence: 9.0] [Reference Citation Analysis]
665 Rasia M, Solinas E, Marino M, Guastaroba P, Menozzi A, Cattabiani MA, Tadonio I, De Palma R, Vignali L. Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry. J Thromb Thrombolysis 2017;44:466-74. [PMID: 28994036 DOI: 10.1007/s11239-017-1567-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
666 Kanic V, Kompara G, Suran D, Ekart R, Bevc S, Hojs R. Impact of KDIGO-Defined Acute Kidney Injury on Mortality after Percutaneous Coronary Intervention for Acute Myocardial Infarction. Cardiorenal Med 2018;8:332-9. [PMID: 30223269 DOI: 10.1159/000492287] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
667 Vranckx P, Frigoli E, Rothenbühler M, Tomassini F, Garducci S, Andò G, Picchi A, Sganzerla P, Paggi A, Ugo F, Ausiello A, Sardella G, Franco N, Nazzaro M, de Cesare N, Tosi P, Falcone C, Vigna C, Mazzarotto P, Di Lorenzo E, Moretti C, Campo G, Penzo C, Pasquetto G, Heg D, Jüni P, Windecker S, Valgimigli M; MATRIX Investigators. Radial versus femoral access in patients with acute coronary syndromes with or without ST-segment elevation. Eur Heart J 2017;38:1069-80. [PMID: 28329389 DOI: 10.1093/eurheartj/ehx048] [Cited by in Crossref: 35] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
668 Täger T, Giannitsis E, Greve K, Fröhlich H, Müller-hennessen M, Vafaie M, Katus HA, Frankenstein L, Biener M. Long-term biological variation of high-sensitivity cardiac troponin T using minimal important differences and reference change values in stable outpatients with cardiovascular disease. Clinical Biochemistry 2019;67:7-11. [DOI: 10.1016/j.clinbiochem.2019.03.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
669 Vas PRJ, Edmonds M, Kavarthapu V, Rashid H, Ahluwalia R, Pankhurst C, Papanas N. The Diabetic Foot Attack: “’Tis Too Late to Retreat!”. The International Journal of Lower Extremity Wounds 2018;17:7-13. [DOI: 10.1177/1534734618755582] [Cited by in Crossref: 43] [Cited by in F6Publishing: 28] [Article Influence: 10.8] [Reference Citation Analysis]
670 Xue S, Zhu W, Liu D, Su Z, Zhang L, Chang Q, Li P. Circulating miR-26a-1, miR-146a and miR-199a-1 are potential candidate biomarkers for acute myocardial infarction. Mol Med 2019;25:18. [PMID: 31092195 DOI: 10.1186/s10020-019-0086-1] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
671 Moumneh T, Richard-jourjon V, Friou E, Prunier F, Soulie-chavignon C, Choukroun J, Mazet-guilaumé B, Riou J, Penaloza A, Roy P. Reliability of the CARE rule and the HEART score to rule out an acute coronary syndrome in non-traumatic chest pain patients. Intern Emerg Med 2018;13:1111-9. [DOI: 10.1007/s11739-018-1803-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
672 Collinson P, Suvisaari J, Aakre KM, Baum H, Duff CJ, Gruson D, Hammerer-Lercher A, Pulkki K, Stankovic S, Langlois MR, Apple FS, Laitinen P; EFLM Task Group on Cardiac Markers. How Well Do Laboratories Adhere to Recommended Guidelines for Cardiac Biomarkers Management in Europe? The CArdiac MARker Guideline Uptake in Europe (CAMARGUE) Study of the European Federation of Laboratory Medicine Task Group on Cardiac Markers. Clin Chem 2021;67:1144-52. [PMID: 34061171 DOI: 10.1093/clinchem/hvab066] [Reference Citation Analysis]
673 Pinaire J, Aze J, Bringay S, Poncelet P, Genolini C, Landais P. Hospital healthcare flows: A longitudinal clustering approach of acute coronary syndrome in women over 45 years. Health Informatics J 2021;27:14604582211033020. [PMID: 34474603 DOI: 10.1177/14604582211033020] [Reference Citation Analysis]
674 Ou Y, Sun SJ, Shi HM, Luo JF, Luo XP, Shen YZ, Chen YF, Fan WH, Liu HY, Shen W. Protective Effects of Salvianolate on Myocardial Injury or Myocardial Infarction after Elective Percutaneous Coronary Intervention in NSTE-ACS Patients: A Randomized Placebo-Controlled Trial. Chin J Integr Med 2020;26:656-62. [PMID: 32572777 DOI: 10.1007/s11655-020-2728-0] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
675 Ma W, Liang Y, Zhu J. Early Invasive Versus Initially Conservative Strategy in Elderly Patients Older Than 75 Years with Non-ST-Elevation Acute Coronary Syndrome: A Meta-Analysis. Heart Lung Circ 2018;27:611-20. [PMID: 28802810 DOI: 10.1016/j.hlc.2017.06.725] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
676 Doll JA, Wang TY, Choudhry NK, Cannon CP, Cohen DJ, Fonarow GC, Henry TD, Bhandary DD, Khan N, Davidson-Ray LD, Anstrom K, Peterson ED. Rationale and design of the Affordability and Real-world Antiplatelet Treatment Effectiveness after Myocardial Infarction Study (ARTEMIS): A multicenter, cluster-randomized trial of P2Y12 receptor inhibitor copayment reduction after myocardial infarction. Am Heart J 2016;177:33-41. [PMID: 27297847 DOI: 10.1016/j.ahj.2016.04.008] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
677 Ferrer-Sargues FJ, Fabregat-Andrés Ó, Martínez-Hurtado I, Salvador-Coloma P, Martínez-Olmos FJ, Lluesma-Vidal M, Biviá-Roig G, Segrera-Rovira MJ, Arguisuelas MD, Valtueña-Gimeno N. Effects of neuromuscular training compared to classic strength-resistance training in patients with acute coronary syndrome: A study protocol for a randomized controlled trial. PLoS One 2020;15:e0243917. [PMID: 33362223 DOI: 10.1371/journal.pone.0243917] [Reference Citation Analysis]
678 Manckoundia P, Buzens JB, Mahmoudi R, d'Athis P, Martin I, Laborde C, Menu D, Putot A. The prescription of antiplatelet medication in a very elderly population: An observational study in 15 141 ambulatory subjects. Int J Clin Pract 2017;71. [PMID: 28940596 DOI: 10.1111/ijcp.13020] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
679 Wu TT, Yang DL, Li H, Guo YS. Development and validation of a nomogram to predict in-hospital cardiac arrest among patients admitted with acute coronary syndrome. Am J Emerg Med 2021;49:240-8. [PMID: 34153931 DOI: 10.1016/j.ajem.2021.05.082] [Reference Citation Analysis]
680 Fileti L, Vecchio S, Moretti C, Reggi A, Aquilina M, Balducelli M, Santarelli A, Grosseto D, Piovaccari G, Rubboli A. Impact of the COVID-19 pandemic on coronary invasive procedures at two Italian high-volume referral centers. J Cardiovasc Med (Hagerstown) 2020;21:869-73. [PMID: 33009170 DOI: 10.2459/JCM.0000000000001101] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
681 Abell JE, Laing SM, Barker TC, Norry EC, Starzyk K, Goodman SG, Dellborg M, Steg PG, Giugliano RP. Adjunctive use of anticoagulants at the time of percutaneous coronary intervention in patients with an acute coronary syndrome treated with fondaparinux: a multinational retrospective review. Eur Heart J Cardiovasc Pharmacother 2017;3:214-20. [PMID: 28430984 DOI: 10.1093/ehjcvp/pvx007] [Cited by in Crossref: 2] [Article Influence: 0.4] [Reference Citation Analysis]
682 Lidón RM. Domino Effect in Quality of Care: Improving One Aspect of a Disease Can Improve Its Entire Spectrum. Rev Esp Cardiol (Engl Ed) 2016;69:730-1. [PMID: 27349878 DOI: 10.1016/j.rec.2016.04.029] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
683 Wouters LTCM, Zwart DLM, Erkelens DCA, De Groot E, van Smeden M, Hoes AW, Damoiseaux RAMJ, Rutten FH. Gender-stratified analyses of symptoms associated with acute coronary syndrome in telephone triage: a cross-sectional study. BMJ Open 2021;11:e042406. [PMID: 34172542 DOI: 10.1136/bmjopen-2020-042406] [Reference Citation Analysis]
684 Cwikiel J, Seljeflot I, Fagerland MW, Wachtell K, Arnesen H, Berge E, Flaa A. High-sensitive cardiac Troponin T and exercise stress test for evaluation of angiographically significant coronary disease. Int J Cardiol 2019;287:1-6. [PMID: 31006595 DOI: 10.1016/j.ijcard.2019.04.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
685 Turcato G, Cervellin G, Bonora A, Prati D, Zorzi E, Ricci G, Salvagno GL, Maccagnani A, Lippi G. Red Blood Cell Distribution Width Improves Reclassification of Patients Admitted to the Emergency Department with Acute Decompensated Heart Failure. J Med Biochem 2018;37:299-306. [PMID: 30598626 DOI: 10.1515/jomb-2017-0054] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
686 Savonitto S, Morici N. Risk stratification vs routine intensive care stay in non ST segment elevation myocardial infarction (NSTEMI). Eur J Intern Med 2020;76:26-7. [PMID: 32334858 DOI: 10.1016/j.ejim.2020.04.011] [Reference Citation Analysis]
687 Zachariah G, Ramakrishnan S, Das MK, Jabir A, Jayagopal PB, Venugopal K, Mani K, Khan AK, Malviya A, Gupta A, Goyal A, Singh BP, Mohan B, Bharti BB, Majumder B, Wilson B, Karunadas CP, Meena CB, Manjunath CN, Cibu M, Roy D, Choudhary D, Das DR, Sarma D, Girish MP, Wander GS, Wardhan H, Ezhilan J, Tummala K, Katyal VK, Goswami K, Subramanyam K, Goyal KK, Kumar K, Pathak LA, Bansal M, Mandal M, Gupta MD, Khanna NN, Hanumanthappa NB, Bardoloi N, Modi N, Naik N, Hasija PK, Kerkar P, Bhattacharyya PJ, Gadkari P, Chakraborthy RN, Patil RR, Gupta R, Yadav R, Murty RS, Nath RK, Sivakumar R, Sethi R, Baruah R, Tyagi S, Guha S, Krishnappa S, Kumar S, Routray SN, Tewari S, Ray S, Reddy SS, Chandra S, Gupta SB, Chatterjee SS, Siddiqui KKH, Sivabalan M, Yerram S, Kumar S, Nagarajan S, Devasia T, Jadhav U, Narain VS, Garg VK, Gupta VK, Prabhakaran D, Deb PK, Mohanan PP; CSI-AMI Study group. Changing pattern of admissions for acute myocardial infarction in India during the COVID-19 pandemic. Indian Heart J 2021;73:413-23. [PMID: 34474751 DOI: 10.1016/j.ihj.2021.06.003] [Reference Citation Analysis]
688 Vignoli A, Tenori L, Giusti B, Takis PG, Valente S, Carrabba N, Balzi D, Barchielli A, Marchionni N, Gensini GF, Marcucci R, Luchinat C, Gori AM. NMR-based metabolomics identifies patients at high risk of death within two years after acute myocardial infarction in the AMI-Florence II cohort. BMC Med. 2019